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Summary 
The aim of the work presented in this thesis was to explore the structural and molecular 
features of a filamentous bacteriophage for incorporation in biosensing platforms. To 
tune the bacteriophage surface as a scaffold for molecular recognition, chemical and 
biological protocols aimed at controlling and enhancing its intrinsic properties were 
developed. A key part of the work was aimed at anchoring bacteriophage particles by 
one-end to surfaces, and on labelling its viral capsid with dyes, antibodies and DNA 
molecules. The tolerance of the bacteriophage for modifications, as well its simplicity 
and robustness, makes it an attractive probe for biosensors. Furthermore, the 
filamentous structure of the bacteriophage was demonstrated to be a valuable feature in 
both microscopy- and spectroscopy-based biosensors. The ability of the bacteriophage 
to align under flow was considered as a simple, yet efficient approach for the detection 
of wall shear stress and pathogenic bacteria.  
 
A novel method to detect wall shear stress (WSS) was developed by using a 
fluorescently decorated bacteriophage particle anchored by one-end to a surface. The 
response of this filamentous nanosensor to flow variations was tracked under a 
microscope, and gave valuable information on the shear flow of a fluid passing over a 
surface. Using a custom-made analysis tool and an algorithm, we were able to derive the 
wall shear stress on the point of attachment of the nanosensor, using endothelial cells as 
a model system. The proof-of-concept to this work highlighted how a simple 
bacteriophage construct can be use as a nanosensor for imaging and mapping flow.   
 
Linear dichroism (LD) spectroscopy also explores the high aspect ratio of the 
filamentous bacteriophage. Linear Diagnostics Ltd., a startup company in Birmingham, 
exploits the natural LD properties of the bacteriophage and integrated it with a 
biosensing platform targeting pathogenic bacteria. The work reported in this thesis 
mainly focused on developing alternative approaches that could improve the biosensor 
sensitivity and simplicity, by modifying the bacteriophage scaffold, further 
demonstrating its versatility.  
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_________________________________________________________________"Chapter"1"
CHAPTER 1 – Introduction 
 
1.1 Historical overview of bacteriophage research  
The word “bacteriophage” means bacteria eater – bacteriophages, or simply 
phages, are a type of virus that infect bacteria. These ancient and diverse 
biological machines are one of the most abundant microbes in the biosphere and 
are ubiquitous in nature [1]. A large number of phage particles have been found 
in the sea, soil, and human gastrointestinal systems. For example, it has been 
reported that phages are the most abundant entity in seawater, exceeding the 
number of bacteria present by 5−25 fold [2,3]. Since their discovery, in the early 
decades of the twentieth century, phages have been of great interest to the 
scientific community as tool for the understanding of molecular biology and as 
powerful biomaterial.  
 
During the World War I, the newly established hospital of the Institut Pasteur, 
an institution primarily dedicated to the study of infectious diseases, was 
investigating a devastating outbreak of dysentery in Paris [4]. The 
microbiological studies were assigned to Félix d’Hérelle, a biologist at the 
Institut, because of his interest in gastrointestinal diseases and experience on 
enteric bacteriology. By analysing stool samples from dysentery patients, 
d’Hérelle discovered “an invisible microbe antagonistic to the dysentery bacillus” 
[5]. He named this “invisible microbe” a bacteriophage, and, during his 
experiments, he established a correlation between the amount of bacteriophage in 
a stool sample and the stage of dysentery infection − bacteriophage titers peaked 
just as the patient started to recover. This led him to suspect that the 
bacteriophage has a biological protective role against the pathogenic bacteria, and 
therefore, the recovery of the patients might have been bacteriophage-mediated. 
D’Hérelle continued his studies on dysentery in humans, and carried 
identification and characterisation of the bacteria. While doing so, he discovered 
that something on these samples was causing lysis of the dysentery bacillus. 
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D’Hérelle, intrigued about this seemly antimicrobial substance, developed novel 
experimental protocols and devised theories to explain the nature of this material. 
His two-page paper, published in September 1917, described the necessary 
procedures to isolate the “invisible microbe” from stool samples of humans 
infected with dysentery bacillus. In a creative leap, d’Hérelle discovered that 
adding a few drops of the isolated “invisible microbe” to a fresh bacterial culture 
clears the culture solution, and that a few drops of this cleared culture has the 
same effect on another fresh bacterial culture. To d’Hérelle, this was evidence 
that the bacteriophage was destroying the bacteria [6].  
 
D’Hérelle is commonly considered the father of bacteriophage research, and 
indeed he actively recognised the importance of this new biological entity. 
However, there is some controversy on who discovered it first [7]. Two years 
earlier (1915), independently from d’Hérelle’s initial findings, a British 
microbiologist named Twort, documented a “patchy and glassy” dissolution on 
some bacterial cultures he was experimenting on. Twort published his 
observations on the “transmissible bacterial lysis” [8], similarly to d’Hérelle, but 
did not pursuit this line of investigation any further. Indeed, phage therapy (term 
referred to the use of phage to treat bacterial infectious) was an idea uniquely 
initiated by d’Hérelle. Moreover, his work was the seed to many of the future 
advancements in molecular biology.  
 
Although d’Hérelle recognised the potential of the bacteriophage as an 
antibacterial agent, the basic ecology of the phage has poorly understood at the 
time, and the results obtained were conflicting and subjected to criticism. Phage 
therapy was later eclipsed by the discovery of effective antibiotics, such as 
penicillin. Recently however, phage therapy was been revived as a potential 
method to circumvent antimicrobial resistance. The Eliava Institute, in Georgia, 
is one of the major centres in bacteriophage research currently developing phage-
based treatments for various bacterial pathogens. The main application of the 
Eliava phages is directed for the treatment of gastrointestinal, gynaecological, 
respiratory and dermatological problems. A different group of researchers, from 
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University of California, recently communicated that they have developed an 
intravenous phage cocktail that successfully treated a terminally-ill patient 
infected with a multi-drug resistant bacteria [9]. 
 
It was not until around the 1940s that scientists across laboratories began to 
understand the usefulness of the bacteriophage biology. The phage was 
recognised as an appropriate model for a number of experimental systems, 
leading to breakthrough discoveries in molecular biology. It started with a 
collaboration between Emory Ellis and Max Delbrück, responsible for the early 
findings on phage growth conditions [10]. Soon, several others merged with Ellis 
and Delbrück, forming the “phage group”. The 40’s and the 50’s were the golden 
age for molecular biology, in large part due to the collaborative interactions 
between members of the “phage group”. Until 1943, it was unknown that 
bacteria had genetic material. It was Delbrück and Salvador Luria who, in 1943, 
explained that bacterial resistance to phages (and antibiotics) are genetically 
inherited mutations, revealing that natural selection principles are applicable to 
bacteria [11]. It was also Luria who, in 1946, pioneered the concepts of genetic 
recombination and DNA repair, by discovering that phage can repair damages 
inflicted by UV irradiation [12]. James Watson, one of the Nobel Prize winners 
for the Watson-Crick DNA molecular structure, was in fact one of Luria’s 
graduate students working at the time on phage genetic recombination. In 1952, 
a series of experiments from Alfred Hershey and Martha Chase supported 
previous and subsequent claims that it is the DNA, and not the proteins, that 
carry genetic information, by showing that the DNA of the phage enters the host 
bacterial cell [13]. Restriction enzymes, essential in genetic engineering, 
originated from studies on a phage system. The phenomenon was first identified 
in the early 1950’s by Luria and Giuseppe Bertani, and further explored in the 
1960’s by Werner Arber and Matthew Meselson [14-17]. In 1954, François 
Jacob and Elie Wollman at Institut Pasteur established the relationship between 
prophage and the genetic material in bacterium. Building from that success, 
François Jacob, jointly with Jacques Monod and André Lwoff, proposed the 
concepts of messenger RNA, operons and regulator genes, developing the field 
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of transcriptional regulation [18-20]. In 1961, at the Cavendish Laboratory in 
Cambridge, Sydney Brenner, Francis Crick and others demonstrated the basic 
nature of the genetic code, unveiling its triplet nature, by using a phage gene 
[21].  
 
Bacteriophages have laid the foundation for molecular biology, helping to 
understand the building blocks and the molecular basis of life itself. Molecular 
biology gave rise to the synthetic biology and biotechnology movement, which 
envisions integrating fundamental, but complex, biological concepts into simple 
designs, to address bioengineering challenges. As explored in section 1.3, the 
bacteriophage became preeminent as a programmable scaffold, originating 
unique biomaterials with multiple nanotechnology applications. 
 
 
1.2 Bacteriophage classification 
Bacteriophages are composed of nucleic acids (DNA or RNA) and a protein 
capsid, with diverse morphologies. Some are tailed with an isometric capsid, 
while others have a filamentous capsid and do not possess a tail. Colloquially, 
phages can be organised in three major categories, based on their life cycle and 
morphology [22-25]:  
 i) lytic or productive phages, such as T7, T4 and MS2 phages, which 
cause bacteria cell lysis and death upon release of the newly synthesised virion 
particles;  
 ii) temperate or lysogenic phages, such as λ phage, which can either 
multiply via a lytic cycle or by lysogeny, incorporating their genetic material into 
the bacterial genome and producing a latent state phage (prophage);  
 iii) filamentous phages, such as f1, fd and M13 phages, which are 
commonly considered lysogenic phages that do not lyse their host cells.  
 
A more comprehensive and detailed classification is done by the International 
Committee on Taxonomy of Viruses (ICTV), which organises phages primarily 
based on the nature of their genomes – single or double stranded, circular or 
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linear, with varying sizes ranging from 5 kilobases to 725 kilobases [26,27]. As of 
2017, there are 19 recognised families of bacteriophage. The Myoviridae, 
Siphoviridae and Podoviridae families are composed of double-stranded DNA 
tailed virions, and represent 96% of all identified bacteriophages [28]. The seven 
T phages (denoted T1-T7) belong to these families, and are complex and large 
biological assemblies, often used as a biotechnology tool. Indeed, most of the 
discoveries by the “phage group” derived from these phages. Phages from the 
Microviridae and Inoviridae families are composed of single-stranded circular 
DNA. The Microviridae have an icosahedral capsid, while the Inoviridae are 
filamentous. All the work presented in this thesis is done in phages from the 
Inoviridae family.  
 
1.2.1 Filamentous bacteriophage  
Over the past 50 years, the structure and life cycle of the filamentous phages has 
been extensively investigated, as reviewed here [29,30]. The interest in 
filamentous phages grew from recognising the potential of their unique structural 
and biological properties – it was noticed that filamentous phage could display 
peptides on their surface when their genome was modified. This technology, 
invented in the 80’s by Smith and colleagues, was named phage display [31,32]. 
The link between genetic material and display of a functional protein allowed for 
the design of screening libraries platforms [33-36], currently widely used for 
studying protein-protein interactions.  
 
Compared to tailed phages, whose DNA is over 200 kilobases long, filamentous 
phages are fairly simple structures. All filamentous phage strains have a similar 
structure and life cycle. They are composed of a few different proteins assembled 
into ordered arrays that encapsulate the viral genome, forming a long thread-
shaped particle. Contrary to most tailed phages, which have on average a 50/50 
ratio of protein and nucleic acid, filamentous phages have a higher proteic 
content with only 6−21% (by weight) of its components being from DNA [27]. 
The first discovered filamentous phage, f1, was isolated in the 1960’s [37] and 
characterised as being part of the Ff phage class, which also includes the best-
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studied M13 and fd phages. These phages, sharing a > 98% genome homology 
[38], are non-lytic and specific for the Escherichia coli conjugative F episome [39-
42]. It was later discovered the existence of filamentous phages, If and Ike, that 
do not need the F pilus to infect the bacterial host [43,44]. The list of discovered 
filamentous phages keeps growing and it includes more than 60 different virions 
[45]. In this thesis, all experimental work will be carried on the M13 and fd 
phages.  
 
The M13 and fd bacteriophages have similar architectures and biophysical 
properties – a thin and long cylindrical particle (Fig. 1.1) with a diameter of 
approximately 6 nm and length of 900 nm, encapsulating a 6407 nucleotides viral 
genome containing eleven protein-coding sequences [30]. Five of these are 
structural proteins; the remaining six proteins are fundamental for the life cycle 
of the phage, but are not present in the viral capsid. The viral capsid is made of 
2700 copies of the major coat protein (p8) capped at both ends by 3-5 copies of 
each minor coat protein (p3 and p6; p7 and p9) (depending on the reference, 
these proteins can be denoted as gp8/gp3/gp6/gp7/gp9, or 
pVIII/pIII/pVI/pVII/pIX) [46-48]. Each p8 protein is a helical 50 amino acid 
long peptide, with the C-terminus interacting with the viral genome and the N-
terminal end exposed to the surface. Neighbouring p8 subunits are connected by 
hydrophobic interactions, and packed in an approximately 20 ° orientation along 
the long axis. The p8 proteins assembly forms a hollow tube, which encloses the 
single-stranded circular DNA [49,50]. The p3 minor protein is the largest 
protein of the viral capsid – a 406 amino acid peptide − and it is responsible for 
the infectivity of the phage. It is composed of three domains, separated by 
glycine-rich linkers, which are involved in the binding of the phage to the 
bacteria surface [38,51-53]. Each p3 protein, containing cysteine residues, is 
stabilised by disulfide bridges [54,55]. 
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Figure 1.1: Transmission electron microscopy (TEM) image of a filamentous 
bacteriophage [56]. 
 
 
As mentioned above, phages from the Ff class can only infect E. coli bacteria that 
express the F pilus, essential for bacterial conjugation. Although filamentous 
phages are not lytic, they hijack the bacterial host machinery during their 
lifecycle [38]. The p3 protein binds to the F pilus, anchoring the phage particle 
closer to the bacterial cell surface. This binding promotes depolymerisation of 
the phage coat proteins, which gather in the bacterial inner membrane, and 
mediates the entry of the phage genomic material into the cytoplasm of the 
bacteria. The viral DNA is replicated and additional phage coat proteins are 
synthesised – the single-stranded viral DNA gets converted into an intermediate 
double-stranded template (termed RF, replicative form), and it is replicated by 
rolling-circle amplification. This produces several new strands of viral DNA that 
are then packed into new phage particles at the inner membrane. The p7 and p9 
coat proteins start the extrusion of the phage particle from the bacteria through a 
phage-created pore, and in a screw-like motion, the phage is coated with p8 
proteins along its length. The p3 and p6 terminate the assembled viral capsid, 
and the newly created phage progeny gets released from the E. coli cell to the 
surrounding environment, ready to attack a new host cell [38]. Typically, wild-
type Ff filamentous phages lifecycles are very efficient, reaching titers of up to 
1013 phage particles per mL of culture. 
 
1.3 Filamentous phages and nanotechnology  
In recent decades, multiple groups have taken advantage of the filamentous 
phages’ structural, chemical and biological features for the development of 
nanotechnology platforms. Their i) stability to a wide range of pH values, 
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elevated temperatures, proteolytic enzymes, and non-aqueous media; ii) 
straightforward and cost-effective large-scale production; iii) tolerance for 
bioconjugation and surface chemistry manipulation; and iv) simple genetic 
tunability, enable the use of filamentous phages as a powerful scaffold with 
numerous applications [25,57-59].  
 
Perhaps, filamentous phages are best known for their biological role on phage 
display, which has been summarised in several reviews [60-62] and books 
[24,63,64]. In essence, phage display consists of genetically inserting a random 
DNA sequence encoding for a peptide into the phage genome, resulting in the 
expression and display of the peptide onto the phage surface. After several 
biopanning rounds, a target-specific binding peptide will be identified and 
selected from screening a random library. Using this technique, several target-
specific binding peptides have been discovered, which contributed for the 
development of vaccines and antibodies, and protein engineering [45,60,63]. 
Despite its irrefutable impact in modern biotechnology, the applications of 
filamentous bacteriophages go beyond phage display. The use of phages in 
bioassays has been reviewed before [25,65-68]; a brief overview with a few 
examples of phage-based materials integrated in biosensing platforms will be 
shown here. 
 
1.3.1 Filamentous phage-based biosensors  
In the era of personalised medicine, there is a clear demand for early diagnostic 
platforms, meaning there is a constant need for smarter, smaller, faster and 
inexpensive biosensors, which ideally provide both qualitative and quantitative 
information. Biosensors are analytical devices that integrate a biological sensing 
entity with sophisticated physicochemical transducers [69]. Escalating healthcare 
costs allied with consumers demand continuously catapults the biosensors 
market, further promoting the ever-increasing search for novel biomarkers, 
measuring techniques and molecular recognition elements. An essential element 
for any biosensing assay is the probe that binds to a target of interest. 
Traditionally, these probes are antibodies. However, functionalised filamentous 
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phage particles may be used as a substitute, by acting as molecular recognition 
elements in immunoassays sensing for a diverse class of analytes, from single 
molecules to whole cells [70]. The phage surface can be genetically programmed 
and chemically modified with functional molecules, such as peptide motifs [71], 
optical labels [72], antibodies [73], nanoparticles [74], and chemical coupling 
tags [75], and incorporated in conventional analytical methods, for example 
spectroscopy or enzyme-linked immunosorbent assay (ELISA). Commonly, 
functionalised phages can participate in biosensing platforms as biorecognition 
elements for target probing (section 1.3.1.1), or as structural templates for the 
controlled synthesis of nanostructures (section 1.3.1.2). 
 
 
1.3.1.1 Phage as a biorecognition element 
The phage anti-immunocomplex assay (PhAIA) [76,77] is an example of a 
modified ELISA method in which filamentous phages replace detection 
antibodies. Due to their size, small analyte molecules are generally precluded 
from non-competitive two-site sandwich immunoassays, which propelled the 
development of anti-immunocomplex antibodies [78-80]. However, these 
antibodies are difficult to produce, and often result in high cross-reactivity with 
the primary antibody [76]. PhAIA uses phage particles functionalised with an 
anti-analyte peptide fused to its p8 proteins, instead of anti-immunocomplex 
antibodies, to detect the formation of the analyte-antibody immunocomplex. A 
plate is coated with the immunocomplex (i.e. analyte molecules bound to anti-
analyte antibodies) to which the peptide-functionalised phages are added. The 
peptide on the phage binds to the analyte-antibody immunocomplex, which can 
then be detected and visualised by using anti-phage/HRP-conjugated antibodies. 
The authors of the PhAIA work claim that the large surface area of the phage 
increases the overall sensitivity of the assay, as the phage can incorporate a larger 
number of labels compared to single antibodies on a regular ELISA [76]. PhAIA 
has been successfully employed to detect several small molecule pesticides, such 
as molinate [76,81], clomazone [82], phenoxybenzoic acid (PBA) [77,83,84], 
and brominated diphenyl ether 47 (BDE 47) [85], and properly integrated with 
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other analytical methods, for instance, polymerase chain reaction (PCR) [84], 
magneto-electrochemical immunoassay [81], and magnetic beads immunoassays 
[83].  
 
Phage particles displaying target-binding motifs have also been used in 
biosensors for detection and imaging of cancer cells and associated biomarkers. 
Zhang and co-workers designed a peptide-functionalised phage particle capable 
of detecting metastatic cells. These modified phages were immobilised onto the 
surface of a light-addressable potentiometric sensor (LAPS) [86] chip, and were 
shown to detect and distinguish between metastatic and non-metastatic cells in a 
blood sample [87]. In another example, researchers at University of California, 
Berkeley engineered a phage displaying antibodies for epidermal growth factor 
receptor (EGFR), which was used as a probe in a NMR sensor [88] and as an 
imaging agent for flow cytometry [89], to detect EGFR-positive cancer cells. 
Ghosh et al. constructed a phage-templated magnetic nanoparticles engineered 
to display a peptide that targets a glycoprotein overexpressed in various cancers. 
This phage scaffold was used for in vivo imaging of cancer cells in mice [90]. To 
expand the versatility of phage-based probes in oncology, functionalised phages 
could be designed to simultaneously target and deliver an antineoplastic agent to 
tumor cells. To explore this dual modality, a group in MIT built an in vitro 
phage-based platform for targeting prostate cancer cells, as an imaging and drug 
delivery probe [91]. 
 
Detection and identification of food-borne pathogens is another emerging 
application of biosensors. Pacheco-Gomez et al. developed a simple 
immunoassay combining an engineered antibody-binding phage scaffold with 
linear dichroism (LD) spectroscopy, targeting the pathogenic Escherichia coli 
O157 [92]. This LD-based biosensor exploited the differences in the phage 
scaffold optical properties when E. coli cells were present in a sample, generating 
a spectroscopic measurable signal. Another common food-poisoning culprit, 
Salmonella typhimurium, is the target to phage-based magnetoelastic (ME) 
biosensors. Genetically engineered phages displaying Salmonella-binding 
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peptides were immobilised on the ME platform and tested on food samples, such 
as fresh tomatoes [93], spinach leaves [94], milk and apple juice [95]. The 
phage-based ME biosensors showed specificity for Salmonella, and were reported 
to be stable even when exposed to harsh environments [96]. In the near future, 
these low-cost, wireless phage-based ME screening devices could be used in situ 
and integrated at multiple points of the food supply chain to monitor for 
bacterial contamination.  
 
1.3.1.2 Phage as a scaffolding element 
As explored above, phages can serve as a biological template to display probes for 
target recognition. Moreover, the filamentous structure of these phage particles is 
a unique platform for controlled nanosynthesis and assembly [97,98]. The large 
surface area of the phage scaffold can generate amplified signals – the minor 
proteins (generally the 3−5 copies of p3 proteins) are involved in antigen-
binding, while the whole structure of the phage (the ~ 2700 copies of p8 
proteins) are supplemented with functional groups and nanomaterials. Phage-
based ordered nanostructured materials can be exploited for nanotechnology. For 
example, phage nanofibers were modified to build semiconductor nanowires [99-
101], lithium ion batteries [102,103], photovoltaic cells [104] and as a matrix for 
tissue engineering and regenerative medicine [105-109].  
 
Hybrid phage-based macromolecular structures, forming films, matrixes and 
nanowires, can be incorporated with analytical methods for the detection of 
antigens. Researchers at University of California, Irvine built a “virus electrode”, 
consisting of a self-assembled monolayer of phage particles, genetically 
engineered for recognition of an antigen, covalently attached to a gold electrode 
surface [110,111]. Building on this success, the same group grafted the antigen-
specific phages into an array of a conducting polymer named poly(3,4-
ethylenedioxythiophene) (PEDOT). This formed a virus-PEDOT biocomposite 
material for electrochemical detection of prostate cancer biomarkers [112-115]. 
This bio-inorganic hybrid material bridged the electronic applicability of a 
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polymeric backbone with the biorecognition versatility of engineered phage 
particles, into a biosensor platform. Magnetic beads and quantum dots have also 
been used as nanomaterials for constructing phage-based bionanostructures. For 
example, Wang et al. engineered a viral scaffold made of phage particles 
decorated with magnetic nanoparticles for the rapid detection of Candida albicans 
[116]. Jin and co-workers designed a quantum dot-phage template to build a 
hybrid composite film on a biosensing platform for 2,4,6-Trinitrotoluene (TNT) 
[117]. 
 
A network of gold nanoparticles and phages is another example of a 
nanoengineering material [74]. Engineered phages coated with gold 
nanoparticles can be explored as a signal reporter in optical methods, including 
spectroscopy and microscopy techniques, and also as a replacement of specialised 
detection enzymes, such as horseradish peroxidase (HRP), in ELISAs. For 
example, Guo et al. tailored bifunctional phages displaying a gold-binding 
peptide on its p8 proteins and an antibody (as a biorecognition element) on its p3 
proteins [118]. The formation of an immunoaffinity complex, between the phage 
and an antigen, can be optically visualised by adding gold nanoparticles. This 
phage-based immunoassay was designed to identify Bacillus anthracis spores, but 
could be easily adapted to target other antigens by changing the biorecognition 
element on the bifunctional probe. The antigen-binding and signal-generating 
capacity of the bifunctional phage eliminates the need to use secondary 
antibodies with HRP molecules [118]. Another example of the use of gold 
nanoparticles as signalling motifs in phage-based biosensors is given in [119].  
 
Without the need for any specialised detection apparatus, Lee et al. built a 
phage-based sensing platform for protein detection. First, engineered antigen-
binding phages (i.e. containing antigen-binding motifs on its p3 proteins) were 
chemically modified to append thiol groups along its surface. Next, the antigen-
binding thiolated phage was mixed with the antigen and then captured using 
magnetic beads. After elution of the phage-antigen complex from the beads, gold 
nanoparticles are added. A visible, by naked eye, colour change from red to blue, 
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associated with the aggregation of the gold nanoparticles, suggests the presence 
of the antigen. The authors stated that, although a single phage only interacts 
with a few antigen molecules, the multiple binding groups can amplify the 
resulting signal by promoting the aggregation effect of a large number of gold 
nanoparticles. The same researchers later designed a similar optical biosensor 
using chemically DNA-conjugated phages loaded with DNA-coated gold 
nanoparticles [120], and developed a colorimetric bioassay using the DNA 
conjugated to an antigen-binding phage as a probe for the presence of the 
antigen [121]. Surface-enhanced Raman scattering (SERS) spectroscopy can also 
be integrated with phage-based biosensors. This was successfully demonstrated 
here [122], in which DNA-modified phage particles were coupled with DNA-
conjugated SERS nanoparticles. In this set up, SERS nanoparticles cover the 
phages surface as a result of DNA hybridization, creating a phage-templated 
SERS nanoprobe for antigen sensing. Target antigen molecules were first 
captured onto silica microbeads. Next, the DNA-modified phages, which display 
an antigen-binding motif on its p3 proteins, were conjugated to the silica 
microbeads. The DNA-conjugated SERS nanoparticles were then mixed with 
the phage-loaded silica beads. Individual silica beads loaded with the phage-
SERS nanoparticles were later analysed on the Raman instrument, detecting as 
low as 10 pM of the tested antigen. A similar design [123] was tested using gold 
nanocubes, labelled with Raman reporters, and bifunctional phage particles, 
displaying an antibody at one end and gold nanoparticle binding peptides along 
its surface. First, the bifunctional phage was conjugated with the gold nanocubes 
– an average of 10-15 50 nm gold nanocubes were aligned along each phage. 
Next, the target antigen was captured and immobilised on magnetic beads. This 
immunocomplex-bead was then conjugated with the phage-SERS probes, and 
later analysed by SERS spectrometry. 
 
Another interesting property of the filamentous phages is their ability to form 
self-templating supramolecular structures, creating materials with unique optical 
and photonic properties [124-127]. By mechanically pulling substrates from a 
phage suspension at controlled speeds, assembled phage films with different 
	  	   14	  
_________________________________________________________________"Chapter"1"
morphologies and levels of hierarchical organisation were generated. Professor 
Seung-Wuk Lee and researchers from his lab pioneered and tuned this self-
templating process building a bio-inspired colorimetric sensor, coined “Phage 
litmus” [125]. This sensing platform is designed to detect volatile organic 
compounds, TNT and humidity levels. 
  
 
1.4 Scope of work  
As illustrated above, due to its structural and biological simplicity, it is possible 
to chemically and genetically modify the filamentous bacteriophage, and adapt it 
for a template on novel biosensing methods. The research presented here mainly 
focused on the development of innovative bacteriophage-based biosensors. 
Particularly, this thesis focus on work done in two biosensors: 
 i) A proof-of-concept platform for imaging and monitoring flow, targeting 
cardiovascular diseases. For this, we developed novel strategies for 
immobilisation of phage particles onto surfaces, enabling a successful integration 
of a biological scaffold and microfluidics with biosensors. This new methodology 
was adapted for in vitro experiments in endothelial cells, further demonstrating 
the versatility and validity of the system.  
ii) Develop new experimental set-ups for a biotech startup (Linear Diagnostics 
Ltd.) diagnostic platform. Linear Diagnostics’ product is a biosensor that detects 
the presence of a target of interest (e.g. pathogenic bacteria) by exploiting a 
spectroscopy phenomenon. While collaborating with Linear Diagnostics, we 
developed new chemical and biological protocols attempting to make their 
technology simpler, cheaper and more sensitive. 
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CHAPTER 2 – Materials and methods 
 
2.1 General production of bacteriophage 
M13 phage was produced as per the method of Pacheco-Gomez et al. [1], fd 
phage and mosaic phage were produced following Brasino et al. [2]. Typically, a 
250 mL flask containing 40 mL of an aliquot of an overnight E. coli culture 
(TOP10 F’, Invitrogen, or E. coli strain K91Kan, provided by Brasino; see Table 
2.2) in LB broth with tetracycline (5 µg/mL) was inoculated with ~ 10 µL of a 
concentrated phage stock (~ 10 mg/mL), and incubated between 5 and 12 hours 
at 37 °C, 200 rpm. To grow the mosaic phage, IPTG (between 0.1–1 mM) was 
also added to the culture broth.  
 
2.2 Purification of bacteriophage 
2.2.1 PEG/NaCl precipitation 
Following incubation (method 2.1), the phage/bacteria culture was centrifuged 
(Avanti series or Allegra X-22R, Beckman Coulter) at 10,000 × g for 15 minutes. 
The supernatant, containing the phage particles, was collected and a 20% (w/v) 
polyethylene glycol (PEG, Mw= 6000 or 8000), 2.5 M NaCl solution was mixed 
at a 1/5th volumetric ratio to precipitate the phages [3]. This mixture was left at 4 
°C overnight. The next day, the mixture was centrifuged at 10,000 × g for 20 
minutes.  The supernatant containing E. coli cells was removed and discarded, 
and the phage pellet was resuspended in 1 mL of buffer (generally PBS, but it 
depends on the intended experiment) and spun at 22,000 × g for 5 minutes to 
precipitate cellular debris. This step was sometimes repeated one more time. The 
~ 1 mL supernatant was transferred to a fresh eppendorf and mixed with 200 µL 
of the PEG/NaCl stock. The mixture was left at 4 °C for ~ 2 hours. This was 
centrifuged at 22,000 × g for 15 minutes and the phage pellet was resuspended in 
buffer. 
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2.2.2 Caesium chloride purification  
To further purify the bacteriophage, the phage sample was mixed with caesium 
chloride (CsCl) powder to give a final concentration of 0.4 mg/mL of CsCl 
[4,5]. The samples were centrifuged for 24 hours at 35,000 rpm at 15 °C. After 
extraction, the samples were dialysed using 3500 MWCO dialysis tubing 
(Sigma) in 50 mM potassium phosphate buffer pH 8 for 24 hours. This 
purification step was not performed in all phage samples. 
 
2.2.3 Size exclusion chromatography purification  
The M13-Antibody-TRITC and M13-WGA-TRITC constructs (Chapter 4) 
were purified using a size exclusion chromatography (SEC) purification system 
(ÄKTA Explorer 10, GE Healthcare), fitted with a Superdex 200 (120 mL 
column volume) HiLoad 16/60 prepacked column. The column was equilibrated 
with 1 column volume of water and 1.2 column volumes of elution buffer (50 
mM potassium phosphate buffer, 150 mM NaCl, pH 8) before sample injection. 
Three wavelengths were recorded simultaneously (269, 280 and 555 nm). 2 mL 
fractions were collected using a Frac-950 fraction collector (Amersham 
Pharmacia Biotech). These samples were then typically concentrated by PEG 
precipitation. 
 
2.2.4 Desalting columns 
Desalting spin columns (Zeba column, 7K MWCO, 0.5 mL, Thermo Fisher 
Scientific) or gravity flow PD-10 desalting columns (Sephadex G-25, 1 mL–2.5 
mL, GE Healthcare) were used to desalt and remove excess reagents from phage 
samples. 
 
2.3 Estimating bacteriophage concentration 
2.3.1 Bacteriophage plaque assay for phage titer 
Plaque assays measure the ability of a single phage particle to form a plaque on a 
monolayer of susceptible host cells. The turbid plaque is developed as part of the 
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infection of a bacterial cell by one phage, followed by rapid replication of that 
phage. Each formed plaque on a bacterial lawn in a LB/agar plate (method 
2.3.1.1) represents an area of bacteria growth inhibition started by a viral particle. 
Agar restricts movement of the phage particles so that a phage can only infect 
adjacent bacterial cells. There are two commonly used methods for assessing 
phage plaque formation: 
• Double agar overlay method (Fig. 5.4, Chapter 5) [6] 
A lawn of susceptible/host bacterial cells (i.e. E. coli expressing F’ pilus, method 
2.11.3) is mixed with serial dilutions of a phage suspension and grown on the 
surface of a “soft” agar layer (with a “hard” agar layer on the bottom of the plate, 
method 2.11.1). The plates are incubated overnight at 37 °C. This method is the 
most commonly used to determine phage titer in pfu/mL (see below) by 
counting the number of visible phage plaques. 
 
• Droplet method (Fig. 5.4, Chapter 5), adapted from [7] 
10 µL drops of diluted phage suspensions are spotted onto a bacterial lawn 
(method 2.3.1.1). The plates are allowed to dry on a laminar flow hood, and then 
incubated overnight, at 37 °C. 
 
2.3.1.1 Preparing a bacterial lawn plate 
Bacterial lawns [6] were prepared by adding plating cells (E. coli expressing F’ 
pilus) to a LB/agar plate. These plates are made of two layers: ~ 8 mL of a “hard” 
bottom layer (1.5%) and ~ 4 mL of a “soft” top layer (0.7%) (method 2.11.1).  
 
2.3.1.2 Counting and calculating titer in pfu/mL 
The viral activity of the constructed phage particles can be measured in plaque 
forming units (pfu) per mL. For this, one has to count the number of cloudy 
patches (plaques) that formed on the surface of the LB/agar plate. The 
assumption is that each isolated plaque represents one phage particle. A plate 
with between 30 and 300 plaques is selected and the number of plaques is 
manually counted. The titer is determined by dividing the number of plaques 
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with the used dilution factor and the volume of diluted phage stock added to the 
plate.  
 
2.3.2 UV-Vis spectrophotometric phage quantification   
Phage concentration was determined from its absorption spectrum, measured 
using a UV-Visible absorption spectrophotometer (Jasco V-550). The 
concentration of phage (in mg/mL) was then calculated using the Beer-Lambert 
law, based on absorbance at 269 nm, arising from a combination of peptide and 
DNA absorbance [8], and the extinction coefficient, which was experimentally 
determined to be 3.84 cm2 mg-1 for the wild-type phage [9]. The molecular 
weight of the wild-type phage is ~ 17×106 Da [10]. The concentration of phage 
in number of virions/mL was calculated from the formula as per [11].  
2.4 Bioconjugation protocols 
2.4.1 p3 chemical modifications 
2.4.1.1 Bioconjugation with antibody 
Anti-collagen antibodies were selectively conjugated to the ~ 5 copies of p3, at 
one end of the M13, by using reducing conditions to break the disulfide bonds of 
the p3 proteins. 2000× molar excess of tris(2-carboxyethyl)phosphine 
hydrochloride (TCEP, Sigma) in 100 mM phosphate buffer pH 7.5 was added 
to an initial mass of M13 (5.8×10–8 mmoles) in order to reduce p3 proteins 
(2.9×10–7 mmoles). The sample was incubated for 1 hour at room temperature. 
The reduced M13 samples were purified by using a PD-10 column (Sephadex 
G-25, GE Healthcare) and eluted in conjugation buffer (50 mM potassium 
phosphate buffer, 150 mM NaCl, 5 mM EDTA buffer, pH 7). The anti-
collagen antibody (abcam, ab19808) was then derivatised with maleimide. 
Succinimidyl-4-(N-maleimidomethyl cyclohexane-1-carboxylate (SMCC, 
Thermo Scientific Pierce) was added to the anti-collagen antibody in a 25× 
molar excess. The modified anti-collagen antibody was added in a 1:1 ratio over 
the p3 proteins. The sample was incubated for 2 hours and eluted in the 
conjugation buffer using a PD-10 column. Finally, the maleimide-derivatised 
	  	   26	  
_________________________________________________________________"Chapter"2"
anti-collagen antibodies and the reduced M13 bacteriophage were mixed and left 
to react overnight at 4 °C. The resulting sample was then purified using PD-10 
column. After conjugation with TRITC dye molecule (method 2.4.2.1), the 
sample was purified by size exclusion chromatography (method. 2.2.3). 
 
2.4.1.2 Bioconjugation with WGA-FITC 
The p3 proteins of the phage were conjugated to wheat germ agglutinin 
fluorescein-conjugated (WGA-FITC), similarly to method 2.4.1.1. The 
disulfide bonds of the p3 protein were reduced using TCEP in 100 mM 
phosphate buffer pH 7.5, and added to an initial mass of M13 phage (5.8×10–8 
mmoles). The sample was incubated for 1 hour at room temperature. The 
reduced M13 was purified using a PD-10 column (Sephadex G-25, GE 
Healthcare), with a conjugation buffer (50 mM potassium phosphate buffer, 150 
mM NaCl, 5 mM EDTA buffer, pH 7) as eluent. Wheat germ agglutinin 
conjugated with FITC (WGA-FITC, lectin from Triticum vulgaris, lyophilized 
powder, Sigma) was used at molar equivalents to the p3 proteins. The WGA was 
maleimide-derivatised with SMCC, in a 25× molar excess. The sample was 
incubated for 2 hours and eluted in the conjugation buffer using a PD-10 
column. The p3-modified phage and the maleimide-derivatised WGA were then 
mixed and left to react overnight at 4 °C. The resulting sample was then purified 
using PD-10 columns. After conjugation with TRITC dye molecule (method 
2.4.2.1), the sample was purified by size exclusion chromatography (method. 
2.2.3). 
 
2.4.1.3 Bioconjugation with magnetic bead  
Following manufacturer’s instructions, 50 nm protein A functionalised magnetic 
beads (Ocean NanoTech) were conjugated with antibodies. Typically, 8 µg of 
anti-p3 antibody (mouse isotype IgG2a, NEB) in PBS-T (PBS + 0.1% Tween-
20) was mixed with ~ 3×1011 magnetic beads, and rotated for 1 hour at room 
temperature. The mixture was placed on a N40 neodymium magnet 
(12.7×12.7×3.2 mm, from Power Magnet Store on Amazon) overnight (~ 10 
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hours). The following day, holding the eppendorf so it would not be displaced 
from the magnet, the supernatant was carefully removed. The beads were 
resuspended in PBS-T buffer, gently vortexed, and captured on the magnet for 
another 10 hours. The supernatant was then carefully discarded. A sample 
containing ~ 2×1010 wild-type phage particles was pipetted into the beads-
antibody complex, and incubated overnight, while rotating. The eppendorf was 
placed on the magnet to capture the beads complex and magnetised for 10 hours. 
The supernatant was carefully collected. PBT-T buffer was slowly added and the 
sample were briefly vortexed, and the beads were magnetised overnight. This 
washing step was repeated three more times. The phage-bead construct samples 
were then stored in the fridge until analysis (TEM, method 2.5.7). 
 
2.4.2 p8 chemical modifications 
2.4.2.1 Fluorescent labelling with dye molecules 
The p8 proteins of the phage were labeled with tetramethylrhodamine- 
isothiocyanate (TRITC, Invitrogen Thermo Fisher Scientific), Alexa Fluor 647 
(AF647, Invitrogen Thermo Fisher Scientific), or 7-Diethylamino-3-((((2-
maleimidyl)ethyl)amino)carbonyl)coumarin (MDCC, Invitrogen Thermo Fisher 
Scientific) [12]. TRITC is an amine-reactive dye that produced a bright orange 
bioconjugate with excitation/emission maxima at 555/580 nm. AF647 and 
MDCC are maleimide-derivatised dyes producing red (extinction/emission 
maxima at 650/665 nm) and blueish (extinction/emission maxima at 420/470 
nm) bioconjugates, respectively. Dye stock solutions were prepared in dimethyl 
sulfoxide (DMSO), typically to a stock concentration of 10 mg/mL, and slowly 
added to 1–2 mg of phage in buffer (pH 7–8, depends on experiment as defined 
in the main body of the thesis), in order to provide a 1:1 molar ratio over the p8 
proteins. Usually, the sample was incubated at room temperature, with 
continuous stirring, for 2 to 8 hours, however longer incubation times seem not 
to present an issue. Phage-dye constructs were separated from unreacted dye 
molecules either by using PD-10 columns, size exclusion chromatography or by 
multiple rounds of PEG/NaCl precipitation.  
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To estimate the degree of labelling of the phage particles with TRITC dye (Fig. 
3.13, Chapter 3) the following steps were carried out. After removing excess 
TRITC dye from the phage-dye sample, the coverage (%) of the phage surface 
with TRITC molecules was estimated. This was done by measuring the 
absorbance of the phage-dye conjugate at 269 nm on a UV-Vis spectrometer 
(Jasco, V-550). However, dyes generally also absorb in the 260–280 nm range, 
contributing to the absorbance at 269 nm. A correction factor (CF) is then 
required. The CF for TRITC was calculated to be ~ 0.34 (by dividing the 
absorbance of the free dye at 269 nm with the maximum absorbance of the free 
dye at 555 nm). The phage concentration in the phage-dye sample was corrected 
by subtracting the absorbance at 269 nm to the absorbance at 555 nm multiplied 
by the CF of TRITC. The degree of labelling of the phage surface with TRITC 
dye was then determined by dividing the molar concentration of TRITC (ε = 
65,000 M-1 cm-1) with the corrected molar concentration of phage (method 
2.3.2), in the phage-dye sample. 
 
2.4.2.2 Chemically introducing antibodies  
2.4.2.2.1 Linear Diagnostics’ protocol  
The first step of this bioconjugation protocol is to modify the primary amines of 
the p8 proteins by adding thiol groups. A phage aliquot (1–2mg) was diluted in 
50 mM potassium phosphate buffer pH 8. N-succinimidyl S-acetylthioacetate 
(SATA, Thermo Fisher Scientific) was dissolved in DMSO and added to the 
phage sample in order to make a 20× molar excess over p8 proteins. This reaction 
was incubated for 1 hour at room temperature. Hydroxylamine (Sigma) dissolved 
in potassium phosphate buffer and 250 mM EDTA was then added to the 
SATA-modified phage and left to react for 20 minutes at room temperature. 
Next, the thiolated phage was purified using PD-10 columns and eluted in 50 
mM potassium phosphate, 150 mM NaCl, 5 mM EDTA pH 7. The second 
step of this protocol is to maleimide-derivatise the antibodies. Antibody (e.g. 
anti-E. coli or anti-Salmonella, BioRad) was first purified on a PD10 column and 
eluted in 100 mM potassium phosphate buffer pH 7.5. Succinimidyl 4-(N-
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maleimidomethyl)cyclohexane-1-carboxylate (SMCC, Thermo Fisher Scientific) 
was dissolved in DMSO, and added in a 25× molar excess over the initial 
amount of antibody. This reaction was incubated for 1 hour at room 
temperature. Next, the maleimide-derivatised antibody was purified using PD-
10 columns and eluted in 50 mM potassium phosphate, 150 mM NaCl, 5 mM 
EDTA pH 7. The thiolated-phage and maleimide-derivatised antibody samples 
were mixed and reacted for at least 2 hours at room temperature. If dye labelling 
of the p8 proteins was intended, the method in section 2.4.2.1 would be 
followed. Finally, the antibody-phage conjugate was purified by PEG/NaCl 
precipitation (2 hours at 4 °C) and the resulting phage pellet resuspended in 100 
mM phosphate buffer pH 7.5.  
 
2.4.2.2.2 Aldehyde-hydrazine bioconjugation 
The protocol was adapted from [13]. First, the amines on the p8 proteins were 
modified with hydrazine groups. For this, phage particles were reacted with the 
crosslinker reagent succinimidyl 6-hydrozinonicotinate (SANH, Solulink). 
Stocks of SANH were prepared in PBS buffer, and the appropriate amount was 
added to typically 1 mg of phage, ensuring the desired molar ratio over protein 
(usually 10-fold molar excess). This mixture was left to stir overnight at 4 °C. 
The next day, phage was purified by PEG/NaCl precipitation (2 hours at 4 °C). 
The phage pellet was then resuspended in 100 mM potassium phosphate buffer, 
pH 6. An aliquot of this sample was saved for quality control experiments, such 
as LD measurements of the SANH-modified phages and the p-NBA test 
(method 2.9.1). The second step of this protocol involved introducing aldehyde 
moieties to glycosylated antibodies (e.g. anti-E. coli, BioRad #4329-4906). 
Sodium periodate (NaIO4, Sigma) was dissolved in water (usually 1 mM was 
used) and immediately added to the antibody sample (diluted in PBS buffer; 
amounts used ranging from 1 mg to 250 µg of antibody). This reaction was 
incubated for 30 minutes at room temperature. The oxidised antibodies were 
then purified using desalting columns (Zeba columns, Thermo Fisher Scientific) 
and eluted in 100 mM potassium phosphate buffer pH 6. An aliquot of the 
oxidised antibody was saved for quality control (Purpald test, method 2.9.2). 
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Finally, the aldehyde-modified antibody sample was mixed with the hydrazine-
modified phage sample. Immediately after, 10 µL, of a 1 M aniline stock in 
acetate buffer pH 4.6 solution was added to catalyse the reaction. This was 
incubated overnight at 35 °C, while mixing at an eppendorf thermomixer at 650 
rpm. The following day, the phage-antibody conjugate was purified by 
PEG/NaCl precipitation (overnight at 4 °C) or by using Zeba columns. The 
phage pellet was resuspended in PBS buffer and stored in the fridge until used in 
the LD-based immunoassay (method 2.8.2.2). Observation – when the phage 
pellet looked like a transparent-gel rather than the usual white compacted pellet, 
this was thought to suggest crosslinking between phage particles.  
 
2.4.2.2.3 DNA-conjugated phage 
The p8 proteins of the phage were modified to facilitate conjugation with short 
DNA strands [14]. Two phage-DNA probes, conjugated with different DNA 
strands, were designed for this (see Chapter 3, Table 3.2). First, the primary 
amines of the p8 proteins were modified with 4-formyl succinimidyl benzoate 
(NHS-CBA), to introduce aldehydes groups on the phage surface. This was 
done by adding 5 µL of a 10 mM NHS-CBA stock (in DMSO) to 1 mg/mL 
phage in 100 mM NaHCO3 pH 8.3 buffer (sodium bicarbonate (Sigma) in 
water). This mixture was then left to react overnight at 4 °C. PEG/NaCl was 
added to the aldehyde-modified phage and this mixture was split in two fractions 
– half to produce the phage-DNA probe 1 and the other half to produce phage-
DNA probe 2. Each fraction of the aldehyde-modified phage was PEG/NaCl 
precipitated (for 1-2 hours at 4 °C) and the phage pellet resuspended in 200 mM 
NH4OAc pH 5 buffer (ammonium acetate (Sigma) in water, pH-adjusted with 
glacial acetic acid (Sigma)). 
 
• Phage-DNA probe 1 conjugate 
62.5 µL of 200 µM I-Link DNA (hydrazine-modified DNA, from Integrated 
DNA Technologies) was mixed with an equal volume of aldehyde-modified 
phage, and left to react at room temperature for 24 hours. After incubation, the 
phage-DNA conjugate was purified by PEG/NaCl precipitation, and 
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resuspended in PBS buffer. Phage concentration was determined by UV 
spectrophotometry. 
• Phage-DNA probe 2 conjugate 
9.15 µL of a 42 mM SANH (Solulink) stock was added to 10 µL of 1.3 mM 
DNA-NH2 (NH2-modified DNA, from Integrated DNA Technologies) in a 
total of 30 µL made up with 300 mM NaHCO3 buffer, and left to react 
overnight at 4 °C. This step was necessary to modify the amines on the DNA 
with hydrazine groups (IDT does not produce 3’ I-Link modifications of the 
DNA). After cleaning the SANH-modified DNA in a NAP-5 column (GE 
Healthcare) and lyophilizing the eluted product, the DNA was resuspended in 
200 mM NH4OAc pH 4.5, and added to the aldehyde-modified phage for a 24 
hours reaction at room temperature. Finally, the phage-DNA conjugate was 
purified by PEG/NaCl precipitation, and resuspended in PBS buffer. Phage 
concentration was determined by UV spectrophotometry. 
 
2.5 Microscopy and imaging experiments 
2.5.1 Imaging on collagen-coated slides 
Images were acquired at 10 frames per second using a spinning disk confocal 
microscope (PerkinElmer Ultraview ERS) with a 1.4 NA, 100× oil immersion 
objective, 561 nm laser, TRITC filter sets (Croma) and an ORCA R2 camera 
(Hamamatsu) under control of Volocity 6.3 (Perkin-Elmer). 
 
2.5.2 Imaging on endothelial cells-coated slides 
Cultures of endothelial cells were grown using standard cell biology procedures. 
The cells were then split and seeded into µ-Slide I Luer0.8 collagen-coated slides 
(ibidi) and incubated until confluence. GEnC cells were cultured and seeded by 
Dr. Hesham Elhegni, from University of Bristol. HUVEC cells were cultured 
and seeded by Dr. Maria Machado, from University of Nottingham. The phage 
constructs on the cells were visualised using a Nikon Ti Eclipse inverted 
microscope through 60× oil immersion objective 1.4 (Nikon Plan Apo VC 60x 
Oil DIC N2). Cells within the imaging window were illuminated at 535 nm 
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using a wide-field fluorescent light emitting diode (Precise Excite Cool LED) 
and emitted light was filtered through a 620 nm filter block and detected on a 
high resolution monochromatic camera (Photometric's CoolSnap HQ2). Images 
were collected using Nikon's NIS Elements software. 
 
2.5.3 Flow experiments on the collagen-coated slides 
A chamber flow slide with a collagen coating (ibidi, µ-Slide I Luer0.8) was 
used.  The channel was carefully filled with the M13-Antibody-TRITC 
construct sample and left to incubate for 1 hour at room temperature. The slide 
was linked to the tubing (‘white’ perfusion set, #10963) of the pump system, and 
the reservoirs were filled with sterile PBS. The experiments were performed at 35 
°C, on the temperature-controlled system box of the microscope. The reservoirs 
and tubing were left inside the box for 1 hour to equilibrate the temperature of 
the buffer. The software allows varying the pressure/flow rate/shear stress to the 
desired testing values. A defined nominal shear stress (WSS on a flat surface due 
to the bulk flow rate) profile was applied, ranging from –3.5 to +3.5 dyn/cm2, 
each cycle lasting 20 seconds.  
 
2.5.4 Flow experiments on the endothelial cells-coated slides 
The apparatus used for the collagen antibody constructs was also used for the 
cells experiments. Endothelial cells were seeded onto the same type of flow 
collagen-coated slide (ibidi, µ-Slide I Luer0.8) and the M13-WGA-TRITC 
construct was added to the chamber and left to react for 1 hour in an incubator at 
37 °C/5% CO2. The slide was linked to the pressure pump and the reservoir of 
the fluidic unit was filled with sterile PBS buffer. A defined nominal wall shear 
stress profile was applied, from –3.5 to +3.5 dyn/cm2, each cycle lasting 20 
seconds. 
 
2.5.5 In vitro labelling of glycocalyx on endothelial cells 
Endothelial cells, previously seeded and grown until confluence onto the 
microfluidic chamber of an ibidi µ-Slide, were rinsed three times with pre-
	  	   33	  
_________________________________________________________________"Chapter"2"
warmed PBS buffer. The cells were incubated for 1 hour at 37 °C with FITC-
conjugated wheat germ agglutinin (WGA-FITC, Sigma), at a 1:200 dilution. 
The endothelial cells were rinsed again three times with PBS, and then fixed 
with ~ 100% methanol for 15 minutes. To label the nucleus of the cells, these 
were incubated for 3 minutes with 4',6-diamidino-2-phenylindole (DAPI, 
Thermo Fisher Scientific) at a 1:500 dilution, and then rinsed three times with 
PBS. Labelled endothelial cells were immediately visualised under a confocal 
laser scanning microscope (Leica TCS SPE), and a Z-stack was collected 
(Chapter 4, Fig. 4.2). 
 
2.5.6 Imaging the M13+WGA-FITC+TRITC phage construct 
A 10 µL drop of M13+WGA-FITC+TRITC phage construct was immobilised 
under a 5% agarose flat pad. A cover slip was gently fixed on top, and sample was 
imaged using a confocal microscope beam splitter (Leica TCS SP8) for the 
TRITC and FITC dye molecules conjugated to the phage. 
 
2.5.7 Transmission Electron Microscopy (TEM) 
TEM grids (Formvar/Carbon on 200 Mesh Copper, Agar Scientific) were 
treated by glow discharge (E200 Auto sputter coater) for 30 seconds. Phage 
samples were prepared (5 µL, typically at concentrations ranging from 0.1 
mg/mL to 0.05 mg/mL) and added onto the TEM grid. The liquid was removed 
by wicking with filter paper after 60 seconds. 1% uranyl acetate (5 µL) was added 
and wicked off with filter paper after 60 seconds. A JEM-2200FS TEM (Joel, 
Japan) was used to visualise the grids, typically at a 10000×, 15000× or 25000× 
magnification. ImageJ/Fiji software was used to analyse and process TEM 
images. 
 
2.6 Enzyme-Linked Immunosorbent Assay (ELISA) 
2.6.1 ELISA protocol in maleimide-coated microplates 
A maleimide-activated microplate (Pierce, Thermo Fisher Scientific #15150) 
was used for this ELISA [15]. The wells were washed three times with 200 µL 
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of 100 mM sodium phosphate buffer, 150 mM NaCl, 0.05% Tween-20, pH 7.2. 
A phage sample (2 mg) was reduced with 5 mM TCEP (Pierce, Thermo Fisher 
Scientific, #20491) for one hour at room temperature, and eluted on a PD-10 
column (GE Healthcare) in 100 mM sodium phosphate buffer, 150 mM NaCl, 
10 mM EDTA, pH 7.2. Phage not reduced with TCEP was used as a control. A 
serial dilution of the phage samples was added to the wells, sealed with an 
adhesive lid and incubated for 3 hours at room temperature.  The wells were 
emptied by flicking the microplate and tapping it onto a paper towel, and adding 
200 µL of wash buffer in each well. This process was repeated four times. 1:5000 
diluted HRP/anti-M13 antibody conjugate (GE Healthcare #27-9421-01) was 
added to each phage-coated well, and incubated for 1 hour at room temperature. 
The wells were then emptied and blotted on a paper towel, and filled with wash 
buffer. The microplate was blotted on paper towel to remove any remaining wash 
buffer. This process was repeated six times. A 2,2'-Azinobis (3-
ethylbenzothiazoline-6-sulfonic acid)-diammonium solution (1-Step ABTS 
Substrate solution, Thermo Fisher Scientific #37615) was added to each well and 
incubated until a green colour has formed. The ABTS-HRP reaction absorbance 
was measured in a microplate reader set at 410 nm. Reactions were blanked 
against a well filled with ABTS. 
 
2.6.2 Phage-binding ELISA 
This ELISA was performed to test the MSal17 phage construct (Salmonella-
binding peptide on phage). Several wells of a 96-well microplate (Nunc 
MaxiSorp™, flat-bottom/clear) were coated with gamma-irradiated Salmonella 
or E. coli bacteria, typically in the range of 107–105 cells/mL, in PBS buffer. The 
plate was cover with adhesive plastic and incubated for 12-18 hours at 4 °C. The 
next day, the wells were emptied, by vigorously flicking the plate over a sink, and 
washed three times with 200 µL of PBS. The plate was gently blotted on paper 
towel between washes. 200 µL of a blocking buffer (1% BSA in PBS) was added 
to each well and left to incubate for two hours at room temperature. The plate 
was then washed three times with PBS buffer. ~ 100 µL (0.5 mg/mL for ELISA 
on Fig. 5.25, and 0.2 mg/mL for ELISA on Fig. 5.26) samples of MSal17 and 
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wild-type phage in PBS buffer were added to the wells, and incubated at room 
temperature for approximately 3 hours. The plate was then washed four times 
with PBS buffer. 200 µL of diluted (1:5000) anti-phage/HRP conjugate 
antibody in blocking buffer was added, and incubated for one hour at room 
temperature. Each well was washed six times with 200 µL of PBS buffer as 
described above, and 200 µL of 1-step ABTS solution was added. Absorbance at 
410 nm was then measured on a plate reader. The blank in this experiment was 
considered to be the absorbance (at 410 nm) of a bacterial-coated well filled with 
ABTS solution. 
 
2.6.2.1 Gamma-irradiated bacteria 
An important consideration for the MSal17 phage construct assays was the 
sterilisation method to which the bacteria were subjected prior to use in the 
immunoassay. Since Salmonella species and some E. coli are pathogenic, most 
commercially available bacterial batches on the market are “dead”, commonly 
destroyed by heat, to accommodate for the standard Bio Safety level 1 
laboratories. The high temperatures that heat-killed bacteria are exposed to can 
denature the tertiary structure of the proteins expressed on its surface, which may 
be essential for some binding-peptides recognition. Exposure to gamma 
radiation presumably only damages bacterial DNA, incapacitating bacteria to 
multiply, without compromising the outer structure morphology and the antigen 
characteristics of the whole cell [16]. Salmonella and E. coli bacteria were 
inactivated by gamma irradiation at 10 kGy in a Gammabeam 650 irradiator 
(Atomic Energy of Canada Limited), to render them safe to use outside a CAT 
II level laboratory. No special precautions, other than usual aseptic technique, 
were required for working with these microorganisms.  These bacterial cultures 
were kindly provided by Dr. Irene Grant, at the Agri-Food and Biosciences 
Institute of Northern Ireland. 
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2.7 Gel electrophoresis 
2.7.1 Agarose gel electrophoresis  
For agarose gel electrophoresis [17], an agarose suspension (1%–2%, depending 
on the purpose of the gel) was prepared by adding agarose powder to 50 ml of 
tris/borate/ethylenediaminetetraacetic acid (TBE) buffer. The suspension was 
heated in a microwave until the agarose was fully dissolved. The suspension was 
briefly left to cool down, while occasionally swirling the flask, at which point ~ 4 
µl of ethidium bromide laboratory stock was added. The gel was poured into a 
casting tray and a comb was introduced to position the wells. Once the gel had 
solidified, the comb was removed. The gel was placed into a gel tank filled with 
TBE buffer. Loading dye (NEB) was added to each sample, and loaded into the 
wells, along with the DNA ladder (2-log or 1 kb ladder, NEB). Typically, the gel 
was run for approximately 60 minutes at 100 V, and later visualised on a gel doc 
imaging system (Syngene or AlphaImager) under a UV lamp.  
 
2.7.2 Sodium dodecyl sulphate polyacrylamide gel electrophoresis  
Samples were separated and visualised under denaturing conditions by a 12% 
sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE, [18]). 
A 10 mL resolving gel – 3.2 mL of water, 4 mL of acrylamide/bis-acrylamide 
(30%/0.8% w/v), 2.6 mL of 1.5 M Tris pH 8.8, 0.1 mL of 10% (w/v) SDS, 
polymerised with 100 µL of 10% (w/v) ammonium persulfate (APS) and 10 µL 
of N,N,N’,N’-tetramethylethylenediamine (TEMED) – was cast using a Hoefer 
Mighty Small kit, and allowed to set. The stacking gel – 2.975 mL of water, 1.25 
mL of 0.5 M Tris-HCl pH 6.8, 0.05 mL of 10 % (w/v) SDS, 0.67 mL of 
acrylamide/bis-acrylamide (30%/0.8% w/v), polymerised with 50 µL 10% (w/v) 
APS and 5 µL TEMED – was immediately poured on top of the solidified 
resolving gel. A well comb was inserted, and the gel was left to set. Typically, 20 
µL samples were mixed with 5 µL 1× loading buffer (5×; 0.2 M Tris pH 6.8, 
20% (v/v) glycerol, 10% (w/v) SDS, 0.05% (w/v) bromophenol blue, 10 mM 
dithiothreitol (DTT)) and denatured for 10 minutes at 95 °C. When running the 
gel under non-reducing conditions, DTT was not added to the samples. The 
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samples were then pipetted into the wells, alongside the molecular weight marker 
(10 µL) (ColourPlus Prestained protein ladder, NEB) in a separate well. 
Electrophoresis occurred in SDS-PAGE running buffer (25 mM Tris pH 8.3, 
200 mM glycine, 0.1% (w/v) SDS) at 180 V and allowed to run until loading dye 
ran off the bottom of the gel. The gel was then stained with Instant Blue stain 
(Expedeon) for 15–30 minutes, briefly washed with water, and imaged 
(Syngene).  
 
2.7.2.1 Silver staining  
For silver staining the gel [19], the SDS–PAGE (method 2.7.2) was firstly 
prefixed in ~ 200 mL 50% (v/v) methanol, 10% acetic acid at 37 °C for 30 
minutes, and then prefixed in ~ 200 mL 50% (v/v) methanol, 7% acetic acid at 
37 °C for 30 minutes. The gel was washed briefly in deionised water and, in the 
fume hood, carefully placed in 150 mL gluteraldehyde for 30 minutes at 37 °C. 
The gel was rinsed again and excess gluteraldehyde was removed by soaking it in 
deionized water overnight at 37 °C. The following day, the gel was rinsed and 
washed at 37 °C in 5 µg/mL DTT for 30 minutes. The DTT was poured off 
and, without rinsing, 0.1% (w/v) AgNO3 was added (150 mL). The gel was 
shaken at 37 °C for 30 minutes. The gel was rinsed briefly in deionised water and 
then developed with 150 mL 3% (w/v) Na2CO3 containing 75 µL 37% 
formaldehyde. Staining was stopped once the appropriate density had been 
reached with 7.5 mL of 2.3 M citric acid. The gel was washed six times with 
deionised water, soaked for another 10 minutes in 0.3% (v/v) Na2CO3 and then 
rinsed again in deionised water. 
 
2.7.3 10–20% Tris-Tricine precast gel  
A 10–20% Tris-Tricine precast gel was acquired from BioRad. The buffers were 
prepared as followed: Loading sample buffer recipe (×6) – 100 mM Tricine pH 
8.8, 40% glycerol, 4% SDS, ~ 2% bromophenol blue. Anode buffer recipe – 100 
mM Tris pH 8.8. Cathode buffer recipe – 100 mM Tricine, 100 mM Tris, 0.1 % 
SDS. After adding the loading buffer to the samples, these were heated at 92 °C 
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for 5 minutes, following manufacturer instructions. 10 µL of Prestained 
Colourplus ladder (NEB) was loaded, and ~ 25 µL of each sample was loaded 
per well. The gel was run at 100 V for 90 minutes, or until dye front leaves the 
bottom of the gel.  
 
2.7.3.1 Fluorescent imaging  
Before staining, the 10–20% Tris-Tricine precast gel (method 2.7.3) was imaged 
using a Typhoon FLA 9500 (GE). Parameters: laser – 635 nm; Filter – LPR; 
Channel – standard Alexa Fluor 647. 
 
2.7.4 4–12% Bis-Tris precast gel 
A gradient 4–12% Bis-Tris precast gel (NuPAGE, Thermo Fisher Scientific, 
catalog #NP0322BOX) was used to analyse the His-tagged phage on the pull-
down assay (Chapter 3, Fig. 3.13), and the DNAzyme experiments (Chapter 3, 
Fig. 3.18). Samples were diluted in LDS sample buffer (NuPAGE, Thermo 
Fisher Scientific, catalog #NP0007), and denatured at 90 °C for 10 minutes, 
following manufacturers’ instructions. Typically, ~ 10 µL of diluted samples were 
added per well, along with 10 µL of pre-stained protein standard (Novex, 
Thermo Fisher Scientific, catalog #LC5800). The gels were resolved in MES 
SDS running buffer (NuPAGE, Thermo Fisher Scientific, #NP0002) for 
approximately 35 minutes at 200 V. After electrophoresis, gels were placed in 
deionized water and microwaved for about a minute until solution almost started 
to boil, and left to shake for 2 minutes. This process was repeated 2 more times. 
~ 30 mL of SimplyBlue SafeStain (Thermo Fisher Scientific, catalog #LC6060) 
was then added, and the gels microwaved for ~ 1 minute until solution almost 
boils. The gels were shaken for 10 minutes, and then washed with water for 10 
minutes. Finally, a solution of 20% NaCl was added to the gels for 10 minutes. 
The gels were then visualised under white light, and pictures were collected. 
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2.7.5 Western blot 
A 4-20% Criterion TGX Stain-Free precast gel was run for ~ 50 minutes at 170 
V (until dye front has reached the bottom of the gel). The gel was then imaged 
on ChemiDoc MP (Stain-free enabled) and Image Lab Software with settings 
for ‘best sensitivity’ and ‘faint bands’ (~ 5 minutes exposure). For the Western 
blot [20], the gel was transferred onto a PVDF membrane (Trans-Blot Turbo 
Midi PVDF Transfer Packs, 1704157) using the Trans-Blot Turbo Transfer 
System with the appropriate settings. The membrane was blocked overnight in 
10% milk in PBS buffer. The following day, the membrane was incubated 
overnight in 0.1% milk in PBS with 0.2 µg primary antibody (anti-his6, Roche, 
1922416). The membrane was washed in 1x PBS-Tween, three times every 20 
minutes for 1 hour, followed by a 2 hours incubation with 0.1% milk in PBS 
with 1:2500 dilution of secondary antibody (anti-mouse IgG, HRP conjugate, 
W402B). The membrane was successively washed 1x PBS-Tween, three times 
every 20 minutes for 1 hour. The blot was incubated for 5 minutes in a 1:1 mix 
of Clarity Western ECL Blotting Substrates, and image on Image Quant 
LAS4000 (auto exposure time). Markers: 10 µL Amersham Low Molecular 
Weight Calibration Kit for SDS Electrophoresis (17-0446-01); 4 µL 
BenchMark His-tagged Protein Standard (Catalog #LC5606). 
 
2.8 Spectroscopy techniques  
2.8.1 MALDI-TOF mass spectrometry 
Matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF, [21]) 
spectra were taken on a Voyager DE-STR system (Applied Biosystems) on 
linear mode, and data was collected and analysed with support from Dr. Brasino. 
Phage samples were denatured at 95 °C for 5 minutes, and some of the samples 
were also desalted (Zeba Spin columns, Thermo Fisher Scientific). Not desalting 
the samples would result in less resolved spectra. Typically, 5 µL of 
trihydroxyacetophenone (THAP) matrix was mixed with 5 µL of phage sample, 
and 2 µL of this was loaded onto the MALDI-TOF plate. The sample-matrix 
droplet was allowed to completely dry before measurements. THAP matrix is 
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made of 18 mg trihydroxyacetophenone, 5 mg ammonium citrate dibasic, in 
acetonitrile:water (50:50), made up to 1 mL. 
 
2.8.2 Linear dichroism and fluorescence detected linear dichroism  
Linear dichroism (LD) and fluorescence detected linear dichroism (FDLD) 
experiments were carried out using Jasco J-720, Jasco J-815 and Jasco J-1500 
spectropolarimeter. Typically, 60–80 µL samples were pipetted into a quartz 
Couette cell, assembled with the quartz capillary rod, and placed inside the LD 
chamber. A baseline was recorded in a non-spinning mode and the resultant 
spectrum was subtracted from the measured samples. Samples were measured in 
spinning mode at ~ 3000 rpm. The FDLD experiments had a similar design, 
except for a cut-off filter (Semrock) which is added in from of the apparatus 
detector, as described in the main body of the thesis. Table 3.1 (Chapter 3) 
highlights the main parameters used for these measurements.  
 
2.8.2.1 Thermostability of phage particles 
The effect of temperature on the structural stability of mutant and wild-type 
phage particles was evaluated by LD (Chapter 5, Fig. 5.7). Several phage aliquots 
in PBS buffer were incubated at increasing temperatures on a thermocycler for 5 
minutes, from 20 °C to 100 °C with 10 °C increments. While collecting the 
spectra, the LD cell apparatus was kept at the temperature being tested.  
 
2.8.2.2 Linear dichroism-based immunoassay 
Typically, 40 µL of functionalised phage sample was diluted in 60 µL of buffer; 
80 µL of this mix was then transferred into the LD quartz cell. The 
immunoassay was performed by carefully mixing 10 µL of a bacterial stock (E. 
coli and Salmonella (Insight Biotechnology, #50-95-90 and #50-74-01) or 
gamma-irradiated bacteria (method 2.6.2.1)) diluted to the intended 
concentration, with 40 µL of phage sample and 50 µL of buffer. This was left to 
incubate at room temperature for 5 minutes, and 80 µL of this mixture was 
measured. Alternatively, phage samples were diluted to LD225 ~ 0.01-0.02 prior 
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to performing the immunoassay (for example, when comparing different phage 
samples across independent LD immunoassays (Chapter 5, Fig 5.11)). When 
indicated, the phage LD spectra was normalised at a single wavelength (225 nm) 
to simplify comparison between samples in another region of the spectra. 
 
2.8.2.3 Phage induced alignment on a quartz window  
A sample of phage was induced to align on a quartz window for LD 
measurements. For this, two layers of a 20 µL drop (5 mg/mL wild-type phage 
stock on water) were dried on a circular quartz window. The first drop was added 
onto the middle of the window, and then, with a pipette tip, induced to orient/dry in 
one direction (i.e. horizontally dragging the drop with the tip, from left to right, 
until the surface of the window looked dry); a second 20 µL drop was added and the 
procedure repeated. The quartz window was then attached in front of the detector 
and LD was measured. A blank (i.e. the quartz window with nothing on it) was 
previously recorded, and subtracted from the measured LD. This same quartz 
window with dried phage was manually rotated by 90 ° to measure the LD data 
named as “90 degrees rotation”, given on Fig. 3.21 (Chapter 3). 
 
2.8.3 Circular dichroism  
0.1 mg/mL of FITC-conjugated wheat germ agglutinin (WGA-FITC) in 
phosphate buffer before and after reaction with SMCC were analysed by circular 
dichroism (CD) spectroscopy. CD experiment was carried out on a Jasco J-1500 
spectropolarimeter using a 1 cm quartz cuvette. A baseline was recorded using 
phosphate buffer and subtracted from the sample spectra. Parameters – Range: 
200–260 nm, Response: 1s, Data pitch: 0.5 nm, Scanning mode: Continuous, 
Scan speed: 100 nm/min, Band width: 1 nm, Number of accumulations: 3.  
 
2.8.4 Dynamic light scattering 
Dynamic light scattering (DLS) measurements were obtained with a Malvern 
Zetasizer Nano-series Range. A 600-seconds equilibration time at 20 °C was set 
before starting measurements, using ~ 100 µL of each phage sample pipetted into 
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disposable cuvettes. Eight measurements over ten runs were recorded, and the 
results were averaged and plotted. 
 
2.9 Colorimetric tests 
2.9.1 p-nitrobenzaldehyde test  
The p-nitrobenzaldehyde (p-NBA) test [13] was used to confirm the presence of 
hydrazine moieties to the phage surface (Chapter 5). A 0.5 mM p-
nitrobenzaldehyde stock was prepared by initially dissolving the compound at a 
higher concentration in organic solvent (DMSO) and then adding the 
appropriate aliquot to 100 mM acetate buffer, pH 5 to result in the final 
concentration. An aliquot of the SANH-modified phage was added to the p-
nitrobenzaldehyde solution, and incubated for 2 hour at 37 °C. Absorbance 
spectra was collected, and signal measured at 390 nm, against a blank prepared 
by addition of an equal aliquot of buffer in p-NBA solution. The p-NBA test 
was used to check for the modifications of the phage surface with SANH. The 
hydrazine modification level of the phages can be estimated quantitatively. The 
absorbance of the chromophore was measured at 390 nm and concentration 
calculated using the molar extinction coefficient. The ratio hydrazine/phage can 
then be estimated by dividing the hydrazine concentration by the phage 
concentration (mol/L).  
 
2.9.2 Purpald test 
The presence of aldehydes on a drop of NaIO4–treated antibody was confirmed 
by a colorimetric change to purple, upon adding a freshly prepared solution of 4-
amino-3-hydrazino-5-mercapto-1,2,4-triazole (Purpald, Alfa Aesar) in sodium 
hydroxide [13]. 
 
 2.9.3 Ellman’s reagent test 
5,5-dithio-bis-(2-nitrobenzoic acid) (DTNB, Ellman’s reagent, Thermo Fisher 
Scientific) was used to confirm the presence of cysteines on the surface of the 
V31C phage (Chapter 5). 25 µL of 1 mg/mL V31C phage was diluted in 25 µL 
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of 100 mM phosphate 1 mM EDTA buffer, and mixed with 50 µL of a 4 
mg/mL Ellman’s reagent. In a few seconds, the solution turned into a bright 
yellow, indicating the presence of thiol groups on the V31C phage. This 
colorimetric change was not noticeable in wild-type phage.  
 
2.10 Magnetic beads-based protocols 
2.10.1 Pull-down assay using nickel-chelating beads 
This assay tested the ability of the His-tagged phage to bind to nickel ions-
coated surfaces. Nickel-chelating magnetic beads (HIS-select nickel magnetic 
agarose beads, Sigma #H9914) were used to capture His-tagged phage, following 
manufacturer’s instructions. ~ 150 µg of untagged phage (control) and His-
tagged phage were added to 20 µL of an uniformly dispersed beads suspension, 
and incubated for approximately 30 minutes. The mixture of phage and beads 
was placed in a magnetic separator, and the supernatant was collected and saved 
for gel analysis (Chapter 3, Fig. 3.13, labelled as “Supernatant”). The beads were 
briefly washed with washing buffer (50 mM sodium phosphate, 300 mM NaCl, 
10 mM imidazole) and collected with the magnetic separator. 100 µL of elution 
buffer (50 mM sodium phosphate, 300 mM NaCl, 250 mM imidazole) was 
added to the beads-phage, and incubated for 15 minutes. Finally, the beads-
phage samples were placed in the magnetic separator and the supernatant was 
collected and saved for gel analysis (Chapter 3, Fig, 3.13, labelled as “250 mM 
imidazole elution”).  
 
2.10.2 Magnetic beads purification of LD immunoassay samples 
100 µL of protein A magnetic beads (SureBeads, Biorad) were resuspended and 
briefly washed in 500 µL of PBS-T (PBS + 0.1% Tween-20) buffer. The beads 
were magnetised using a magnetic separator rack, and the supernatant was 
discarded.  This step was repeated two more times. 300 µL of an immunoassay 
sample was mixed to the beads, and this mixture was rotated for 1 hour at room 
temperature. The beads were then captured using the magnetic separator, and 
the supernatant (the immunoassay sample) was collected to re-test on the LD 
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immunoassay. The magnetic beads were kept for further analysis on a silver 
stained SDS-PAGE. 
 
2.11 General cloning techniques  
2.11.1 Recipe for LB medium and LB/agar plates  
To prepare 500 mL of lysogeny broth (LB), 5 g of tryptone (Oxoid), 2.5 g of 
yeast extract (Sigma), and 2.5 g of NaCl (Sigma) were added to deionised water. 
After autoclaving and cooling down the medium, the appropriate antibiotic was 
added. Plates were prepared by adding either 15 g/L or 7 g/L of agar (Difco) to 
the LB medium, to make 1.5% “hard” agar plates or 0.7% “soft” agar plates 
(commonly used in phage techniques, method 2.3.1). The LB/agar solution was 
then autoclaved, briefly cooled down, and the appropriate antibiotic was added 
(generally, tetracycline or kanamycin). When using XL-1 blue competent cells, 
plates also contained isopropyl β-D-1-thiogalactopyranoside (IPTG, Sigma) to a 
final concentration of 20 mM, and 5-bromo-4-chloro-3-indoyl-β-D-
galactopyranoside  (X-gal, Bioline) to a final concentration of 80 µg/mL. The 
LB/agar/antibiotic solution was immediately poured into sterile petri dishes and 
left to solidify on a laminar flow cabinet. Plates were wrapped in parafilm and 
stored in the fridge for up to a week.  
 
2.11.2 Making competent cells 
The protocol was followed as per [4]. One mL of a 5 mL overnight E. coli 
culture was added to 100 mL of LB media and incubated at 37 °C until OD600~ 
0.4. The bacterial culture was split into two 50 mL Falcon tubes and incubated 
on ice for 30 minutes. The incubated cells were centrifuged at 2700 × g for 10 
minutes at 4 °C, the supernatant was discarded and tubes were inverted and set a 
paper towel to dry for 1 minute. The bacterial pellet was resuspended with gentle 
vortexing in 30 mL of chilled 0.08 M MgCl2/0.02 M CaCl2. The resuspended 
cells solution was spun at 2700 × g for 10 minutes at 4 °C, decanted and dried as 
before. The bacterial pellet was resuspended in 2 mL of 0.1 M CaCl2. 70 µL of 
DMSO was then added and the bacterial solution was gently swirled, and left on 
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ice for 15 minutes. Another 70 µL of DMSO was added and the tubes were 
again gently swirled to mix. 200 µL of the bacterial solution was then dispensed 
in pre-chilled eppendorfs, and frozen in liquid nitrogen. The competent cells 
were stored at the –80 °C freezer. 
 
2.11.3 Preparing E. coli cultures 
A liquid culture of E. coli was streaked onto a LB/agar plate supplemented with 
the appropriate antibiotic (method 2.11.1) and incubated overnight at 37 °C. A 
single colony was then picked (method 2.11.4.5) and grown in LB medium 
supplemented with the appropriate antibiotic, overnight at 37 °C, shaking at 200 
rpm. A final concentration of 20% (v/v) glycerol was added to the E. coli culture. 
Stock cultures were stored at the –80°C freezer. Working cultures were prepared 
by inoculating LB medium with an aliquot (10–100 µL) of the stock culture, and 
incubated overnight at 37 °C, 200 rpm. 
 
2.11.4 Cloning on a fd phage vector 
Genetic engineering the p3 and p8 proteins of the phage was explored, to build 
phage mutants (Chapter 5). Standard molecular techniques were employed [4]. 
The cloning illustrated in Table 2.1 was done on a phage cloning vector derived 
from the fd-tet phage (termed f8 when the display of the foreign peptide was 
done on every copy of the p8 protein, or mosaic f88 when the display of the 
foreign peptide was done on the synthetic p8 proteins), containing a tetracycline 
resistance gene and restriction sites within the phage proteins. Therefore, the 
term “wild-type” or “control” used on the experiments presented on the main 
body of the thesis refers to the non-mutated fd phage. 
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Table 2.1: List of primers and restriction enzymes, and of phage plasmids. 
Oligonucleotide set of primers and restriction enzymes used for cloning on the synthetic 
p8, wild-type (WT) p8 and p3 proteins of the phage, to build the His-tagged, extra 
tryptophan (TRP), Salmonella-binding (MSal17) and V31C mutant phages. Phage 
plasmids were used for the cloning work described below. 
 
 
Table 2.2: List of bacterial strains. These bacteria were used for growing bacteriophage 
cultures and for the cloning work described in this thesis. 
 
2.11.4.1 Annealing oligomers 
This method was carried out to construct the His-tagged, extra tryptophan 
(TRP) and MSal17 mutant phages. 1 µL of each oligomer/primer (reverse and 
Phage&constructs& Phage&protein& Primers&set& Restric2on&Enzymes&
His$tagged*phage* WT*p3* R:*5’*GGCCGCATGGTGATGATGGTGGTGCATGGCCACGT*3’*F:*5’*TGGCCATGCACCACCATCATCACCATGC*3’*
NotI*
SfiI*
TRP*mutant*phage* WT*p8* R:*5’*GATCCTCTCCTCCCCACTCTTGCA*3’*F:*5’*GAGTGGGGAGGAGAG*3’*
BamHI*
PstI*
V31C*phage* WT*p8* R:*5’*TGCGCCGACAATGCAAACAACCATCGC*3’*F:*5’*GCGATGGTTGTTTGCATTGTCGGCGCA*3’* –*
MSal17*phage* SyntheJc*p8* R:*5’*GGGCCGCCGCCGTGGTGAAGCCAGAATTGTGCCGAATCGGGGCGGTTGGCAA*3’*F:*5’AGCTTTGCCAACCGCCCCGATTCGGCACAATTCTGGCTTCACCACGGCGGCGGCCCTGCA*3’*
HindIII*
PstI*
Phage&plasmids& Source& Reference&
M13mp18' New'England'Biolabs' [4]'
f8'and'f88' Cha’s'lab'bacteriophage'collec@on'(Boulder,'USA)' [2,'24]'
Bacteria(strains( Genotype( Source( Reference(
Escherichia)coli)
TOP10&F’&
F´{lacIq,&Tn10(TetR)}&mcrA&Δ(mrr7
hsdRMS7mcrBC)&Φ80lacZΔM15&ΔlacX74&
recA1&araD139&Δ(ara)leu)&7697&galU&galK&
rpsL&(StrR)&endA1&nupG&
Thermo&Fisher&ScienRfic& –&
Escherichia)coli)
K91Kan& Hfr7C&lacZ&mkh&thi&
Cha’s&lab&bacteria&culture&
collecRon&(Boulder,&USA)& [2,&22]&
Escherichia)coli)
DH5α&
F7&Φ80lacZΔM15&Δ(lacZYA7argF)&U169&
recA1&endA1&hsdR17&(rk7,&mk+)&phoA&
supE44&λ7thi71&gyrA96&relA1&
Thermo&Fisher&ScienRfic&
& –&
Escherichia)coli)
XL17blue&
recA1&endA1&gyrA96&thi71&hsdR17&
supE44&relA1&lac&
[F&́&proAB&lacIqZΔM15&Tn10&(TetR)]&&
Stratagene&(Agilent&
Technologies)&&
&
–&
Salmonella)
enterica)spp.) –&
CollecRon&from&the&Agri7
Food&and&Bioscience&
InsRtute&(Belfast,&UK)&
[16,&23]&
	  	   47	  
_________________________________________________________________"Chapter"2"
forward, with the restriction cutting sites, Table 2.1) were diluted in 18 µL of 
annealing buffer (10 mM Tris, 50 mM NaCl, 1 mM EDTA pH 7.3). This was 
briefly incubated at 95 °C for 5 minutes, and left to anneal at room temperature 
for approximately 1 hour. 
 
2.11.4.2 Cloning vector digestion and extraction 
The f8 or f88 cloning vector (derived from the fd-tet phage) was digested with 
the appropriate restriction enzymes for approximately 1 hour at 37 °C, and the 
product was run on a 2% agarose gel (method 2.7.1). The digested vector was 
excised from the gel under a UV lamp and extracted using a gel extraction kit 
(Qiagen, QIAquick #28704), following suppliers’ recommendations. 
 
2.11.4.3 DNA ligation  
Ligation reactions were conducted following protocols provided by the enzyme 
suppliers (New England Biolabs, NEB). Typically, 1 µL of T4 ligase enzyme 
and 2 µL of ligation buffer were added per 20 µL of total volume of ligation 
reaction. Molar ratio of vector to DNA insert varied, but generally 7 µL of DNA 
fragment (annealed product from method 2.11.4.1) was mixed with 10 µL of 
cloning vector (method 2.11.4.2), and incubated for 6 hours at 16 °C, followed 
by inactivation of the enzyme at 65 °C for 10 minutes. 
 
2.11.4.4 Transformation of competent E. coli cells  
An aliquot of competent cells (DH5α from Thermo Fisher Scientific, or E. coli 
K91Kan cells, method 2.11.2) was gently thawed on ice. 3-5 µL of ligation 
reaction (method 2.11.4.3) was mixed to 100–200 µL of cells, and left on ice for 
30 minutes. The cells were then subjected to a heat shock of 42 °C for 45 
seconds. The transformed cells were chilled on an ice bath for 5 minutes, and 
800–900 µL of super optimal broth (SOC, NEB) medium was added. The cells 
were incubated at 37 °C for one hour. Then, 200 µL of the incubated cells were 
plated on previously set 1.5% LB/agar/antibiotic plate, and allowed to grow 
overnight at 37 °C. 
	  	   48	  
_________________________________________________________________"Chapter"2"
2.11.4.5 Picking single E. coli colonies 
Each isolated E. coli colony, infected with the replicative form dsDNA of the 
phage, was picked from the LB/agar/tetracycline plate with a sterile loop, 
transferred to 5 mL of LB/tetracycline medium, and allowed to grow for 20 
hours at 37 °C, 200 rpm.  
 
2.11.4.6 Miniprep  
The miniprep procedure was done using a Qiagen kit, following manufacturers’ 
instructions. Briefly, an overnight E. coli culture (method 2.11.4.5) was 
centrifuged and the resulting cell pellet was resuspended in Qiagen P1 buffer 
with ribonuclease. P2 buffer was then added to the cell suspension and the tube 
was gently inverted several times. This mixture was centrifuged and the 
supernatant was applied to a miniprep column (Qiagen). The columns were 
centrifuged and the flow through was discarded. PB buffer was applied to the 
column and centrifuged. PE buffer with ethanol was applied to the column and 
centrifuged. The flow through was discarded and the column was centrifuged 
again to remove any residual ethanol. 30-40 µL of water was applied directly to 
the center of the column membrane and left to stand for 2 minutes before 
undergoing centrifugation. The eluted sample, containing the plasmid phage 
DNA, was collected, and the DNA concentration was determined using a 
Nanodrop. If necessary, the DNA product was sent to sequencing, to confirm 
the success of the cloning protocol. 
 
2.11.4.7 Growing the mutant phage constructs 
If sequencing confirmed successfully mutagenesis, the minipreped DNA was 
again transformed into competent cells (method 2.11.4.4) and plated on 
LB/agar/antibiotic plates. A few colonies were then picked (method 2.11.4.5) 
and grown in ~ 40 mL of LB/antibiotic medium for 20 hours at 37 °C, 200 rpm. 
Phages were subsequently purified by PEG/NaCl precipitation as before 
(method 2.2.1), and stored in fridge in the desired buffer. Perhaps, the yield of 
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mutant phages production would benefit from optimising the growing 
conditions, however this was not explored in this thesis. 
 
2.11.4.8 Site directed mutagenesis  
Site directed mutagenesis by polymerase chain reaction (PCR) was conducted to 
replace a valine of the wild-type p8 protein for a cysteine, originating the V31C 
phage (Chapter 5). The oligo-primers were designed following QuikChange 
(Stratagene) guidelines. A PCR reaction was set using: 1 µL of a 1:40 dilution of 
each primer (Table 2.1), 0.5 µL of deoxynucleotide triphosphates mix (dNTPs, 
NEB), 5 µL of 5× red buffer (NEB), 2 µL of template DNA (phage vector, 2 
ng/µL), 0.5 µL of Phusion HF polymerase (NEB), made up to a total of 25 µL 
in water. The cycling program instructed into the thermocycler (GeneAmpPCR 
System 9700) was 5 minutes at 95 °C, followed by 50 seconds at 95 °C, 50 
seconds at 60 °C, 1 minute per kb of template at 68 °C, for 18 cycles, and then 
extension time at 68 °C for 7 minutes. Methylated DNA was digested with 0.5–
1 µL DpnI enzyme (NEB) for 1 hour at 37 °C. The digested PCR product was 
then transformed into competent cells (method 2.11.4.4), and a few colonies 
were picked (method 2.11.4.5). Minipreps of phage DNA (method 2.11.4.6) 
were sequenced to check if clones contained the desired mutation, and the 
successful clones were grown into the V31C phage (as in method 2.11.4.7). 
 
2.11.5 Cloning on a M13mp phage vector 
2.11.5.1 Longer mutant phage constructs 
The pQR226 plasmid (from the Ward lab collection, at UCL) was utilised as a 
source plasmid for the generation of sticky-end DNA fragments by restriction 
digestion. The pQR226 plasmid was cut with KpnI (2 sites) or with BamHI (2 
sites) restriction enzymes (NEB) which generates two fragments, one of 
approximately 1 kb and another of 4 kb, respectively. After digesting the source 
plasmid with the restriction enzymes for 1 hour at 37 °C, the DNA fragments 
were run and excised from a 2% agarose gel (method 2.7.1). The digested 
	  	   50	  
_________________________________________________________________"Chapter"2"
fragments were excised from the gel under a UV lamp and extracted using a gel 
extraction kit (Qiagen, QIAquick #28704), following suppliers’ 
recommendations. Similarly, the cloning vector (M13mp18 plasmid, NEB) was 
digested with restriction enzymes, ~ 1 µL KpnI for the “+ 1kb” construct and ~ 1 
µL BamHI for the “+ 4kb” construct, and extracted from a 2% agarose gel 
(method 2.7.1). The 1 kb and 4 kb fragments were then ligated with the digested 
M13mp18 cloning vector (as in method 2.11.4.2) and transformed into XL-1 
blue competent cells (Agilent). For this, 50 µL of XL-1 bue competent cells were 
mixed with ~ 5 µL of the ligation mixture for transformation. This mixture was 
left on ice for 20 minutes, and was then subjected to a heat shock at 42 °C for 45 
seconds. The transformed cells were then left on ice for 3 minutes. 200 µL of LB 
medium was added to the transformed cells and briefly mixed. 100 µL of this 
mixture was added to ~ 4 mL of 0.7% LB/agar (containing 200 µL of E. coli 
cells, IPTG, and X-gal), and gently mixed. Immediately after, the mixture was 
poured onto a 1.5% LB/agar plate, and quickly but gently swirled clockwise to 
evenly distribute the LB/agar over the surface. The plate was left to set on a 
laminar flow hood, and incubated for 16 hours, at 37 °C. The following day, the 
recombinant plasmids were selected by blue-white colour screening. Single 
isolated white plaques were picked from the plates using a sterile loop or a 
pipette tip, and transferred into 5 mL of LB/tetracycline medium inoculated 
with an overnight culture of E. coli cells, and allowed to grow overnight at 37 °C, 
200 rpm. The cultures were then miniprep (method 2.11.4.6). The collected 
plasmids were run on a diagnostic digestion gel and sequenced, to confirm the 
phage plasmids contained the inserted DNA fragments. If cloning was 
successful, a ~ 100 µL aliquot of the cultured mutant phage (used for the 
miniprep) was added to 40 mL of LB/tetracycline medium inoculated with ~ 200 
µL of E. coli cells, and incubated overnight at 37 °C, 200 rpm. The next day, the 
phage was purified by PEG/NaCl precipitation (method 2.2.1). 
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CHAPTER 3 – Filamentous bacteriophage as a scaffold for 
chemical and genetic modifications 
 
 
3.1 Introduction 
The simplicity of the filamentous bacteriophage, combined with its stability, 
allows for surface chemistry and genetic modulation. Most of its proteins can be 
chemically manipulated without compromising its functionality, making the 
phage an attractive platform for controlled and site-specific modifications [1]. 
The virus is also stable to a broad range of conditions unlike many other 
biological materials, being resistant to elevated temperatures and the presence of 
non-aqueous solvents [2]. Although the virus’ genome tolerates mutations, this 
can be problematic as it may disrupt the correct assembly of the bacteriophage 
particle [2,3] – quite frequently, the only method to assess if the mutation of 
interest results in a viable phage is by trial-and-error. In that sense, genetic 
engineering is generally considered to be more time consuming than chemical 
approaches. In the long term, however, it may counterbalance. Bioconjugation 
protocols to chemically modify the phage have usually longer hands-on time as 
they need to be constantly repeated to replenish the used sample; if correctly 
handled, a genetically modified phage plasmid can be stored almost indefinitely, 
resulting in a homogeneous sample of the mutated phage particles. As with most 
things in science, it is a matter of trade-off. 
 
In this chapter, chemical and genetic engineering methods to modify the p3 and 
p8 proteins of the filamentous phage are explored. Ultimately, some of these 
modifications will be integrated in phage-based biosensing platforms, as 
exemplified by the work in Chapter 4 and 5. 
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3.1.1 Filamentous bacteriophage structure and properties  
Filamentous bacteriophages are a family of single-stranded DNA viruses that 
infect a variety of Gram-negative bacteria, including Escherichia coli, Salmonella 
enterica, Xanthomonas campestris and Pseudomonas aeruginosa [4]. The most well-
studied and characterised of these filamentous phages belong to the Ff class, 
named after their method of host cell infection via the F pilus on the surface of 
E. coli cells. The Ff viruses include the M13, fd and f1 bacteriophages, which 
possess a > 98% homology at the DNA sequence level [2]. All experiments 
described in this thesis were done using the M13 and fd phages. The overall 
structure of these phages is identical, with their p8 protein sequence differing in 
a single amino acid (M13 has an asparagine at position 12 while the fd phage has 
an aspartic acid residue). 
 
Ff viral particles are thin and long, semi-flexible filaments, with a diameter of 
about 6 nm and 800 nm to 1 µm long; interestingly however, the length of the 
bacteriophage can vary depending on the length of its encapsulated DNA [5] – 
this specific feature was explored in Chapter 5. Ff phages are not lytic, but 
opportunistic − the phage release does not result in bacterial cell death; yet, the 
infected cells grow and divide at a reduced rate [4], which is visible by a much 
less turbid (and hence, a lower optical density, OD) growth media solution, 
suggesting less bacterial cells present in the culture. Fig. 3.1 shows a picture of 
the sidewall of two flasks, one containing an E. coli culture not infected with 
phage, and the other containing an E. coli culture infected with the phage. 
 
As described in Chapter 1, Ff phage genome encodes a total of eleven proteins, 
five of which are structural – 2700 copies of a major coat protein (p8) capped 
with 3–5 copies of four minor coat proteins (p3 and p6, p7 and p9, on the 
proximal and distal ends, respectively). An illustration of the filamentous 
bacteriophage is given in Fig. 3.2. 
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Figure 3.1: Differences in turbidity of a bacterial culture inoculated with phage. 
Cropped sidewall picture of flasks of a non-infected E. coli (TOP10 F’) culture and of an 
E. coli culture infected with M13. Although the M13 is a non-lytic phage, it slows down 
E. coli bacterial growth. The decrease of turbidity, indicating fewer E. coli cells in 
solution, is obvious by eye. Both cultures were grown using the same conditions, in LB 
media, and incubated at 37 °C, for 5 hours. E. coli was infected with M13 at the zero 
hour time point. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2: Scheme illustrating the structure of the filamentous bacteriophage. The ~ 
900 nm filament has five structural proteins and a 6.4 kb single-stranded circular DNA 
(not drawn to scale). Section of the long axis of the filamentous bacteriophage (PDB 
entry: 2C0W) made of 2700 copies of assembled p8 proteins along its length. Structure 
of a single p8 protein, with lysine (Lys 8) and alanine (Ala 1) highlighted in red. 
Hydrophobic interactions between the adjacent copies of p8 protein are responsible for 
the packed capsid surrounding the bacteriophage.  Bacteriophage illustration adapted 
from [4]. 
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3.1.2 Filamentous phage as a versatile biomaterial  
As illustrated in Chapter 1, multiple groups have taken advantage of the 
bacteriophage structural features, and also its tolerance to extreme conditions of 
temperature (> 80 °C), pH (pH 3 to pH 11), and presence of organic solvents [2, 
7]. Filamentous phages have been reported as a scaffold in material sciences, such 
as nanowires and films for nanoelectronic applications [8–10], and in medical 
sciences, in both diagnostics and therapeutics, such as for bioimaging [11], drug 
delivery systems [12], as probes for detecting cancer biomarkers [13], and in 
biosensors for the detection of pathogenic targets [14]. The extensive list of 
nanotechnology applications relies on the development of methods to chemically 
and genetically modify the bacteriophages’ surface. Furthermore, the filamentous 
structure of these phages also grants them with the ability to align under flow, 
which has also been exploited for diagnostic purposes [15]. 
 
3.1.2.1 LD and M13 alignment 
M13 is a long and thin semi-rigid construct [16] and its alignment in flow on 
spectroscopy techniques has been investigated [15, 17]. Linear dichroism (LD) is 
an absorbance-based spectroscopy technique that informs on the orientation of 
the electronic transition moments of a sample, by using polarized light [18]. LD 
will be a technique used throughout this thesis, especially on Chapter 5, where 
different phage designs were integrated in a LD-based diagnostic platform. 
 
The first example of a filamentous bacteriophage LD spectrum was shown by 
Clack and colleagues, in 1992 [19]. To obtain an LD spectrum, the sample must 
be induced to align, so ideally, these molecules should have a high aspect ratio. 
Fig. 3.3 illustrates LD spectroscopy main components and how they contribute 
to the alignment of filamentous structures. 
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Figure 3.3: Linear dichroism principle and quartz components. (Left) Illustration of an 
LD quartz Couette flow cell and the principle of LD on the alignment of filamentous 
particles (green) when shear force is off (a) and on (b) by the rotation of the capillary 
(blue arrows). (Right) Photo of some of the components for LD and FDLD 
spectroscopy. From left to right: a filter, a rod and a quartz capillary. Disposable yellow 
tip for size reference. 
 
 
LD is mathematically defined as the difference in absorption of light linearly 
polarized parallel and perpendicular to the orientation axis of a molecule [18]. 
When the transition moments within a sample are aligned more parallel than 
perpendicular with respect to its orientation axis, this results in a positive LD 
signal. A negative LD signal is observed when the transition moments are 
aligned more perpendicular than parallel in regards to the molecules’ orientation 
axis. In simpler terms, a linear molecule, such as DNA or a filamentous 
bacteriophage, can align under flow and the degree of its alignment can be 
measured. Fig. 3.4 shows the M13 filamentous bacteriophage LD fingerprint 
spectra, using the parameters given in Table 3.1. The signal derived from the 
viral DNA and the p8 proteins dominates the LD spectrum over the minor coat 
proteins. The more concentrated the phage sample (hence, more phage particles 
in the sample), the more intense the LD signal will be – both due to the Beer-
Lambert law and inter-particle interactions favouring the phage being parallel to 
each other. The largest peak detected is in the far-UV region and it corresponds 
to the electronic transitions from the peptide backbone. Throughout this thesis, 
the LD signal at 225 nm is tracked for modifications happening to the overall 
alignment of the phage, because it illustrates alterations to its long orientation 
axis. The broader peak in the near-UV region is from the absorbance of the 
aromatic amino acids tryptophan and tyrosine in the p8 protein.  
a)# b)#
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Table 3.1: Parameters used for LD and FDLD experiments. All measurements made 
on Jasco J-815, Jasco J-1500 and Jasco J-720 spectropolarimeter. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: Filamentous bacteriophage LD spectra. Example of LD spectra at a range 
of M13 bacteriophage concentrations in phosphate buffer (Chapter 2, method 2.8.2). 
The peaks intensity at 225 nm and near-UV region increase with increasing phage 
concentrations. Measurements recorded using parameters given in Table 3.1. 
 
 
 
3.1.2.2 FDLD and M13 intrinsic fluorescence 
Fluorescence detected linear dichroism (FDLD) is a spectroscopy technique that 
follows the same principles as LD, except it detects fluorescence rather than 
absorbance of the aligned molecules. For this reason, it is considered to be a 
more sensitive technique [20,21]. This is observable when comparing the near-
UV peak of the phage, illustrated in Fig. 3.4 and Fig. 3.5 – for example, at the 
same concentration of 0.2 mg/mL, the LD signal intensity at 280 nm is 0.0054 
and the FDLD signal intensity at 280 nm is 0.0996, an almost 20-fold increase. 
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The near-UV peak in the phage originates from the two tyrosines and one 
tryptophan of the p8 protein [1]. This grants the phage with intrinsic 
fluorescence, which can be measured in a spectrofluorimeter (Fig. 3.5). An 
important consideration is that of tryptophan emission fluorescence strong 
dependency to the surrounding microenvironment [20]. The fluorescence 
properties of the phage were further discussed in Chapter 5, when constructing a 
longer mutant phage and a mutant phage with an extra tryptophan.  
 
 
 
 
 
 
Figure 3.5: Filamentous bacteriophage intrinsic fluorescence. (Left) FDLD spectra of a 
range of concentrations of M13 bacteriophage (Chapter 2, method 2.8.2). The near-UV 
peak derives from the aromatic amino acids in the p8 protein, tryptophan and tyrosine. 
Measurements recorded using parameters given in Table 3.1. A Semrock 300 nm long-
pass edge filter was used to block transmitted incident light. (Right) 3D plot illustrating 
the fluorescence emission intensity at a range of excitation wavelengths, of the aromatic 
amino acids on the phage surface. Data collected on a Jasco FP-6500 spectrofluorimeter. 
 
 
 
3.2 Results and discussion 
Chemical and biological approaches for manipulation of the bacteriophage 
surface were explored. More specifically, we describe modifications to the p3 
proteins (section 3.2.1) and to the p8 proteins (section 3.2.2). 
 
3.2.1 Anchoring the phage by one-end 
Functionalised-phage particles immobilised onto a surface could be used on the 
design of M13-based microfluidics biosensing platforms. This type of set-up was 
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used to develop the work on Chapter 4. It could also be an interesting and useful 
feature to integrate in the spectroscopy-based biosensor described in Chapter 5.  
Anchored phage particles have been previously used as detection elements in 
biosensing platforms [22–25]. The reported advantage of this set-up over 
standard immunoassays is that the large surface area of the anchored 
functionalised phage results in amplified output signals [25]. Anchoring the 
particle by its p3 protein allows for the surface of the phage, made of 2700 copies 
of p8 proteins, to be functionalised with molecular recognition elements, such as 
antibodies. Thus, for example, a biosensing platform using antibody-
functionalised phages (e.g. anti-E. coli antibodies) anchored onto a surface, could 
be integrated with a microfluidics system for the detection of pathogenic bacteria 
(e.g. E. coli). Another application for the anchored phage particle could be to use 
it as a nanosensor to detect flow variations – the proof-of-concept to this 
biosensing platform, with envisioned application on vascular flow imaging, is 
explored in Chapter 4.  
 
An approach to anchor the phage by one-end could be to chemically or 
biologically modify the p3 protein. In here, three methods were experimented – 
immobilising the phage onto a surface by an antibody, by a magnetic bead, and 
by a His-tag motif. The considerations were costs and overall simplicity of the 
protocol, time required to complete the protocol, and how easy would it be to 
transfer this system to a microfluidic biosensor set-up. 
 
3.2.1.1 Anchoring the phage using an antibody 
Anchoring the phage using an antibody was the approach chosen for the 
biosensing platform described in Chapter 4.  Although the work in Chapter 4 
was the only application in which this set-up was tested, it is believed that it 
could be easily integrated in different biosensing designs. This method exploited 
the eight cysteines present on the p3 protein, each of these being involved in 
disulfide bonds [26]. These disulfide bridges can be broken using a reducing 
agent, such as TCEP (tris-(2-carboxyethyl)phosphine). The exposed thiol groups 
can be then conjugated to maleimide groups. A reaction with a bifunctional 
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reagent, such as SMCC (succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-
carboxylate), would then crosslink the thiol groups from the p3 protein of the 
bacteriophage to the maleimide-modified amino groups of an antibody. Hence, 
the final product of this reaction is a bacteriophage with antibodies on the p3 
protein (i.e. an antibody on the end of the phage).  A detailed protocol is given in 
Chapter 2 (method 2.4.1.1), and illustrated in Fig. 3.6. To our knowledge, this 
was the first report of the cysteines on the p3 proteins being used for this 
purpose. 
 
 
 
 
 
 
 
 
 
Figure 3.6: Schematic representation of the 2-steps modification of the bacteriophage 
to conjugate antibody (i.e. anti-collagen antibody) and fluorescent dye (i.e. TRITC). a) 
Conjugation of the maleimide-derivatised antibody (maleimide group introduced using 
SMCC) to the thiol groups (-SH) of the p3 protein. b) Conjugation of the dye (shown 
as red dots) to the primary amines (-NH2) of p8 protein, as explored in section 3.2.2.1. 
Figure not drawn to scale. 
 
 
It is known, from the M13 genome sequence, that wild-type phage has cysteines 
in the minor coat proteins – however, the p8 protein can be mutated to have 
thiol groups on its surface, as explored in Chapter 5. The presence of cysteines 
on the p3 protein of the bacteriophage was further confirmed by ELISA 
(enzyme-linked immunosorbent assay). For this, maleimide-coated 96 well-
plates were used. The disulfide bonds of wild-type M13 bacteriophage were 
reduced using TCEP, to produce free sulfhydryls. The reaction was left to 
incubate for an hour at room temperature and excess reagent removed using a 
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PD-10 column. Wild-type M13 bacteriophage not reduced with TCEP was 
used as a control for this experiment. A standard ELISA protocol was then 
followed (Chapter 2, method 2.6.1), using a horseradish peroxidase (HRP) 
conjugated anti-M13 antibody to detect for the presence of phage. If the wells 
with reduced phage turned into a colourful product, we could confirm the 
coupling between the thiols of the phage and the maleimide molecules anchored 
to the microplate was successful. If the cysteines on the p3 protein are not 
reduced, and hence there are no thiol anchoring molecules to attach to the 
maleimide groups on the wells, the phage would be simply rinsed off the 
microplate and there would be no colour development. Indeed, these 
suppositions were observed during an ELISA, as shown in Fig. 3.7. 
 
 
 
 
 
Figure. 3.7:  Anchoring the phage onto a maleimide surface. (Left) ELISA picture of 
serial dilution of the wild-type phage with and without TCEP on a maleimide-coated 
plate, after adding 2,2'-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) 
solution. (Right) Plot of the average absorbance at 410 nm at decreasing phage 
concentrations, preceded by a 5 mM TCEP reaction (black bars) or without a TCEP 
reaction (grey bars).  Error bars represent standard deviation from two independent 
ELISA wells. 
 
 
The wild-type M13 phage has cysteines residues on the p3 proteins. The ELISA 
confirmed there are sulfhydryl groups in the phage, as long as a reducing agent 
(such as TCEP) is added to the reaction. Hence, it was expected the phage was 
anchored to the surface of the wells by its p3 proteins, only by one end. This 
explored ability, to anchor the wild-type phage to surfaces by the existing 
cysteines, is important for the assay described on Chapter 4.  
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3.2.1.2 Anchoring the phage using a magnetic bead 
Anchoring phage particles to a surface could also be achieved using magnetic 
beads. A seemly straightforward method to attach the phage by one-end to a 
magnetic bead would be to capture it using anti-p3 antibodies (reactive against 
p3 proteins of the phage) that have been conjugated to protein A-functionalised 
beads (the Fc region of antibodies binds to protein A [27, 28]). This final 
product, of a phage attached to the surface of a magnetic bead via an anti-p3 
antibody, will be denominated as phage-bead immunocomplex. An illustration of 
this set-up is given in Fig. 3.8. 
 
 
 
 
 
 
 
 
 
 
Figure 3.8: Schematics of the idealised phage-bead immunocomplex on a microfluidics 
set-up. In an ideal scenario, a monolayer of the phage-bead would cover the surface of a 
microfluidic slide. Not drawn to scale. 
 
 
The set-up illustrated on Fig. 3.8, using a phage-bead immunocomplex anchored 
onto a microfluidics platform, was initially designed to integrate in the LD-based 
biosensor described in Chapter 5. It was hypothesised that this system could 
improve the range of detection and increase the versatility of the current 
biosensor. Immobilising the phage particles onto a surface using magnetic beads 
has the advantage of an easy switching on/off modality (i.e. a magnet would be 
enough to capture/release the phage-bead from the surface). The phage-bead 
immunocomplex illustrated in Fig. 3.8 would have to be created in a chemically 
controlled process. One phage per bead was the intended final product – this 
would cover the surface of a microfluidic set-up, ideally creating a monolayer of 
Wild%type*phage*
An0%p3*an0body*
Protein*A%func0onalised**
magne0c*bead*
PHAGE%BEAD*IMMUNOCOMPLEX*
MAGNET'
Microfluidic*chip*surface*
Magnet'ON'
Magnet'OFF'
Microfluidic*chip*surface*
FLOW*
Y 
Y Y Y Y 
Y
Y 
Y Y Y 
Y
Y Y Y 
YY Y YY Y
Y Y 
Y Y Y 
Y
Y Y 
Y Y Y 
Y
Y Y 
Y Y Y 
Y
Y Y 
Y Y Y 
Y
Y Y Y 
Y Y Y 
	  	   64	  
_________________________________________________________________"Chapter"3"
phage-bead particles. The motivation for having only one phage rather than 
several phages anchored to a bead was simplicity – one phage per bead was 
believed to be an easier, more predictable system for the subsequent spectroscopy 
experiments.  
 
In order to integrate the phage-bead immunocomplex into a spectroscopic-based 
biosensing platform, the size of the magnetic beads is a factor to consider, as 
large diameter beads would unfavorably increase the amount of light scattered 
during the spectroscopy measurements. From serial experimentation, it was 
concluded the commonly used 2.8–1 µm diameter magnetic beads were not 
compatible with our spectroscopy techniques. A more exhaustive market search 
revealed that the available magnetic beads that are simultaneously small and 
functionalised with protein A are limited. Ultimately, 50 nm diameter protein A 
functionalised magnetic beads were tested to conjugate with the phage. Although 
the observable effect of light scattering was indeed insignificant, smaller diameter 
beads were found to be much harder to work with, as they take much longer to 
sediment with a magnet. 
 
Additionally to the properties of the chosen magnetic beads, the magnet used to 
capture these beads is another important consideration in the design. The main 
application of 50 nm magnetic beads is on magnetic-activated cell sorting 
(MACS), in which high-gradient magnetic field columns are used to capture 
cells that were tagged with the beads [29]. At a stage where the method was still 
being devised, these columns were considered to be prohibitively expensive. 
Standard neodymium magnets were tested instead. Because the application of 
the purchased magnets is not targeted for immunoprecipitation assays, an 
experiment was carried out to test whether the neodymium magnets could 
magnetise the 50 nm magnetic beads. Since these beads are functionalised with 
protein A, it is possible to label them with an amine-reactive fluorescent dye 
(such as TRITC, tetramethylrhodamine isothiocyanate). 20 µL of a stock 
solution of TRITC (10 mg/mL) was added to an aliquot of 1011 50 nm magnetic 
beads in PBS buffer, and left to react for 2 hours at room temperature. The 
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labelled beads were then collected and the supernatant discarded. The labelled 
beads were washed two times with PBS buffer. 2 µL of the beads (in a total of 
100 µL in PBS) were pipetted into the chamber of the microfluidic slide. This 
slide was fixed to the stage of a fluorescence microscope and the top wall of the 
microfluidics chamber was set on focus. A time-lapse was recorded before and 
after the N40 neodymium magnet was set on top of the microfluidic slide. As 
shown in Fig. 3.9, after approximately 1 minute, several of the fluorescently 
labelled magnetic beads were pulled to the surface, towards the magnet. Thus, it 
seemed the N40 neodymium magnet could pull the 50 nm magnetic beads out of 
solution, with some of the beads reacting instantly to the applied magnetic field.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9: Neodymium magnet capturing 50 nm magnetic beads. (Top) For this 
experiment, a N40 neodymium magnet was fixed on top of a chambered microfluidic 
slide and then set on the stage of an inverted microscope (Bottom) Two snapshots of the 
top of the microfluidic slide, before and after the magnet was fixed to the surface of the 
slide. Several TRITC-coated 50 nm magnetic beads (bright spots) got pulled by the 
magnet after a few seconds. Time-lapses were collected using a 10x objective on an 
inverted wide-field microscope (Olympus, IX71). Focus was on the top wall of the 
microfluidics chamber. Scale bar: 100 μm. 
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The question of if and how long it takes to collect all the beads out of solution 
was left unanswered by this experiment. By naked eye, a suspension of 
approximately 1011 50 nm beads in buffer became completely clear after leaving it 
on the magnet for approximately 10 hours. 
 
The first part of the protocol consisted of conjugating anti-p3 antibodies to the 
magnetic beads. The second part was to immobilise the phage particles onto the 
surface of the antibody-coated magnetic beads. This protocol was set-up 
following manufacturer instructions, and as described in Chapter 2 (method 
2.4.1.3). The antibodies were captured on the surface of the protein A-
functionalised magnetic beads, and these were then added to the phage sample so 
that there are more beads than phage particles. The reaction was set at a roughly 
10:1 bead-to-phage ratio, envisioning that the antibody-coated beads would 
capture a phage particle. TEM images of the samples were collected, in search of 
the phage-bead immunocomplex (Fig. 3.10).  
 
 
 
 
 
Figure 3.10: TEM image of the phage-bead immunocomplex. Micrograph of apparent 
single phages anchored by one-end to the surface of magnetic beads (examples indicated 
with arrows). TEM image zoomed at phage anchored by one-end to magnetic bead. 
Scale bar: 100 nm. 
 
 
Fig. 3.10 shows TEM images of a single phage anchored by one-end to the 
surface of a magnetic bead. As observed, most of the magnetic beads did not 
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capture phage particles and remained phage-free. Based on eight TEM images, 
the apparent efficiency of the described conjugation protocol was approximately 
5 %. This was calculated by counting the number of phage-free beads and the 
number of beads with a phage attached to it, in these eight micrographs. 
Nonetheless, the estimated yield is possibly an overestimation – it is challenging 
to measure this value based only on TEM, as the images might not be 
representative of the whole sample and it is difficult to confirm the phage is 
actually anchored to the bead. Further testing and complementary experiments 
would be necessary to investigate the phage-bead immunocomplex. An ELISA 
would not be suitable, as this would require the use of an anti-phage/HRP 
antibody to detect the phage – this antibody could simply bind to the protein A 
on the beads. Perhaps, labelling the phage with a fluorescent dye prior to its 
conjugation to the beads and measuring the fluorescence intensity of the sample 
after conjugation could provide some insight into the phage-bead 
immunocomplex. Using standard spectroscopy techniques, it may be challenging 
to measure the signal generated as it would be diffused in a large volume and 
may not be above background. Optical methods have been developed to detect 
single molecules, which confine samples to very low volumes ensuring a high 
local concentration of recognition molecules [30].  
 
The ultimate goal of these experiments was to design and develop a method to 
anchor a phage particle onto a magnetic bead. This phage-bead construct was 
believed to have applications extendable to microfluidic biosensor, in a 
spectroscopy-based platform. Although in principle it appeared to be a simple 
design, several experimental components of this project were rather challenging. 
The small sized beads were difficult to work with, and capturing/washing the 
magnetic beads using a magnet was a rather lengthy protocol – on average, 6 
days were needed to complete the whole protocol, mainly because of the number 
of washing/capturing steps required to remove unbound molecules (each taking 
approximately 10 hours). It was also noticed that the pellet resultant from the 
captured beads is delicate and unstable – any vibration on the working bench or 
even during pipetting could dislocate the pellet, making it necessary to wait 
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another several hours for the pellet to get compacted. Another limitation of this 
design is the cost of the reagents (the anti-p3 antibodies and the functionalised 
50 nm magnetic beads). This would be especially obvious during early 
development stages and optimisation, which would require a trial-and-error 
approach, flagging a warning for its adoption as a proof-of-concept assay. To 
produce the 1-to-1 phage per bead complex in a robust method, it would be 
necessary to kinetically study the interaction between the beads and the phage, to 
understand, for example, the diffusion rate of the phage and capture efficiency of 
the beads. Although it is potentially feasible to integrate a phage-bead 
immunocomplex in a microfluidics set-up, these samples proved to be inadequate 
for the originally intended spectroscopy-based biosensing platform.  
 
3.2.1.3 Anchoring the phage using a His-tag moiety 
Since the previous method, using the 50 nm magnetic beads, was concluded to 
be challenging to integrate with the spectroscopy-based biosensing platform, 
His-tag motifs were considered as an alternative. Genetically inserted His-tag 
motifs on the p3 proteins [31] could be used to pull the phage particles onto 
nickel-coated surfaces, anchoring them by one-end.  
 
A polyhistidine-tag, generally called His-tag, comprises six to fourteen histidine 
residues, fused to the N- or C-terminal of a protein. His-tags have a wide range 
of applications for binding assays and immobilisation protocols [32]. 
Polyhistidine-tags are a commonly used tool for affinity purification methods. 
Most His-tagged recombinant proteins can be effortlessly purified as the 
histidines on the His-tag have high affinity for divalent nickel ions. Nickel ions 
can be loaded over surfaces derivatised with chelating agents, such as 
nitrilotriacetic acid (NTA), covalently linked to a matrix. This way, nickel-
coated surfaces can be used to immobilise the His-tagged proteins of interest. 
Bound proteins can be then released from the nickel surface using mild 
conditions. Imidazole, an analogue of histidine, is generally used to displace the 
His-tagged protein as it competes for the coordination bond between histidine 
and the nickel ions. Low pH buffers can alternatively be used to elute the 
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proteins, as they protonate the histidines on the His-tags, although care must be 
taken as exposure to low pH may damage the protein of interest [33]. The 
common drawback of using a polyhistidine affinity tags is the nonspecific 
binding of untagged proteins. Other anchoring tag motifs, such as biotinylation-
accepting domain affinity tags, have shown to give higher yields and purity of 
tagged proteins [34].  
 
A six histidines His-tag motif was cloned to the N-terminal of the p3 proteins of 
the phage (Chapter 2, method 2.11.4), and a western blot (Chapter 2, method 
2.7.5) was set-up to confirm its expression. Two His-tagged phage cultures were 
checked – the 1st generation His-tagged phage and the 2nd generation His-
tagged phage.  
 
 
 
 
 
 
 
 
 
 
Figure 3.11: Western blot to confirm His-tag on the p3 proteins of the phage. Lane on 
the left, marker with respective protein molecular weight (kDa). Lanes on the right, two 
independent propagations of the His-tagged phage (1st and 2nd generation). 
 
 
A 2nd generation His-tagged phage was grown directly from an aliquot of the 1st 
generation phage. This was to determine whether the p3 proteins of these 
phages are still functional and capable of infecting the bacterial host despite the 
histidine tag. It was confirmed that the 2nd generation phage was viable and its 
production yield was comparable to the 1st generation His-tagged phage. 
Looking at the western blot in Fig. 3.11, both 1st and 2nd generation phages 
expressed the His-tag motif – on both lanes, a band is visible at ~ 60 kDa, which 
is known to be the size at which p3 protein runs on a gel [35]. These are useful 
observations as it suggests it may not be necessary to repeat molecular cloning 
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steps to replenish the stocks of His-tagged phage. A carefully stored aliquot of 
the parental His-tagged phage could be enough to propagate another generation. 
 
After successfully confirming the p3 proteins were modified with His-tag motifs, 
it was necessary to check whether these His-tags were actually exposed and 
capable to interact with nickel ions-coated surfaces. Nickel-chelating magnetic 
beads were used for a pull-down assay, aiming at testing the binding of His-
tagged phage to nickel. Initially, an ELISA was designed to detect if this binding 
occurred. However, it was observed that probably the nickel ions from the 
magnetic beads react with the horseradish peroxidase (HRP) conjugated to 
antibodies, giving a green coloration even without the presence of the analyte of 
interest (and hence, giving false positive results). Consequently, a protein gel was 
used instead to assess for the interaction between the His-tagged phage and the 
nickel-coated beads.  
  
An illustration of a pull-down assay, using nickel-chelating magnetic beads to 
capture His-tag phage, is given in Fig. 3.12. Protocols for the pull-down assay 
and the protein gel are given in Chapter 2 (method 2.10.1; method 2.7.4). Four 
samples were separately handled – two His-tagged phage samples and two 
controls. His-tagged phage and untagged phage (control) were mixed with 
nickel coated-magnetic beads in phosphate buffer. With the use of a magnet, the 
magnetic beads were pelleted to the bottom of the eppendorf and the 
supernatant carefully discarded and kept to later run on a gel (Fig. 3.12, Lane 2-
5). 250 mM imidazole elution buffer was added to the magnetic beads. The 
magnetic beads were again precipitated using the magnet, and the elution 
samples were collected to run on a gel (Fig. 3.12, Lane 6-9).  
 
The gel shows fewer bands on the elution samples, implying that a considerable 
fraction of the phage did not bind to the beads and was therefore washed away. 
Nonetheless, a characteristic band is visible in these lanes corresponding to the 
p8 proteins, suggesting the presence of phage. One of the control samples  
(untagged phage, on lane 8) also shows a fainter band for p8, however this was 
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considered to be due to non-specific interactions to the beads. The presence of 
this band on lane 8 could be explained by the higher initial concentration of 
phage on this control sample (especially visible by the brighter 10 kDa band on 
lane 4 in comparison with the other lanes), which could have further promoted 
unspecific binding to the magnetic bead. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.12: Pull-down assay using nickel-chelating magnetic beads. (Left) Precast (4-
12%) Bis-Tris gel of nickel-chelating magnetic beads assay. Lane 1 - protein ladder. 
Lane 2,3 and 6, 7 respectively – 2 samples of His-tag modified phage (1st and 2nd 
generation) after incubation with beads, and the samples of His-tag modified phage (1st 
and 2nd generation) after elution with imidazole. Lane 4, 5 and 8, 9 respectively – 2 
control samples (untagged phage) after incubation with beads, and the control samples 
(wild-type phage) after elution with imidazole. (Right) Pull-down assay design using 
nickel-chelating magnetic beads. In the illustrated example, the sample is a mixture of 
untagged phage and His-tagged phage. Ideally, the beads would capture only the tagged 
phages, which could then be eluted. In the experiments demonstrated by the gel 
however, the tagged and untagged phage samples were handled separately.  
 
 
The resulting protein gel from the pull-down assay using the magnetic beads 
provided a good indication that the His-tag motifs on the p3 proteins are 
exposed and capable of binding to nickel-chelating surfaces. Therefore, the His-
tag motif could be used as a simple and affordable alternative to immobilise 
phage particles by one-end onto appropriate surfaces. Featuring the His-tagged 
phage in the microfluidics biosensor design has great interest, as the genetically 
introduced His-tag could serve as an anchoring point to surfaces, which could 
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then be “turned off” by using low pH or imidazole elution buffers, releasing the 
phage particles from the surface. We consider it is possible to integrate this 
anchoring functionality with the spectroscopy-based biosensor described in 
Chapter 5, similarly to how other His-tagged proteins are immobilised to the 
surface of chips [36]. However, this was not pursued further as the biosensor 
platform was not developed to the point that this could be tested. The His-tag 
moieties could also be explored as a method to separate phage particles from a 
reaction mixture containing other biomolecules – for example, after chemically 
modifying the phage surface (as explored in section 3.2.2), the modified phages 
could be captured using nickel-chelating surfaces of magnetic beads or columns, 
ensuring a standardised purification method for functionalised phage particles. 
 
 
3.2.2 Modifying the phage surface  
The p8 protein is the most abundant of the phage proteins, with 2700 copies 
around its long axis, and it is smaller (~ 5 kDa) than the p3 protein. It seems 
intuitive to think any modifications to p8 will make the biggest impact on the 
phage. However, care must be taken on chemically and genetically modifying the 
p8 proteins, as the overall structural change to the phage could be too drastic to 
keep it viable. In this section, we describe three functional modifications to the 
p8 proteins: labelling with TRITC dye for the imaging work on Chapter 4, 
bioconjugation with an antibody as a probe for the biosensor platform described 
in Chapter 5, and decorating the phage surface with DNA molecules using a 
novel protocol. Genetic engineering techniques to mutate the p8 protein were 
also explored, and documented in Chapter 5. These include the expression of a 
Salmonella-binding peptide in some of the p8 proteins of the phage, the design of 
a mutant phage with a cysteine residue in every p8 protein, a mutant phage with 
an extra tryptophan residue in every p8 protein, and a longer version of the phage 
by encapsulation of a larger genome. 
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3.2.2.1 TRITC dye conjugation 
Tetramethylrhodamine isothiocyanate (TRITC) is an amine-reactive dye, which 
can be conjugated to the lysine residues (position 8) and to the N-terminal of the 
p8 proteins of the phage capsid (Chapter 2, method 2.4.2.1). Others 
fluorophores and near-infrared fluorescent dyes have been previously conjugated 
to the phage [20]. TRITC is commonly used in bioimaging protocols [37] 
because of its photostability and reasonable price. Therefore, it was considered to 
be suitable for labelling the phage for the microscopy imaging done in Chapter 4. 
Because imaging quality directly depends on the quality of labelling, an 
experiment was designed to test which pH would favor the labelling of the 
primary amines on the p8 protein. UV-Vis measurements were used to estimate 
the dye per phage particle ratio. As shown in Fig. 3.13, considering there are 
2700 copies of p8 proteins per phage, using a pH 7.6 buffer results in a ~ 15% 
labelling of the phage surface. A more alkaline buffer promotes a more efficient 
conjugation, resulting in more than 500 molecules of TRITC dye per phage. At 
a pH higher than 8.7, it appears the labelling efficiency is reaching a plateau. 
This is consistent with the literature [38] and believed to be caused by steric 
hindrance and contact quenching between the dye molecules.  
 
 
  
 
 
 
 
 
Figure 3.13: Labelling the phage surface with TRITC. (Left) Plot of the total 
percentage coverage of the phage surface with TRITC in 100 mM borate buffer at a 
range of pH values.  (Right) Illustration of TRITC dye molecule conjugated to the N-
terminal of p8 proteins of the M13 bacteriophage. Molecular docking was done on 
Chimera (PDB entry: 2MJZ) by Dr. Shirin Jamshidi. 
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The labelling of the phage with TRITC was confirmed by LD, in which a 
characteristic dye peak can be observed in samples conjugated in buffers at pH 8 
and pH 9 (Fig. 3.14).  
 
 
 
 
 
Figure 3.14: LD spectra of phage decorated with TRITC in buffer at pH 8 and pH 9. 
LD signal zoomed at TRITC dye peak, showing that the signal is more intense at 
higher pH (which translates into having more dye molecules per phage particle). 
 
 
Labelling the surface of the phage with TRITC was an important step for the 
microscopy-based platform described in Chapter 4, ensuring an adequate 
fluorescence signal to image the phage constructs. Other fluorophores, such as 
Alexa Fluor and coumarin dyes, were also successfully conjugated to the phage to 
decorate its capsid, and explored as probes in spectroscopy-based platforms 
(Chapter 5). Indeed, the aptitude of the phage to accommodate chemoselective 
dual-modifications (i.e. with a dye molecule plus another biomolecule, such as an 
antibody) endows it with great versatility for the development of multifunctional 
biomaterials, which can be integrated with biosensors. 
 
3.2.2.2 Antibody conjugation 
Linear Diagnostics Ltd. developed a LD-based biosensor using the phage as a 
scaffold. This diagnostic technology is further explored in Chapter 5. Illustrated 
in Fig. 3.15 is the protocol developed by Linear Diagnostics to chemically 
conjugate antibodies and dye molecules to the p8 protein for the LD-based 
biosensor. This method employs the use of p8 protein’s primary amines and, by 
converting them to thiol groups using SATA (N-succinimidyl S-
acetylthioacetate), it is possible to conjugate maleimide-derivatised antibodies. 
One of the strategic attributes of this platform is that it can simultaneously detect 
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a variety of targets in a sample (i.e. multiplexing). This is achieved by conjugating 
a readily maleimide-modified dye to the remaining thiol groups on the surface of 
the phage. A detailed method is given in Chapter 2 (method 2.4.2.2.1). 
 
 
 
 
 
 
Figure 3.15: Scheme of the bioconjugation protocol developed by Linear Diagnostics 
Ltd. for the LD-based immunoassay. All steps carried out at room temperature. a) 
SATA converts primary amines (-NH2) of the p8 protein to thiol groups (-SH). A de-
protection step is also required (with hydroxylamine) to expose the thiol group from the 
reagent. b) Conjugation with the maleimide-derivatised antibody (modified with 
SMCC). c) Conjugation with a maleimide-modified Alexa Fluor 647 dye (shown as 
blue dots) required for the multiplexing modality of the assay. Figure not drawn to scale. 
 
 
Despite the indisputable value of Linear Diagnostics’ biosensing platform, it was 
discussed that several aspects of the technology could be improved and 
alternative methods could be explored. For this, a number of modifications to the 
biosensor were considered, as described in Chapter 5. An example is the 
alternative bioconjugation protocol we explored to conjugate antibodies to the p8 
proteins of the phage, using an aldehyde-hydrazine reaction (Fig. 3.16).  
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Figure 3.16: Scheme illustrating the 2-steps hydrazine-aldehyde chemical reaction, to 
conjugate antibodies to the phage surface. a) Treatment with SANH to incorporate 
hydrazine moieties to the primary amines of the p8 proteins; b) Conjugation of NaIO4 
treated-antibody to the hydrazines. 
 
 
The bioconjugation method from Fig. 3.16 explores the modification of the p8 
protein’s primary amines with hydrazine groups, upon treatment with SANH 
(succinimidyl 6-hydrazinonicotinamide acetone hydrazine) reagent. The 
aldehyde groups of a NaIO4-treated antibody, can then be reacted with the 
hydrazine groups of the phage, producing a phage-antibody conjugate. The 
advantage of using this type of chemical modification instead of the one 
proposed by Linear Diagnostics lays on the ability to control the directionality of 
the antibodies conjugated to the phage. A full explanation and details on the 
outcome of this bioconjugation protocol are given in Chapter 5 (section 5.2.5).  
 
3.2.2.3 DNA strands conjugation 
As detection elements, DNA molecules have the advantage of being cheaper to 
synthesise and, reportedly, more stable than antibodies. Maybe for that reason, 
there has been an increasing interest on chemically conjugating DNA to the 
filamentous phage [15,39,40]. In here, we explored the conjugation of 
DNAzymes to the phage surface, envisioning a LD-based assay for the detection 
of lead ions (Pb2+). 
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3.2.2.3.1 DNAzymes for a Pb2+ detection assay 
Heavy metal ions are common pollutants of the soil and water, and present a 
public health concern [41]. Lead ions (Pb2+) are a widespread metal pollutant 
that can cause serious health damage because of its known adverse effects in 
humans – lead is a potential neurotoxin that can accumulate in the bones and 
kidneys [42]. Recent news, exposing Michigan’s environmental scandal, covered 
the toxicity of lead to humans by consuming contaminated water [43,44]. In this 
incident, several children were critically sick which was believed to have been 
caused by lead poisoning. 
 
DNAzymes [45, 46], also termed catalytic DNA or deoxyribozymes, are 
attractive molecules for heavy metal detection because of their metal-dependent 
activity. DNAzymes have already been explored for metal ions biosensors [47-
53] and are composed of two almost complementary DNA strands, the enzyme 
and the substrate strand. Pb2+-specific DNAzymes, known as “8-17” 
DNAzymes, are made of a substrate strand (17DS) and an enzyme strand (17E). 
Both strands are made of DNA, except for a RNA (riboadenosine, rA) residue 
on the 17DS strand. This rA is the cleavage site – the substrate strand gets 
cleaved by the enzyme strand in the presence of Pb2+ ions [50]. To integrate a 
DNAzyme system in a phage-based biosensor, it is necessary to attach DNA 
probes to the phage surface. Labelling of the phage surface with DNA strands 
has been explored before, using different conjugation methods [15,39,40]. 
However, to our knowledge, this application was not yet considered. The metal 
selectivity of the “8-17” DNAzyme joined with the phage properties could be 
harnessed in an assay for lead detection, exploring the phenomenon of LD. 
 
The phage-DNAzyme system described here was inspired by the work of Yi Lu 
and colleagues [51-53] on DNAzymes and gold nanoparticles. The sequences of 
the constructed DNA structures are given on Table 3.2. To conjugate the 
DNAzyme to the phage, its substrate strand was extended at both the 3’ and 5’ 
ends. These 12-mer extensions are complementary to the DNA strands 
conjugated to the phage (termed as DNA probe 1 and DNA probe 2), 
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consequently hybridising the DNAzyme with the phage. This was expected to 
cause aggregation between the phages, and hence less alignment, resulting in an 
overall decrease on LD signal. However, when lead ions (Pb2+) are added to the 
system, the DNAzyme collapses. The hypothesis was this breakage would result 
in less aggregation between the phages, which would result in an increase on the 
LD signal. Fig. 3.17 illustrates the principle of a LD-based Pb2+ detection 
biosensor.  
 
 
 
Table 3.2: DNA probes and DNAzyme sequences. Sequence of the “8-17” DNAzyme 
17DS substrate strand with 12 bases extension on its ends, 17E enzyme strand, DNA 
probe 1 with a 5’ modification, and DNA probe 2 with a 3’ modification.  
 
 
 
 
 
 
 
 
 
Figure 3.17: Integrating a DNAzyme with phage probes. Two types of chemically 
modified phages, each containing different DNA probes (red, DNA probe 1; green, 
DNA probe 2), were designed. These DNA probes are complementary to the 
extremities of the substrate strand of the Pb2+-DNAzyme. When the DNAzyme binds 
to the DNA probes on the phages, this was expected to cause aggregation between the 
phages, and hence less alignment, resulting in an overall decrease on LD signal. When 
lead (Pb2+) is present however, the DNAzyme collapses. The hypothesis was this 
breakage would result in less aggregation between the phages, which would result in an 
increase on the LD signal.  
DNAzyme rA Pb
2+ 
No aggregation of  phage Aggregation 
(decrease in LD signal) 
Less aggregation 
(increase in LD signal) 
Phage DNA 
Name%% DNA%sequence%
DNA$Probe$1$ 5’$I.link$–$CACGAGTTGACA$3’$
DNA$Probe$2$ 5’$TCACAGATGAGT$–$NH2$3’$
17DS$substrate$strand$ 5’%ACTCATCTGTGAACTCACTATrAGGAAGAGATGTGTCAACTCGTG$3’$
17E$enzyme$strand$ 5’$CATCTCTTCTCCGAGCCGGTCGAAATAGTGAGT$3’$
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3.2.2.3.2 Bioconjugation and gel characterisation 
The bioconjugation protocol to conjugate the DNA probes to the chemically 
modified p8 proteins of the phage was developed with Dr. Dylan Domaille, at 
University of Boulder Colorado. A detailed protocol is given in Chapter 2 
(method 2.4.2.3).  
 
DNA probe 1 and DNA probe 2 were purchased from IDT with chemical 
modifications on its ends – DNA probe 1 had a hydrazine (I-link) group on its 5’ 
end, and DNA probe 2 had an amine modification on its 3’ end. Firstly, the 
amines on the p8 proteins of the phage were modified to aldehyde moieties. The 
phage-aldehyde was conjugated to the I-link of the DNA probe 1. A 
crosslinking reagent was used to conjugate the amine groups of the DNA probe 
2 to the aldehydes of the phage. This bioconjugation protocol generated two 
types of phage-probes, here denominated as phage-DNA probe 1 and phage-
DNA probe 2. As illustrated in Fig. 3.17, the idea was that the DNAzyme 
would link phage-DNA probe 1 to phage-DNA probe 2, by complementary 
pairing between the DNA probes conjugated to the phage and the extensions at 
the ends of the DNAzyme substrate strand. The success of the chemical 
conjugation between the phage and the DNA probes was confirmed by gel 
(Chapter 2, method 2.7.4). Fig. 3.18 illustrates the built phage-probes and the 
characterisation of the constructs on a protein gel. A similar conjugation protocol 
between an I-link modified DNA strand to an aldehyde-phage has been explored 
[39], but, to the best of our knowledge, this is the first report of conjugation 
between an amine modified DNA strand and an aldehyde-phage. 
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Figure 3.18: Labelling the phage with DNA strands and characterisation by gel. (Top) 
Scheme of the conjugation of DNA to the p8 protein of the phage modified with 
aldehyde groups. DNA probe 1 is a hydrazine modified 12-mer strand of DNA, 
conjugated to the modified phage-aldehyde. DNA probe 2 is an amine modified 12-mer 
strand of DNA, conjugated via a crosslinker to the modified phage-aldehyde. (Bottom 
left) Precast (4-12%) Bis-Tris gel. From left to right: protein ladder; 1.3× and 4× 
dilution of phage-aldehyde; 2×, 4× and 10× dilution of phage-aldehyde conjugated with 
DNA probe 1; 1.3×, 2× and 4× dilution of phage-aldehyde conjugated with DNA probe 
2. All samples in PBS buffer. (Bottom right) Precast (4-12%) Bis-Tris gel. Left to right: 
protein ladder; phage-DNA probe 1 reacted for 6 hours with 25 mM hydroxylamine 
(pH 6); Phage-DNA probe 1 without hydroxylamine. Hydroxylamine dissociates the 
conjugated DNA strands from the p8 proteins, and hence the p8+DNA band is no 
longer visible on the gel. This confirms the band is a result of the conjugated DNA. 
 
 
3.2.2.3.3 Preliminary LD studies 
Simple LD experiments were set to explore the properties of the newly 
constructed phage-DNA probes. Unfortunately, due to time restrictions, the full 
potential of this phage-based biosensor could not be investigated.  
 
An interesting observation from the preliminary experiments was the phage-
DNA probe 1 LD signal, which was inverted compared with naked phage, as 
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shown in Fig. 3.19. This result was replicated with another independently 
constructed phage-DNA probe 1 conjugate, in which the same peculiarity was 
noted. A literature search revealed that this phenomenon has been previously 
observed by Carr-Smith and colleagues [15]. They reported that by loading a 
phage particle with several DNA strands, the LD signal of the phage is mirrored, 
probably due to hydrodynamic properties changes to the filamentous structure of 
the phage. 
 
 
 
 
 
 
 
 
Figure 3.19: LD of the phage-DNA probes. LD spectra from the phage-DNA probe 1 
(solid line) and phage-DNA probe 2 (dashed line) constructs, in PBS buffer.  
 
 
To further investigate this phenomenon, a non-conventional LD experiment was 
designed. In these experiments, a circular quartz window was used instead of a 
Couette flow cell, and, contrary to standard LD measurement that induce 
alignment by spinning the phage solution, a manual motion was applied to force 
the filamentous phage particles to align. A drop of wild-type phage stock was 
pipetted onto the surface of a quartz window and induced to align. This was 
achieved by horizontally dragging the drop with a pipette tip, from left to right, 
in parallel strokes over the surface, until completely dry (Chapter 2, method 
2.8.2.3). Next, the quartz window was attached to the front of the LD detector 
and the resulting LD spectrum from the aligned phage was collected. The 
window was then manually rotated 90 ° with respect to the previous position, as 
illustrated in Fig. 3.20, and LD was measured again. 
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Figure 3.20: Alignment of phage on a quartz window. Illustration of the circular quartz 
window with aligned phage (shown as blue lines) dried onto its surface. By rotating the 
quartz window by 90 °, the phage particles will be perpendicularly oriented in respect to 
their original alignment.  
 
 
Fig. 3.21 shows the resulting LD spectra collected from the physically aligned 
wild-type phage onto the quartz window. As expected, the LD spectrum is 
characteristic for filamentous phage particles, with the fingerprint peaks at the 
near-UV (aromatic side chains) and far-UV regions (peptide backbone). By 
manually rotating the quartz window by 90 °, the aligned phage particles take a 
perpendicular orientation with respect to the original alignment, resulting in an 
almost exact inversion of the phage LD spectrum. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.21: LD from the induced aligned wild-type phage on the surface of a quartz 
window. The resulting spectrum shows all the expected characteristic peaks from 
filamentous phage particles. By rotating the quartz window by 90 ° in respect to its 
original position, the phage LD spectra gets inverted (dashed line). 
 
 
This experiment, along with the observations from [15], suggested the inversion 
of the LD spectra of the phage-DNA probe 1 sample resulted from a difference 
in the overall orientation of the phage particles, probably induced by the 
90#°#rota)on#
Circular#
quartz#window#
200 250 300
-0.002
-0.001
0.000
0.001
0.002
Wavelength (nm)
LD
 (Δ
O
D
)
90° rotation
Original alignment
	  	   83	  
_________________________________________________________________"Chapter"3"
conjugated DNA strands. Strangely however, this behavior was not observed in 
the phage-DNA probe 2 sample. This was thought to be due to the differences 
in the bioconjugation protocol, which resulted in a lower yield of conjugation of 
DNA probe 2 to the phage surface, and therefore there was a minor contribution 
to the overall phage alignment.  
 
The described LD spectrum inversion was also observed in subsequent 
experiments. Fig. 3.22 illustrates the LD spectra of the phage constructs, phage-
DNA probe 1 and phage-DNA probe 2, mixed together with the DNAzyme. 
Typically, 0.05 mg/mL of phage-DNA probe 1 and phage-DNA probe 2 were 
mixed in PBS buffer, followed by adding the enzyme and substrate strands, in a 
total of 100 µL. The phage-DNA probes and the DNAzyme were incubated for 
one hour at room temperature prior to LD measurements. 
 
 
 
 
 
 
 
 
 
 
Figure 3.22: LD of the phage-DNA probes and DNAzyme. LD spectrum of phage-
DNA probe 1 and phage-DNA probe 2 in PBS buffer (dashed line). LD spectrum of 
phage-DNA probe 1, phage-DNA probe 2, 1 µM substrate strand (17DS) and 1 µM 
enzyme strand (17E) in PBS buffer (solid line). 
 
 
The effect on LD signal inversion, believed to be caused by the phage-DNA 
probe 1, seemed to predominate when phage-DNA probe 1 and phage-DNA 
probe 2 were mixed together. Interestingly however, the signal flipped when the 
DNAzyme (substrate (17DS) and enzyme (17E) strands) was added to the 
system. This effect seemed to be reproducible as it was observed in following LD 
measurements, using independent batches of the constructed phage-DNA 
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probes. To further investigate whether the DNAzyme had an effect on the 
observed LD signal inversion, LD measurements were made in which only the 
substrate (17DS) strand was added to the system, because this strand is physically 
responsible for linking the phage-DNA probes (Fig. 3.23).  
 
 
 
 
 
 
 
 
 
Figure 3.23: LD of the phage-DNA probes, mixed with the substrate strand of the 
DNAzyme. LD spectrum of phage-DNA probe 1, phage-DNA probe 2 and 1 µM 
substrate strand (17DS) in PBS buffer (dashed line). 
 
 
As observed in Fig. 3.22, when the DNAzyme was added to the phage-DNA 
probes, the LD signal reverted back to the “standard” LD spectrum. From the 
data on Fig. 3.23, it seemed the substrate strand (17DS) played a role on that 
flip. When the enzyme strand (17E) is added to the phage-DNA conjugates, the 
overall LD signal remained inverted on the negative quadrant of the spectrum 
(data not shown). When the 17DS strand (which has complementary extensions 
at both its ends to hybridise with the DNA on the phage) was added to the 
phage-DNA probes, the LD signal reverted back to the positive quadrant of the 
spectrum.  
 
The previously described experiments were thought to be important to 
demonstrate the unpredictability of newly designed phage-based probes, in this 
case the phage-DNA probes/DNAzyme system, on an LD-based assay. For a 
throughout analysis, it was obvious the number of variables and possible 
conditions to test were large. These experiments provided limited insight on the 
LD-related aspects of the phage-DNA probes. In order to fully understand the 
behaviour of the phage-DNA constructs and its interaction with the lead-specific 
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DNAzyme, several experiments needed to be conducted, testing, for example, a 
range of concentrations of phage-DNA probes, and 17DS and 17E strands 
ratios. It would also be necessary to determine which factors interfere with 
DNAzymes kinetics – Lu and colleagues found that optimal conditions of 
temperature and salt ions are important aspects to consider when designing a 
lead sensor [53]. Other experiments should confirm and clarify on the interaction 
between the phage-DNA probes and the DNAzyme strands. An example of this 
could be to set up a FRET (Förster Resonance Energy Transfer) experiment. A 
FRET system would be in place by labelling the DNA probes conjugated to the 
phage with a chromophore molecule (FRET acceptor), and the ends of the 
DNAzyme substrate strand with a different chromophore (FRET donor) – when 
at a certain distance from each other, a light of specific wavelength would be 
emitted. This distance-dependent fluorescence would suggest on the proximity 
between the substrate strand and the DNA probes, indicating if hybridisation 
did occur and potentially also providing some insight on the stability of this 
interaction. 
 
 
3.3 Conclusion 
Filamentous bacteriophages have a number of features that make them an ideal 
choice as a programmable scaffold for nanotechnology applications. In this 
chapter, chemical and biological approaches for manipulation of the 
bacteriophages structure were explored. The goal of this work was to experiment 
on modifications to the phage structure that could be integrated into biosensing 
platforms. M13 bacteriophages are good scaffolds for biosensing platforms 
because they are simple and stable macromolecules that can be easily grown in 
large amounts, tolerating both chemical and genetic modifications. Phage surface 
functionalisation can be achieved by genetic engineering; however, excessive 
mutation may interfere with the life cycle of the phage, and does not allow for 
incorporation of synthetic compounds. Strategic chemoselective modifications 
tackle these limitations, and expand the potential applications of phage-based 
biomaterials. In here, it was shown to be possible to anchor and functionalise the 
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surface of the filamentous phage by modifying its proteins. To immobilise 
phages onto surfaces, antibodies, magnetic beads, and polyhistidine tags were 
conjugated to the p3 proteins and serve as anchoring points. The phage capsid, 
made of 2700 copies of p8 protein, comprises a large area for multivalent 
modifications, allowing for conjugation of fluorophores, antibodies and DNA 
molecules. We also exploited one of the phage’s simplest features – being a long, 
thin molecule that can be aligned under flow. Combining this principle with 
phage surface functionalisation, two optical-based biosensing platforms were 
designed, as described in Chapter 4 and Chapter 5. 
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CHAPTER 4 – Imaging wall shear stress using the M13 
bacteriophage as a nanosensor 
 
 
This chapter was adapted from the published work in Nano Research (2015) [1]. 
 
4.1 Introduction 
It is well-established that wall shear stress (WSS) - defined as the force exerted 
by blood flowing over the surface of an arterial wall - is involved in many normal 
biological phenomena, but also plays a key role in vascular disorders. WSS 
profiles are abnormal, for example, when atherosclerotic plaque builds up and 
obstructs a vessel, changing the surrounding blood shear flow and therefore 
indicating an unhealthy vasculature. Although WSS is of paramount importance 
in vascular biology, there is currently no method to measure it accurately in 
physiological systems. Understanding vascular dysfunctions and how to diagnose 
it, treat it and even prevent it, can not be clearly elucidated without knowledge 
on the WSS dynamics. 
 
In this work, a strategy for immobilisation of a phage nanosensor was developed, 
enabling a successful integration of a biological scaffold with a microfluidic 
biosensor. A fluorescent phage nanosensor was constructed to detect changes in 
shear flow, in real-time, intended for applications in vascular flow imaging in 
cardiovascular diseases and therapeutics. We show that these nanosensors can be 
tracked using standard optical tools. The versatility of our nanosensors was 
further demonstrated by adapting it for in vitro experiments, imaging WSS in 
the micro-domains of endothelial cells. At a later stage, this phage-based 
construct could help better understand how blood vessels change in vivo, how 
they become wider or tighten up, and how they respond to cardiovascular drugs. 
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4.1.1 M13 bacteriophage and wall shear stress  
Wall shear stress (WSS) is defined as the force that a moving fluid exerts parallel 
to a surface, such as that of blood flowing across the surface of the endothelial 
cells lining blood vessels [2,3]. WSS affects cellular and biochemical reactions 
and plays a crucial role in normal vascular physiology. Abnormal WSS has been 
linked to medical conditions, such as atherosclerosis, diabetes, and angiogenesis-
dependent cancers, and it is therefore an important parameter in understanding, 
preventing and diagnosing vascular disorders [4-11].  
 
In the vasculature, the velocity gradient near the wall is often measured using 
bulk flow techniques, such as particle image velocimetry (PIV) [12]. PIV 
methods struggle with the complex dynamics of WSS, which might not only 
lead to missing valuable data but also introducing interferences to the results.  
One problem with PIV technique is that of the concentration of tracer particles 
along the vessel – the lumen of the vessel will contain a larger number of tracer 
particles, which decrease as the surface of the wall is approached. Fewer particles 
reach the wall surface and therefore less data on this region of the vessel can be 
collected. Another challenge of this method is that it makes assumptions on the 
uniformity of the flow and the surfaces the fluid crosses [13]. Such an average 
measurement may hide variability critical to the understanding of vascular disease 
states in dynamic systems, as of a blood vessel.  
 
As described in Chapter 1, the M13 phage has been explored to create novel 
biomaterials and used as a scaffold for nanowires, biosensors, and in bioimaging. 
The M13 bacteriophage, having a filamentous structure, is an adequate candidate 
for the experiments described in this chapter. Moreover, it has other inherent 
properties that are advantageous – it is biologically and mechanically stable, 
inexpensive to produce using simple microbiology techniques, and it has several 
available functional groups on its surface for the necessary chemical 
modifications [14]. As investigated in Chapter 3, it is possible to tether one end 
of the phage to a surface. The nanosensor construct designed for the work 
developed in this chapter is a chemically modified phage with a specific binding 
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element (e.g. an antibody) conjugated to the p3 proteins, and a fluorophore dye 
labelling the p8 proteins (Fig. 3.6, Chapter 3). The nanosensor is anchored to 
the surface of a microfluidic slide by one-end only, and its behaviour under 
various shear flow conditions is visualised. Subsequent data analysis allows 
determining the WSS applied to the surface of the microfluidic slide. The result 
is a biological flow nanosensor that is potentially usable in vivo in the vessel-
blood interface.  
4.1.2 Glycocalyx – the endothelial gatekeeper 
Wall shear stress (WSS) regulates several vascular parameters, as it acts on and is 
sensed by the endothelial cells. More specifically, it is sensed by the glycocalyx. 
The endothelial glycocalyx is a thin layer of polysaccharide matrix covering the 
apical surface of endothelial cells lining the vessel walls [15,16]. It acts as a 
barrier between the vascular lining and the blood stream (Fig. 4.1). This mesh-
like structure is composed of a network of proteoglycans, glycoproteins and 
plasma proteins, and has an important role in maintaining the integrity of the 
vascular walls. An example of in vitro imaging of the glycocalyx on endothelial 
cells is shown in Fig. 4.2 (Chapter 2, method 2.5.5). 
 
It is widely accepted that the glycocalyx plays a physiological role as a 
mechanotransducer (i.e. translation of biomechanical forces into biochemical 
signals), on vascular permeability (as it limits the access of certain molecules to 
the endothelial cell membranes), and participates on protein-cell interactions (for 
example, in the leucocyte-vessel wall interaction and the adhesion of the 
leucocytes to the surface of endothelial cells). The glycocalyx is crucial in normal 
vascular physiology (e.g. angiogenesis) but also in vascular disease – degradation 
to this layer is thought to be associated with several pathophysiological 
conditions, such as diabetes, atherosclerosis and cancer [16,17]. 
 
The components making up the glycocalyx are continuously synthesised and 
shed from the endothelial cells surface, in a dynamic process driven by the flow 
forces of circulating blood. Since the glycocalyx is located in the interface 
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between blood and the endothelium, it mediates flow-induced shear stress on the 
endothelial cells.  It is in here, a few hundred nanometers above the cell surface, 
the phage nanosensor was designed to detect and measure shear stress. 
 
Although experimental data strongly suggests the vasculoprotective role of 
glycocalyx and its overall functional importance [16], research on this subject 
lacks techniques to properly detect and measure the mechanical forces applied on 
this layer. Understanding the mechanical properties of the glycocalyx and, 
therefore, measuring wall shear stress at the surface of blood vessels, is essential 
to many biological functions and could be crucial to study blood vessels function 
in health and vascular disease. 
 
 
 
 
 
Figure 4.1: Schematic representation of the endothelial glycocalyx. The glycocalyx is a 
carbohydrate-rich brush-like structure lining the vascular endothelium, and can extend 
150–500 nm from the endothelial cell surface. Not drawn to scale. 
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Figure 4.2: Visualisation of the glycocalyx on 5-days cultured human umbilical vein 
endothelial cells (HUVECs). (Left) Confocal microscopy image of labelled HUVECs. 
DAPI (blue) - nucleus; WGA-FITC lectin (green) - glycocalyx. Wheat germ agglutinin 
(WGA) binds to sugar residues, and therefore the green labelling suggests expression of 
heavily glycosylated glycoproteins, which are present in the glycocalyx. Scale bar: 100 
µm. (Right) 3D reconstruction of a series of Z stacks obtained with confocal 
microscopy. Arrows indicate the direction of the X, Y and Z axis.  
 
4.1.3 Imaging wall shear stress using a chemically modified phage  
The method described here, developed to study WSS, anchors a filamentous 
structure by one-end to a surface and tracks changes in its orientation in response 
to flow. An illustrative metaphor could be how, in a similar way, a windsock 
gives information about the wind strength and direction.  
 
The in vitro experiments, described in Fig. 4.9, show the behaviour of the phage 
nanosensor under various flow conditions. The basic principle is the following – 
the nanosensor, in the absence of flow, oscillates randomly due to Brownian 
motion, not preferring any specific position. However, when flow is applied, the 
movement of the nanosensor becomes restricted. The nanosensor lines up with 
the direction of the flow and it is sensitive to the flow intensity. An illustration of 
this concept is given in Fig. 4.3. In a system were the direction and/or intensity 
of flow are unknown, this platform could give valuable information. The 
chemically modified phage can be adapted to study the flow in the vasculature, in 
which knowing what alters the blood flow and how it changes in diseases and 
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therapeutics, can be of great medical importance.  
 
 
 
 
 
 
 
Figure 4.3: Schematic of the concept for measuring WSS developed in this work. The 
top banner is a microscope film-strip of images of an anchored fluorescent M13 phage 
responding to flow. The bottom scheme represents the concept of using the 
bacteriophage as a nanosensor for mapping flow. The black dot represents the anchoring 
point of the bacteriophage; colourful elliptical shapes illustrate the bacteriophage at 
different positions in space at different time points. From left to the right: increasing 
shear flow (black arrow) induces bacteriophage to align in the direction of flow, resulting 
in a smaller variation of the orientation angle. 
 
4.2 Results and discussion 
4.2.1 Building the M13 bacteriophage nanosensor 
An overview of the 2-step chemical modification used is given in Chapter 3 (Fig. 
3.6). Detailed bioconjugation protocols and purification methods are given in 
Chapter 2.  Firstly, we developed a method to anchor the bacteriophage by one 
end to a surface. As explored in Chapter 3, a possible approach is to modify the 
cysteines present on the p3 protein of the phage, by reducing its disulfide bridges 
to sulfhydryl groups. These thiols are exposed and available to conjugate with the 
maleimide groups previously inserted on an antibody of choice. Next, 
fluorophore molecules were chemically attached to the p8 protein of the phage, 
decorating its capsid. TRITC (tetramethylrhodamine isothiocyanate) is a red-
orange dye for chemical labelling of amines. An illustration of the dye-coated 
phage capsid may be seen in Chapter 3 (Fig. 3.14). This latter step is crucial for 
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the imaging component of this work, which is required to observe the dynamic 
behavior of the bacteriophage under a microscope. Since the labelling of the 
amines on the p8 proteins with TRITC is pH-dependent, an optimal pH for this 
reaction was investigated (Fig. 3.14, Chapter 3). A buffer of pH 8 was chosen as 
a compromise, to avoid interfering with the stability of the antibody. The final 
constructs were purified by size exclusion chromatography (SEC) (Chapter 2, 
method 2.2.3). The SEC chromatogram on Fig. 4.4 shows that the reaction 
mixture contained the M13-Antibody-TRITC conjugates and other small 
molecules, possibly PEG, unreacted reagents and proteinaceous material. As 
expected, the M13 conjugates have the largest mass, eluting first from the 
column, at approximately 40 mL. The fractions from this peak were collected, 
concentrated by PEG precipitation, and run on the LD to confirm for presence 
of bacteriophage. Moreover, since the filamentous structure of the M13 is crucial 
for the proposed imaging platform, TEM images were collected to confirm the 
M13 conjugates were intact following the bioconjugation protocols. A LD 
spectrum (Chapter 2, method 2.8.2) and a transmission electron microscopy 
(TEM) image (Chapter 2, method 2.5.7) of the purified M13-Antibody-
TRITC are shown in Fig. 4.5, suggesting chemically modifying the surface of 
the bacteriophage has no observable negative effects on the phage filamentous 
structure and its overall alignment under flow.  
 
  
 
 
 
Figure 4.4: Size exclusion chromatogram of M13-Antibody-TRITC conjugates. 
Multiple absorbance wavelengths monitored: 269 nm (blue) for M13 bacteriophage, 280 
nm (black) proteins, 555 nm (red) TRITC dye. The fractions were collected, 
concentrated and run on LD to confirm for the presence of bacteriophage. The fractions 
corresponding to the first peak were used for the following experiments. Eluted in 100 
mM potassium phosphate buffer, 150 mM NaCl, pH 7.2. 
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Figure 4.5: LD spectrum and TEM image of the M13-Antibody-TRITC construct, 
after purification with size exclusion chromatography. Black marks on the TEM image 
are unwashed stain. 
 
The first stage of experiments for this work was done using collagen-coated 
microfluidic slides, in which the phage was attached to this surface by an 
antibody specifically against the collagen (anti-collagen antibody). Although this 
system was suitable for proof-of-concept, it is a rather artificial and generally not 
a good representation of what happens in vivo. Therefore, a second experimental 
set-up was designed in which the microfluidic slides were coated with 
endothelial cells, GEnC (glomerular endothelial cells), as a closer model for the 
physiological vascular lining. To anchor the phage nanosensor to the endothelial 
cells’ surface, a carbohydrate-binding protein (wheat germ agglutinin, WGA) 
was used. WGA is a ~ 36 kDa protein that binds to glycoproteins in the 
membrane of endothelial cells, more specifically to the N-acetyl-D-glucosamine 
and sialic acid of the glycocalyx expressed by the endothelial cells [18]. This 
lectin, which can be conjugated to fluorescent dyes such as fluorescein (FITC), 
has been used for imaging of the glycocalyx [18-20], as shown in Fig. 4.2. The 
bioconjugation protocol and purification steps were similar to the first set of 
experiments (Chapter 2, method 2.4.1.2). Schematics of these two set-ups are 
illustrated in Fig. 4.8. 
 
With most proteins, interfering with its structure could result in loss of function; 
in this case, the bioconjugation protocol could result in the inability of WGA to 
recognise and bind to the surface of the glycocalyx. To check the bioconjugation 
protocol did not substantially affect the WGA structure, a circular dichroism 
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(CD) spectrum (Chapter 2, method 2.8.3) was collected from the lectin before 
and after the crosslinking reaction step (with SMCC). As shown in Fig. 4.6, no 
significant alteration to the WGA structure could be observed on the CD 
spectrum after treatment with SMCC and purification on a PD-10 column. 
There is no guarantee, however, the protein kept its function, but it was expected 
that if the structure was not drastically modified, WGA would still be able bind 
to the components on the membrane of cells. 
 
 
 
 
Figure 4.6: CD spectra of WGA-FITC. These spectra were collected to check whether 
WGA-FITC (solid line) suffers any major conformation change after reacting with 
SMCC and being purified on a PD-10 column (dashed line).  
 
The FITC molecules conjugated to WGA were used to characterise the success 
of the bioconjugation of WGA to the bacteriophage. The UV-Vis spectra of 
WGA-FITC, M13+WGA-FITC and M13+WGA-FITC+TRITC samples 
were collected (Fig. 4.7). The peak at 490 nm, corresponding to FITC, is present 
in the M13+WGA-FITC sample, suggesting WGA is present in the phage 
sample. However, this experiment alone does not prove the FITC dye is attached 
to the phage – it only informs about the presence of FITC in the sample. For 
this reason, another experiment was carried out, in which the M13+WGA-
FITC+TRITC was observed under a microscope with a double-beam filter, 
looking for the fluorescence of FITC and TRICT (Chapter 2, method 2.5.6). As 
shown in Fig. 4.7, a green blob at the end of a red rod-shaped figure seems to 
indicate the presence of FITC molecules at the end of what one can imagine 
being the phage coated with TRITC dye. These data suggested the conjugation 
of WGA to the p3 proteins of the phage was successful. 
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Figure 4.7: UV-Vis spectra and microscopy image of the M13+WGA-FITC+TRITC 
conjugate. (Left) UV-Vis of the lectin conjugated to a FITC dye molecule (WGA-
FITC, black line); of the product of reaction between the M13 phage and the lectin 
(M13+WGA-FITC, green line) after being purified through a PD-10 column and 
PEG/NaCl precipitation; and of the product of the final step of the bioconjugation 
between the phage-lectin and the TRITC dye (M13+WGA-FITC+TRITC, red line) 
after being purified. Inset - zoom of the dye absorbance regions on the spectra. (Right) 
Double-beam (red-TRICT, green-FITC) confocal microscopy image of the 
TRITC+WGA-FITC modified phage. Scale bar: 1 µm.  
 
4.2.2 Experimental set-up and analysis overview 
M13 were grown, purified [21] and labelled as outlined in Chapter 2. M13 was 
derivatised with the anchor-molecule attached to the p3 protein and its p8 
proteins fluorescently decorated. The nanosensor construct anchored to a 
microfluidic slide is schematically illustrated in Fig. 4.8. Microfluidic slides (µ-
Slide I Luer, ibidi) were assembled into a controlled flow system by using a 
peristaltic pump (ibidi). It has been previously shown that ibidi systems are able 
to orient semi-rigid molecular systems [22]. The M13 construct was bound to 
the surface of the microfluidic slide (coated with collagen for the first set of 
experiments, and coated with endothelial cells for the second set of experiments) 
and unbound M13 was rinsed off. A nominal WSS (0−3.5 dyn/cm2) was applied. 
The fluorescent images of the derivatised and labelled phage constructs in flow 
were measured by using either a spinning disk confocal microscope or a wide-
field inverted microscope. Flow experiments and imaging details are described in 
Chapter 2. Recorded time-lapses images were post-analysed using a function in 
MATLAB scripted by Dr. Alan Wemyss [23], who also plotted the data shown 
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on Fig. 4.9, 4.11, 4.12 and 4.13. 
 
From imaging analysis, the orientation angle and approximate length and width 
of the M13 sensor in each frame was determined. Using MATLAB, the region 
that the M13 occupies on each frame was first defined by finding a threshold 
pixel intensity below which all pixels were set to zero and above which they were 
set to one (Otsu method, [24]). The pixels with value one, whose nearest 
neighbour also had value one, were defined as regions of interest (ROI). The 
largest of these was assumed to be the M13. An image stack with the largest 
ROI subtracted out was created to be the background and was subtracted from 
the original binary image, leaving only the M13 sensor in each image. The major 
axis was then defined as the longest possible straight line that could be drawn 
within the ROI, and its angle, determined relative to the horizontal axis of the 
image, defined the phage’s orientation.  
 
The tethered nanoparticle motion under Brownian effects and flow was also 
modeled phenomenologically by Dr. David Smith, from University of 
Birmingham. Although crucial to take conclusions from the experimental data, 
the modeling component of this work falls out of the scope of this thesis – 
further details are described in the supplementary information of [1]. 
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Figure 4.8: Scheme of the microfluidic design using the anchored phage to study flow 
variations. a) (Top circle) An ibidi slide flow chamber coated with collagen (blue line) 
with a phage attached via an anti-collagen antibody. (Bottom circle) An ibidi slide flow 
chamber coated with endothelial cells with an anchored phage via WGA (green blob). 
The two arrows illustrate the in/out of the microfluidic slide chamber. The microfluidic 
slide is observed under a microscope. The dynamic behavior of the chemically modified 
phage anchored by one-end to a surface b) orients to the right or to the left depending 
on the direction of the flow, and c) differentiates between flow intensities − less intense 
flow allows for a wider angle between the phage and the microfluidic slide surface; 
stronger flow forces the phage to align more parallel to the surface. 
 
 
4.2.3 Imaging wall shear stress 
To image WSS, two systems were developed using the novel M13 nanosensor: 
 i) Fluorescent M13 constructs derivatised with anti-collagen antibodies 
(M13-Antibody-TRITC) anchored to a collagen coated microfluidic slide. The 
collagen was designed to act as a relatively flat surface to test the principles of the 
constructed nanosensor. 
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 ii) Fluorescent M13 constructs derivatised with WGA (M13-WGA-
TRITC) anchored to cultured endothelial cells (via the glycocalyx) on a 
microfluidic slide. The endothelial cells were considered to act as a closer model 
to a blood vessel. 
 
4.2.3.1 Imaging wall shear stress on collagen-coated slides 
Spinning disc images of M13-Antibody-TRITC exposed to a range of nominal 
WSS (0–3.5 dyn/cm2) were collected. The data from these experiments take the 
form of time-lapse images of individual M13-Antibody-TRITC constructs on 
the surface. The constructs could be recognised under the microscope as bright 
points, agitating in the buffer. Once under high digital magnification, the M13-
Antibody-TRITC constructs appears as elliptical shapes that adopt different 
angles as a function of time (Fig. 4.9). Once an M13-Antibody-TRITC 
construct was in focus, the flow was induced to test if the construct was bound. 
Images of the flow slide with no shear flow applied suggested that the M13-
Antibody-TRITC construct is on the surface and randomly oriented (in response 
to Brownian motion). The reaction to flow-induced shear is obvious by eye – the 
fluorescent ellipse orients, seemingly instantaneously, with its long axis 
preferentially aligned with the shear flow direction. The degree of orientation 
increases with flow rate. The microscope focus typically required adjustment to 
achieve optimal imaging, once flow was applied. The signal-to-noise decrease 
over time as would be expected if bleaching was occurring; however, more than 
10 minutes of continuous imaging was possible without compromising the 
quality of the data collected. 
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Figure 4.9: Example of wall shear stress visualised by M13-Antibody-TRITC bound to 
a collagen-coated flow slide. The plot illustrates the functionalised M13 orientation 
versus time in a typical experiment. The nominal wall shear stress (assuming a linear 
relationship between bulk fluid flow and WSS) is indicated at the top in dyn·cm–2. The 
flow direction and magnitude at each time point are indicated by the arrows and by the 
color and intensities of the overlays (negative (green), positive (blue), and zero (grey)). 
Example of bacteriophage images at time points corresponding to the red circles in 
background subtracted spinning disk confocal image frames are shown below.  
 
4.2.3.2 Imaging wall shear stress on endothelial cells-coated slides 
Glomerular endothelial cells (GEnC), typically used as a model capillary system 
for kidney disease [25], were seeded onto sterile flow slides. These kidney-
derived cells provide an intellectual bridge to future work in how complications 
of diabetes (e.g. nephropathy) affect flow in kidneys. WGA conjugated to the p3 
protein of M13 (M13-WGA-TRITC) made a nanosensor that was visualised by 
using a wide-field fluorescent microscope showing that the bacteriophage had 
successfully adhered to a confluent layer of cells on the flow slide surface. A 
picture of a phage nanosensor anchored to the surface of an endothelial cell is 
given in Fig. 4.10. 
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Time-lapse images show that in the absence of flow the conjugates move fairly 
randomly in response to Brownian motion in a manner consistent with the 
attachment to the cellular surface by only one-end. The angle space it explores is 
reduced compared with the collagen-coated slides. This suggested the phage 
nanosensor is responding to a non-uniform surface. 
 
 
 
 
 
 
 
 
Figure 4.10: Microscope image of a M13-WGA-TRITC construct on the surface of an 
endothelial cell. Modified phage (white dot on top of the cell) is bound to the surface of 
the cultured cell, and various flows are passed over it. In the box area are examples of 
images from the modified phage under -3.5, 0.5 and 3.5 dyn/cm2 (from left to right). 
 
4.2.4 Response of M13-Antibody-TRITC and M13-WGA-TRITC constructs 
to flow  
To use the data to quantify WSS, a robust data analysis methodology was 
required. This has two parts: turning the videos into orientation data of the type 
summarized in Fig. 4.9, and the development of a theoretical model of how the 
phage orientation relates to the flow. 
 
MATLAB code was written to extract the phage orientation and major axis 
length data. Its angle relative to the horizontal axis of the image defined the 
bacteriophage’s orientation. The MATLAB segmentation code was found to be 
accurate by eye and gave similar results to a Fiji/ImageJ directionality plugin 
[26]. Videos of these time-lapses are available. The mathematical model gave 
!!
Flow% Flow%
2.5μm%
25μm%
	  	   105	  
_________________________________________________________________"Chapter"4"
insight on how to judge the relationship between WSS and the behaviour of the 
nanosensor under various flow rates, on two different surfaces.  
 
The data collected from M13-Antibody-TRITC on the collagen-coated slides 
were used as a simplistic model to demonstrate that WSS can be predicted from 
the behavior of the nanosensor in flow, using David Smith’s proposed 
mathematical model. In the collagen-coated slides experiments, the movement of 
the anchored M13-Antibody-TRITC nanosensor was unrestricted in all 
directions. The nanosensor has a similar response to positive and negative flow 
direction, being likely to take any orientation ranging from –90° to +90°. This 
symmetry in response to flow, regardless of its direction, is illustrated in the top 
plot of Fig. 4.11. This plot illustrates the behaviour of the nanosensor in various 
flow rates. When no flow is applied, the anchored nanosensor moves freely 
taking any random orientation from –90° to +90°. Increasing flow rates constrain 
the movement of the nanosensor - higher flow rates result in a smaller variation 
in the nanosensor orientation, which is shown by the size of the red error bars on 
the plot. 
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Figure 4.11. Tracking the orientation of the anchored phage construct. Orientation vs. 
nominal WSS for an M13 anchored to collagen (top) and GEnC endothelial cells-
coated slides (bottom), representing negative flow (arrow to the left) and positive flow 
(arrow to the right). σ is denoted by the red bars for each flow around the mean value. 
 
 
The bottom plot of Fig. 4.11 shows the processed data from the collected time-
lapses of the M13-WGA-TRITC nanosensor anchored to an endothelial cells-
coated slide. This plot clearly illustrates the difference in behaviour of the 
nanosensor on a flat collagen-coated microfluidics slide and on a non-uniform 
GEnC-coated microfluidics slide. This plot shows that in the negative flow 
direction, the average orientation adopted by the nanosensor is around 0, 
whereas the average variance in orientation of the nanosensor is reduced when 
flow is applied in the positive direction. This illustrates that the nanosensor is 
not moving freely, which is probably due to its location on the surface of the cell. 
Protruding endothelial cells have been shown to interfere with local wall shear 
stress [27,28]. In the specific example of this data, the M13-WGA-TRITC 
nanosensor was observed to be anchored on top of the nucleus of the endothelial 
cell, which may have hindered its movement.  
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The mathematical model predicted that a plot of ln(σ) versus ln(nominal WSS) 
will have a slope of –0.5 and that the nominal WSS is proportional to the inverse 
square of the standard deviation of the particle’s adopted orientation at a given 
flow rate. This was confirmed to be accurate for the collagen-coated slides 
experiments, as shown in Fig. 4.12. Plotting the ln(σ) versus ln(nominal WSS) 
for the M13-WGA-TRITC nanosensor anchored to an endothelial cell, would 
make it easier to visualise the effect of the non-uniformity of the surface on the 
WSS. These data are illustrated in Fig. 4.12. 
 
 
 
 
 
 
 
 
 
 
Figure 4.12: ln(σ) versus ln(nominal WSS) on collagen- and endothelial cell-coated 
surfaces. (Top) ln(σ) versus ln(nominal WSS) of 5 movies of the M13-Antibody-
TRITC nanosensor anchored to a collagen-coated microfluidics slide. (Bottom) ln(σ) 
versus ln(nominal WSS) of 1 movie of the M13-WGA-TRITC nanosensor anchored to 
an endothelial cells-coated microfluidics slide, under positive and negative direction 
flow. 
 
Although the slopes of the data of Fig. 4.12 for the M13-WGA-TRITC 
nanosensor are smaller than the predicted −0.5 from the model, this was 
considered to still be in agreement within the large error of the experiment. In 
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order to reduce the error from these experiments, it would be necessary to collect 
and analyse more data points using the M13-WGA-TRITC nanosensor on flow 
experiments. Nominal WSS is the value of the WSS if the bulk flow is a correct 
predictor of the flow at the surface. We expect this to be accurate for the uniform 
collagen coated-slides experiments. By way of contrast, endothelial cells-coated 
slides are non-uniform surfaces. These data suggest that the bulk flow-
determined nominal WSS from the collagen-coated slide is not a good estimate 
of WSS at a cell surface. This is clearer in Fig. 4.13.  
 
From the equations of the mathematical model we could derive that the nominal 
WSS is proportional to the inverse variance of the phage’s orientation. 
Therefore, a plot of 1/σ2 versus the nominal WSS could demonstrate what is the 
effect of the endothelial cells on the WSS. Fig. 4.13 illustrates these data for the 
nanosensor anchored to the collagen and endothelial cells slide.  
 
 
 
 
 
Figure 4.13. Relationship between WSS and the topography of a surface. Plot of the 
inverse variance (1/σ2) versus nominal WSS from Fig. 4.12 and the combined collected 
data from M13-Antibody-TRITC anchored to a collagen-coated slide.  
 
From analysing Fig. 4.13, it seems clear the endothelial cells are altering the 
WSS, which is locally sensed by the phage nanosensor. The slopes of the two 
GEnC lines in Fig. 4.13 are larger than those of the collagen-coated slides. For 
example, for a 3.5 dyn/cm2 nominal WSS, the nanosensor anchored to the 
collagen uniform surface senses the equivalent to an inverse variance of 0.015; the 
nanosensor anchored to the surface of an endothelial cell surface however senses 
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5
0.00
0.02
0.04
0.06
0.08
Nominal WSS / dyn.cm-2
1/
σ
2
GEnC Negative Flow 
GEnC Positive Flow 
Collagen Combined
	  	   109	  
_________________________________________________________________"Chapter"4"
higher values – the inverse variance was calculated to be 0.071 for positive flow 
direction and 0.043 for negative flow direction. This indicates that the observed 
movement of the nanosensor, free or restricted, depends on the surface 
topography and the direction of flow. This data further suggested that averaging 
shear stress over a surface, as commonly used methods tend to do, might lead to 
erroneous estimations of the local wall shear stress. 
 
4.3 Conclusion 
Reported in this chapter is a strategy for imaging and detecting WSS by using a 
chemically modified version of the M13 phage as a nanosensor. M13 phage 
naturally possesses different chemical groups on its structure, which were 
explored to anchor it to surfaces. The bioconjugation protocols to modify the 
surface of the phage, together with the observation of the behaviour of the phage 
nanosensor in flow, produced a system that can be used to study flow dynamics 
applied to a surface. It resulted in a simple, novel, and scalable method for 
imaging WSS on a micron scale level, using fluorescent microscopy.  
 
WSS is usually calculated by using flow velocity gradients measured close to the 
wall, which are often unreliable approximations. We have shown that by 
anchoring one end of a fluorescent M13 bacteriophage onto a surface, the free 
body of the nanosensor particle repositions itself in response to the direction and 
intensity of shear flow, depending on the topography of the surface of 
attachment.  
 
This method relied on the construction of two nanosensors, the M13-Antibody-
TRITC and the M13-WGA-TRITC, which have been tested on two types of 
surfaces, respectively: relatively flat collagen-coated slides, which compare well 
with bulk flow expectations, and endothelial cell-coated slides. It was 
demonstrated that the relationship between the nanosensor particle flow 
behavior and WSS could be predicted by using a simple theoretical model. 
Measurement of the local WSS on the irregular surface of a slide coated with 
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endothelial cells was possible, further demonstrating the validity of the concept. 
The collected data and the mathematical model suggested that WSS in 
physiological systems is likely to deviate significantly from that expect on bulk 
flow estimates.  
 
The nanosensor construct is adaptable and can, in principle, be used in in vivo 
systems. There are several key areas to develop before the technique can be used 
in vivo to explore how differences in cell surfaces are affected by local flow 
effects. The biophysical properties of the phage nanosensor, in particular its 
binding to different surfaces, may require an improvement to the modulation of 
the p3 proteins. Possible alternatives to the current WGA anchoring system are 
genetically inserting binding peptides specific for the surface of endothelial cells 
[29] or chemically conjugating adhesion anti-CD31 antibodies. 
 
In summary, we developed a microscopy-based biosensing platform for tracking 
differences in flow, using a chemically modified phage. Although further 
nanosensor and data-quality developments are needed, this phage construct, with 
low manufacturing costs and high adaptability, suggests a way to map flow and 
WSS in biological systems, thus opening up a wide range of potential 
applications in fundamental research and medicine. 
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CHAPTER 5 – Expanding on the original design of a linear 
dichroism-based biosensor 
 
 
5.1 Introduction 
As illustrated in Chapter 3, phages are good scaffolds for biosensing platforms 
because of their simplicity, versatility, and robustness, tolerating both chemical 
and genetic modifications. This, for instance, allowed for a controlled anchoring 
of the phage particles to a surface (which was then explored for building a 
microscopy-based biosensing platform, as shown in Chapter 4). In Chapter 5 the 
main focus is on genetic and chemical alterations to the phage surface specifically 
aimed at optimising an existing spectroscopy-based biosensor. Linear 
Diagnostics Ltd., a biotech startup that spun from University of Birmingham, 
developed a biosensing diagnostic platform that exploits the phenomenon of 
linear dichroism (LD), based on the work of Pacheco-Gomez and colleagues [1]. 
During the course of this work, a collaboration with Linear Diagnostics led to 
the design of new protocols to expand on the existing immunoassay. This 
chapter describes the proposed biological and chemical engineered modifications 
to the phage, particularly interested on simplifying the current immunoassay, 
reducing its costs and improving its sensitivity.  
 
5.1.1 The principle of the LD-based biosensor 
Antibody-based detection methods, collectively named immunoassays [2], are 
one of the major biomolecular diagnostic platforms. Traditional microbial culture 
methods, which are slow, time consuming and have limited applicability, have 
been evolved to sophisticated immunoassays, such as enzyme-linked 
immunosorbent assays (ELISA) and lateral flow assays (LFA). Complexity, cost 
and time are the main three pillars of diagnostic platforms. One of the main 
limitations of most immunoassays tends to be on multiplexing: the capacity of 
detecting, simultaneously, several different antigens in the same sample. 
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Therefore, an inexpensive, simple, multiplexed and fast immunoassay are 
valuable in diagnostics. Linear Diagnostics’ LD-based biosensor aims at 
integrating these features through the use of a phage scaffold. 
 
Linear Diagnostics’ biosensor platform uses a chemically modified version of the 
M13 bacteriophage capable of binding to a target of interest (e.g. pathogenic 
bacteria) by the conjugated antibodies on its surface (i.e. on its p8 proteins). 
These modified phages were constructed using the bioconjugation protocol 
described in Chapter 3. When the target is present in a sample, the modified 
phage interacts with it, perturbing the phage overall alignment. That changes the 
phage spectroscopic LD signal, allowing for detection and quantification of the 
target. An illustration of this principle is given in Fig. 5.1.  
 
 
 
 
 
 
 
 
Figure 5.1: Illustration of the concept behind the LD-based biosensor immunoassay. 
Chemically functionalised M13 bacteriophages (blue lines) with antibodies (light blue 
Y-shapes) naturally align under flow, giving an expected phage LD signal. When a 
target of interest (orange shape) is added, the antibody-functionalised phage interacts 
with it. This results in an overall reduced phage LD signal because, in the presence of 
the target, the phage aggregates. Ultimately, the biosensor assay exploits the principle 
that functionalised M13 bacteriophages have a more intense LD signal than the 
aggregated mesh of phage-target. 
 
 
A bench-top LD spectrometer is a heavy (> 100 kg) and expensive piece of 
equipment, and can only be used by trained scientists. Thus, Linear Diagnostics, 
in partnership with Molecular Vision, designed and built a portable, handheld 
device to use as the reader for the biosensor (Fig. 5.2). This reader, which is easy 
to use and can give results in less than 10 minutes, is expected to be a versatile 
tool to be utilised in situ in a wide range of sectors, including medical, 
Target of  interest 
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environmental, defence and security, food safety and agriculture.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2: Linear Diagnostics’ biosensing platform. (Left) Prototype of the biosensor 
reader, designed by Linear Diagnostics Ltd. In contrast to the bench-top LD machine, 
this miniaturised LD device is a light, handheld and portable platform. (Right) Example 
of a LD spectrum illustrating the drop in the phage LD signal upon addition of a target 
of interest (e.g. bacteria) to the functionalised phage.   
 
 
As illustrated by the LD plot in Fig. 5.2, when target bacteria are added to the 
functionalised phage, this interaction perturbs the overall alignment of the 
filamentous phage, resulting in a decrease of its LD signal. This LD-based 
immunoassay has been tested and the proof-of-concept is now well-established. 
However, there are features of the technology that were considered as significant 
aspects to improve. The major drawback of the current biosensor is its limit of 
detection (LOD). The biosensor was presented as capable of detecting up to 105 
cells per milliliter, but it struggles to detect bacteria below that threshold. The 
sensitivity of the current immunoassay is considered to be insufficient for most 
medical diagnostics, where a two or three order of magnitude lower LOD would 
be desirable. Other downsides are the associated costs, time and complexity of 
the chemical approaches used to modify the phage scaffold. 
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5.1.2 Proposed modifications to the biosensor by genetic and chemical 
modulation of the phage surface  
The goal of the work reported in this chapter was to explore alternatives to the 
existing biosensing platform. Linear Diagnostics continuously optimised their 
immunoassay, but adjustments to the current bioconjugation protocol (see 
Chapter 3, Fig. 3.6) seemed not to produce significant improvements. Therefore, 
it was concluded that more radical changes to the phage scaffold might be 
necessary. Our main focus was on exploring genetic and chemical modifications 
to modulate the phage surface, hoping to enhance the sensitivity and the 
simplicity of the biosensor. Among the possible changes, these were the ones 
considered and developed in this work: increase to the overall surface of the 
phage by increasing its length (section 5.2.1), introducing an extra tryptophan on 
each p8 protein (section 5.2.2), introducing a cysteine on the p8 proteins (section 
5.2.3), expression of a Salmonella-binding peptide (section 5.2.4), directional 
conjugation antibodies by aldehyde-hydrazine chemistry (section 5.2.5), 
purification of the biosensor samples using magnetic beads (section 5.2.6). A 
brief background to the biological and chemical approaches is given in each 
section, prior to describing and discussing the results obtained in this work. For 
clarity, each of the sections exploring the modifications to the phage scaffold has 
been divided in two main sub-sections, “context” and “results and discussion”. 
 
 
5.2 Results and discussion 
Firstly, the assumption that the phage LD signal decreases upon binding of the 
functionalised phage to the target of interest, creating a mesh-like structure of 
phage-target, was challenged. For this, a replication of the LD-based biosensor 
assay was set on a microscope slide. Chemically modified phage, with anti-
Salmonella antibodies conjugated to the p8 proteins, was used for this 
experiment. Three independent samples were set - modified phage on its own, 
modified phage plus E. coli, and modified phage plus Salmonella. E. coli bacteria 
were used as a control - since the antibodies on this sample were Salmonella-
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specific, no interaction was expected. After a short incubation time between the 
modified phage and the bacteria, an aliquot of the samples was dropped on a 
microscope slide and immediately observed under a microscope. Snapshots of the 
collected microscopy images can be seen in Fig. 5.3.  
 
 
 
 
Figure 5.3: Testing the immunoassay principle on a microscope. In this experiment, a 
sample of chemically modified phage (with anti-Salmonella antibodies and a fluorescent 
blue dye) is used. The bacteria (E. coli and Salmonella) were previously conjugated with a 
red dye. Three samples were prepared: modified phage on its own; modified phage and 
E. coli bacteria (as a control); modified phage and Salmonella bacteria. The modified 
phage and the bacteria were mixed together and left to interact for 10 minutes prior to 
visualisation under a microscope (Leica SP8), immobilised under a 5% agarose pad. 
(Left) Microscopy image of the chemically modified phage, which can be seen as blue 
dots and blobs. (Middle) Microscopy image of the interaction between E. coli bacteria 
(red) and the chemically modified phage (blue). (Right) Microscopy image of the 
interaction between Salmonella bacteria (red) and the chemically modified phage (blue). 
 
 
As observed in Fig. 5.3, the modified phage (with anti-Salmonella antibodies on 
its surface) does not seem to interact with E. coli; however, when Salmonella is in 
the sample, the phage binds to the bacteria creating an aggregate composed of 
several phages and bacteria interlocking together. This was the first time the 
immunoassay was visualised under a microscope, and provided proof that the 
detected drop in the phage LD signal upon addition of bacteria, is due to the 
formation of aggregates between the phage and the bacteria.  
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5.2.1 Mutation to increase the length of the bacteriophage 
5.2.1.1 Context 
An interesting line of investigation was to test whether an increase in the phage 
length would result in a substantially different LD signal, as it was expected a 
longer phage would orient better. More importantly, it was speculated if using a 
longer phage on the LD-based biosensor would enhance the sensitivity of the 
current immunoassay. An extension on the length of the phage (by increasing the 
number of p8 proteins) would result in an increased available surface area, which 
could translate into more antibodies being conjugated to the phage. This section 
describes the method to construct mutant phages that are physically longer, the 
characterisation of these mutants and the collected spectroscopic results. 
 
5.2.1.2 Results and discussion	  
The rationale behind engineering longer bacteriophages comes from knowing 
that the p8 protein that encapsulates the genome of the M13 bacteriophage can 
accommodate larger or smaller genomes [3]. An increase in the length of the 
viral particle by cloning extra DNA into the genome is, therefore, expected. 
Making use of that knowledge, in collaboration with Henry de Malmanche from 
University College London, a set of mutant bacteriophages with different lengths 
were designed and successfully grown. In the work reported in this thesis, only 
two of these mutants were fully explored – phages that were estimated to be ~ 
1150 nm and ~ 1575 nm in length, which corresponds to an approximate 250 
nm (28%) and 675 nm (75%) increase in length, comparing to the wild-type 
phage of 900 nm. These two mutants will be addressed as “+ 1kb phage” and “+ 
4kb phage”, respectively, because this represents the approximate amount of 
kilobase pair (kb) DNA added to the phage genome. 
 
5.2.1.2.1 Genetically engineering longer bacteriophages 
The molecular cloning method for engineering longer bacteriophages is given in 
Chapter 2 (method 2.11.5) and described with more detail in [4]. Briefly, a 
fragment of DNA of specific length (1 or 4 kb) was cut from a plasmid using 
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restriction enzymes. A phage plasmid (M13mp18 plasmid, NEB) was also cut 
using the same restriction enzymes. After an overnight ligation, the M13mp18 
plasmid with the inserted fragment of DNA was transformed into competent 
cells and plated on a LB/agar plate. After an overnight incubation, a single phage 
plaque was picked. The mutant phages were then grown and purified by standard 
PEG/NaCl protocols. Phage plaque assays (Chapter 2, method 2.3.1) were 
performed to confirm the engineered mutant phages were infective against the 
bacterial host, E. coli (Fig. 5.4). 
 
 
 
 
 
                                                            
 
 
Figure 5.4: Plate pictures of the mutant phage plaque assay. (Left) The double agar 
overlay method. The mutant phage was spread over a LB/agar plate lawn with E. coli 
bacteria. The visible turbid plaques are in fact the areas where the E. coli did not grow 
efficiently because of being infected with the phage. (Right) The droplet method. Small 
drops of the mutant phage were pipetted over a LB/agar plate lawn with E. coli bacteria, 
confirming its infectivity. 
 
 
Commonly, phage concentration is given in mass (mg per mL), molarity 
(number of virion particles per mL) or by plaque forming units (pfu per mL). 
Phage concentration, in mg/mL and number of virions/mL, rely on UV-Vis 
spectroscopy measurements and the absorbance registered at 269 nm, arising 
from a combination of peptide and DNA absorbance [5] (Chapter 2, method 
2.3.2). Throughout this work, the phage concentration will be mainly given in 
number of virions/mL, as it was thought to be simpler to convey. Pfu/mL is a 
common way to express the concentration of a phage sample, and it is typically 
estimated from the double agar overlay method [6]. Pfu/mL is correlated with 
the ability of a phage to infect a bacterial host on a bacterial lawn. Both “+ 1kb” 
and “+ 4kb” mutant phages consistently showed lower pfu/mL than the wild-
type phage (i.e. over the same period of incubation, the mutant phages 
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consistently produce fewer plaques over a lawn of bacteria on a plate than the 
wild-type phage). This may be related to the mutant phages’ structure, which 
could have hampered the phage diffusion over the lawn of bacteria to 
neighboring bacteria cells, resulting in a lower number of bacteria being infected 
[4]. Moreover, although the plaque assay experiments confirmed the mutant 
phages are able to infect E. coli, this was noticed to be a slower and less efficient 
process, which was observed on the plaque morphology – longer phage mutants 
gave rise to smaller diameter plaques comparing to the wild-type phage. It was 
assumed mutant phages are either hindered in their capacity of infecting the 
bacterial host, or take more time to assemble and get released from the bacteria.  
 
After verifying the mutant phages were capable of infecting the bacterial host, 
the phage plasmids were analysed. To confirm the 1 kb and 4 kb DNA 
fragments were inserted into the M13mp18 plasmid, resulting in the “+ 1kb” and 
“+ 4kb” phages, respectively, a diagnostic gel was carried out (Fig. 5.5). Plasmids 
of the phage mutants were digested with the corresponding restriction enzymes 
and resolved on an agarose gel (Chapter 2, method 2.7.1). 
 
 
 
 
 
 
 
 
Figure 5.5: Diagnostic digest of the mutant phages on an agarose gel. The plasmids of 
the “+1kb” and “+4kb” phages were analysed to confirm the extra DNA fragment was 
inserted into the M13mp18 plasmid. Lane 1 – DNA marker (2-Log ladder). Lane 2 – 
uncut 7.2 kb M13mp18 plasmid, with no DNA insert. Lane 3 – uncut “+ 1kb” phage 
plasmid. Lane 4 – restriction enzyme digest of the “+ 1kb” phage plasmid, showing a 
band for the M13mp18 plasmid and a band for the 1 kb DNA insert. Lane 5 – uncut “+ 
4kb” phage plasmid. Lane 6 – restriction enzyme digest of the “+ 4kb” phage plasmid, 
showing a band for the M13mp18 plasmid and a band for the 4 kb DNA insert.  
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Distinctive bands corresponding to the inserted DNA fragments can be seen – 
the gel on Fig. 5.5 suggests the mutation to the phage plasmid was successful. 
The plasmid of the “+ 1kb” mutant phage (lane 3), when cut with the appropriate 
restriction enzyme, gave rise to two bands, one at around 7.2 kb from the 
M13mp18 original plasmid and another band at around 1 kb from the inserted 
DNA fragment (lane 4). Similarly, the plasmid of the “+ 4kb” mutant phage 
(lane 5), when cut with the corresponding restriction enzyme, gave rise to two 
bands, one at around 7.2 kb from the M13mp18 original plasmid and another 
band at 4 kb from the inserted DNA fragment (lane 6).  
 
The diagnostic digest of the mutant phage plasmids and DNA sequencing [4] 
confirmed successful cloning of the extra fragment of DNA into the M13mp18 
plasmid. However, this does not guarantee the phage grown from these 
recombinant plasmid constructs will be with the expected length. To confirm a 
population of longer viral particles was created, transmission electron microscopy 
(TEM) images (Chapter 2, method 2.5.7) of the mutant and wild-type phages 
were collected and processed using ImageJ, to measure their length. Fig. 5.6 
shows the general distribution in size/length of 40 phages of each population 
(wild-type phage (WT), “+1 kb” and “+4 kb” mutant phages).  
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Figure 5.6: Plot of the length distribution of each phage population, measured using 
TEM images. a) WT phage, 904 nm ± 5 nm; b) “+ 1kb” longer phage, 1155 nm ± 6 nm; 
c) “+ 4kb” longer phage, 1635 nm ± 12 nm. Measurements were done using ImageJ 
(n=40, for each). Magnification was 25000× for WT phage, and 15000× for the longer 
phages. ± represents standard error of the mean.  
 
 
The average measured length of each phage population was similar to the 
theoretically calculated length of the filaments (from simply assuming their 
length will scale linearly with genome size). Since a wild-type M13 phage has a 
6.4 kb genome and is around 900 nm in length, the “+ 1kb” longer phage, which 
has a genome of ~ 8.2 kb, should be around 1150 nm and the “+ 4kb” longer 
phage, which has a genome of ~ 11.2 kb, should be around 1575 nm. The 
a)#
b)#
c)#
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average length of the wild-type, “+ 1kb” and “+ 4kb” mutant phages was 904 nm 
± 5 nm, 1155 nm ± 6 nm, and 1635 nm ± 12 nm, respectively. Therefore, it was 
thought to be reasonable to conclude the mutated phage plasmid, with the extra 
DNA inserts, originates longer versions of the filamentous phage.  
 
5.2.1.2.2 LD and FDLD profile of the mutant phages 
Since the ability of the filamentous phage to align under flow is a major 
component of the previously described LD-based biosensor, the next step was to 
test the mutant phages on a LD system. The thermostability of the mutant 
phages was also considered an important characteristic, as it was envisioned that 
some of the features of the LD-based biosensor might later involve polymerase 
chain reaction (PCR) protocols [7]. Since the LD signal of the phage is linked to 
its filamentous nature, this spectroscopy technique can be used to evaluate the 
structural integrity of the phage particles when exposed to elevated temperatures 
[8].  
 
The effect of temperature on the mutant phages was tested by incubating an 
aliquot of phage sample for 5 minutes at a range of temperatures, and then 
measure its LD signal (Chapter 2, method 2.8.2.1). The results are clearer by 
looking at the change of LD at a single wavelength, 225 nm – for all the three 
phage populations, as the temperature reaches 80 °C, the overall LD signal 
decreases, suggesting the phage fiber conformation is compromised, not aligning 
properly under flow (Fig. 5.7). These results suggest that the mutant phages are 
as thermally stable as the wild-type, and that temperatures above 80 °C destroy 
the phage filamentous structure.  
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Figure 5.7: Effect of temperature on the stability of the wild-type, “+ 1kb” and “+ 4kb” 
phages (left to right). For all three samples, the LD phage signal at 225 nm remains 
fairly constant up to 80 °C. Above that temperature, the LD signal intensity decreases 
abruptly. 
 
 
LD experiments, such as the one shown in Fig. 5.7, give information on the 
mutant phages structural integrity. It was also speculated that, due to their 
length, the mutant phages might be less resistant to mechanical forces and need 
to be handled more carefully. Shredding, often caused by repetitive pipetting of 
filamentous particles, could present a problem. However, after repeated cycles of 
vortex and pipetting the mutant phage stock solutions, it was observable that the 
phage LD signal from several aliquots (derived from the same phage stock) was 
comparable across samples. This suggested there is no substantial alteration to 
the filamentous structure of the phages after standard laboratory procedures. 
Knowing this, it was assumed the mutant phages could be handled as the wild-
type phage, with no extraordinary precautions.  
 
An interesting question is to determine whether there is a relationship between 
the phage length and its LD spectrum (specifically, its magnitude). Intuitively, it 
was expected that longer filaments would have more intense LD signals when 
compared with the LD spectra of shorter filaments. However, it is known that 
the degree of alignment of a filamentous particle, such as the phage, is not a 
straightforward property [9]. The persistence length of the phage is related to its 
flexibility. The wild-type phage is considered to be a semi-flexible filament, 
which is the property explored by LD [10], and on the creation of phage 
nanorings [11]. An engineered increase in the phage length could result in either 
a more rigid or flexible particle, which could, in any case, result in changes to the 
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LD spectrum [12]. LD spectra of mutant phages are shown in Fig. 5.8 (Chapter 
2, method 2.8.2).  
 
 
 
 
 
 
 
 
Figure 5.8: LD spectra of the “+ 1kb” and “+ 4kb” mutant phages. The column plot 
shows LD signal at 225 nm. Data are mean values and error bars represent the standard 
deviation from three LD measurements. Phages in PBS buffer at concentration of 1012 
virions/mL. 
 
 
Based on Fig. 5.8, there seems to be a relationship between the length of the 
mutant phage and its LD spectrum – the ~ 1575 nm phage (“+ 4kb” phage) has a 
greater LD signal than the ~ 1150 nm phage (“+ 1kb” phage). However, these 
data on their own do not facilitate determining the correlation between length 
and molecular alignment. Assuming proportionality, if the wild-type phage has 
2700 copies of p8 proteins, the “+ 1kb” and “+ 4kb” phage will have around 3450 
and 4800 copies, respectively. An equal number of phage particles of the mutant 
and wild-type phage, means that the mutant phage will have more p8 proteins, 
which translates into more molecules capable of absorbing light contributing to 
the LD signal. Therefore, the longer mutant will naturally have a higher intensity 
LD signal, without necessarily meaning it aligns better under flow. Section 
5.2.1.2.4 explores this topic in greater detail.  
 
As explored in Chapter 3, the major coat protein of the phage, the p8 protein, 
has one tryptophan amino acid in its sequence. Tryptophan fluorescence has 
been extensively used to study protein structure and function, and because of its 
sensitivity to the local surrounding environment, conformational changes to the 
protein are generally reflected in the tryptophan spectra. Although a complex 
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phenomenon, it also appears tryptophan is uniquely sensitive to quenching by 
nearby residues within the protein [13]. 
 
In the case of the mutant phage constructs, a more fluorescent phage could 
indicate a higher amount of tryptophans in its surface (which would be expected, 
given that longer phages have more p8 proteins to encapsulate the viral genome). 
To test this, FDLD measurements of the wild-type and mutant phages were 
taken. FDLD is a similar technique to LD, differing in the fact that FDLD 
detects fluorescence. The fluorescence derived from the aromatic residues of the 
aligned phages can be measured. Since the phage major proteic component is 
from the p8 protein, the spectroscopic detected peaks correspond to the amino 
acids (mainly, tryptophans) on this protein. The resulting FDLD spectrum from 
wild-type and mutant phage samples is plotted in Fig. 5.9 (Chapter 2, method 
2.8.2).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.9: FDLD spectra of 1012 virions/mL wild-type and mutant M13 phages. A 
300 nm cut-off filter was introduced in front of the LD machine detector. Parameters 
used as per Table 3.1 (Chapter 3). 
 
 
The peak observed between 260 and 280 nm corresponds to the side chains of 
the aromatic amino acids, deriving mainly from tryptophan residues. Looking at 
Fig. 5.9, it is apparent that the “+ 4kb” phage has a more intense peak at this 
wavelength range, suggesting there are more tryptophans in this phage in 
comparison with the wild-type and “+ 1kb” phage. This finding supports the idea 
that a longer phage has greater intrinsic fluorescence.  
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5.2.1.2.3 Mutant phages as scaffolds for the LD-based biosensor 
The motivation for building a longer phage particle came mainly from the 
assumption that a mutant phage would have more points of attachment on its 
surface for recognition elements – more p8 proteins could be modified by the 
bioconjugation protocol (illustrated in Chapter 3, Fig. 3.15), possibility resulting 
in more antibodies and dye molecules per phage. Theoretically, this could 
improve the sensitivity of the LD-based biosensor. 
 
An essential step of the bioconjugation protocol is the conjugation of maleimide 
molecules to the phage surface. Therefore, an experiment was designed to test 
the ability of the p8 proteins of the mutant phages to be conjugated to maleimide 
groups. The mutant phages were labelled with AF647, a maleimide-derivatised 
dye (Chapter 2, method 2.4.2.1), and the LD of the dye-labelled phages was 
measured. The phage LD signal at the dye wavelength is plotted in Fig. 5.10.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.10: LD signal at 660 nm illustrating AF647 maleimide-derivatised dye 
conjugation to wild-type and mutant phages. LD spectra normalised at 225 nm. Data 
are the mean values of three LD measurements, and error bars represent standard 
deviation. 
 
 
The experiment on Fig. 5.10 confirmed the p8 proteins on the mutant phages 
are maleimide-reactive. It is also noticeable that an increase in p8 proteins 
seemed to correspond to an increase in amount of conjugated maleimide-
derivatised molecules. This suggests that a longer mutant phage can 
accommodate more dye molecules on its surface than a wild-type phage.  
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Building on these results, the mutant phages were chemically conjugated with 
maleimide-derivatised anti-Salmonella antibodies (Chapter 3, Fig. 3.15), and 
tested in Linear Diagnostics’ LD-based biosensor (Chapter 2, method 2.8.2.2). 
The immunoassay results were plotted in Fig. 5.11. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.11: LD-based immunoassay using the “+ 1kb” and “+ 4kb” mutant phages as 
scaffolds for the detection of bacteria. Mutant phages were conjugated with anti-
Salmonella antibodies, and E. coli bacteria were used as control. The variation of LD 
signal at 225 nm was tracked, as it relates to the overall alignment of the long axis of the 
phage particles. The initial amount of mutant phage on each immunoassay was so that 
LD225 ~ 0.01. Data are the mean values and error bars represent standard deviation on 
LD measurements of three independent immunoassays using the same phage conjugate 
sample. (Left, grey bars) LD signal resultant from the interaction between the anti-
Salmonella “+ 1kb” mutant phage and Salmonella bacteria. Anti-Salmonella mutant phage 
detects 107 Salmonella cells per mL. (Right, black bars) LD signal resultant from the 
interaction between the anti-Salmonella “+ 4kb” mutant phage and Salmonella bacteria. 
Anti-Salmonella mutant phage detects 106 Salmonella cells per mL. 
 
 
As illustrated in Fig. 5.11, both anti-Salmonella mutant phages were sensitive to 
the presence of Salmonella, which is indicated by the drop in LD signal when this 
bacterium was added. Furthermore, it is interesting to note that the anti-
Salmonella “+ 4kb” mutant phage was sensitive to 106 bacterial cells, while it took 
107 bacterial cells to perturb the “+ 1kb” mutant phage LD signal. Although 
these results seem to suggest the longer phage particles can be successfully 
integrated with the LD-based immunoassay, no apparent improvement to the 
sensitivity of the current biosensor (105 bacterial cells per mL) was achieved. 
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Further experiments needed to be conducted to expand on these findings. 
However, this line of investigation was not continued, as it was realised these 
mutant phages might not be an ideal biological scaffold, as discussed below. 
 
5.2.1.2.4 Unresolved challenges 
• Comparing the LD alignment of the mutant phages  
Both concentration and degree of alignment of the mutant phage are variables 
that contribute to the LD data collected. The major challenge in assessing the 
LD spectrum of the mutant phages was on how to compare them with the wild-
type phage and between themselves. The chosen phage concentration unit 
depends greatly on the research question. An interesting line of investigation 
would be to investigate whether a longer phage particle aligns better than a wild-
type phage. As previously noted, directly comparing the LD spectra of 1012 
longer phage particles with the spectra of 1012 shorter phage, in a 1-to-1 ratio, 
may not be a fair comparison, because there are substantial differences in the 
number of p8 proteins contributing to the LD signal. Instead, by keeping the 
concentration of the phage populations constant in mg/mL, the number of p8 
proteins will be similar between different samples. For perspective, one can 
imagine comparing the LD signal of the following two phages – a phage of 
length A and a phage of length 2A (that is exactly double the length of phage A). 
To keep the mass proportionality, two phages A would have to be compared to 
one phage 2A, in a 2-to-1 ratio. Comparing the LD of longer phage particles by 
mass means that any observable change in the spectra will be largely due to 
differences in the overall phage structure. An LD spectrum of the mutant and 
wild-type phages at 0.2 mg/mL was plotted in Fig. 5.12. By normalising to mass 
units, it was expected that the structural changes of the mutant phages would be 
evident, as it was assumed that longer filamentous particles would orient better 
and give higher LD signals. However, as shown, the differences between the LD 
spectra of the three phage populations were unremarkable. From looking at these 
LD data, it seemed the ability of the mutant phages to align under flow was not 
enhanced by its increase in length.  
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Figure 5.12: LD spectra of wild-type (WT) and mutant phages at 0.2 mg/mL. 
 
 
As mentioned above, the degree of alignment of a filamentous particle is not a 
straightforward characteristic, and it depends greatly on the flexibility of the 
filament. This is found to be true, for example, for calf thymus DNA molecules, 
where it was shown that an overall increase in DNA flexibility (caused by factors 
such as elevated temperature, reduced viscosity and increased ionic strength) 
resulted in a reduction of the orientation of the molecules in flow which 
ultimately reduced the LD signal magnitude [14]. It is likely that longer phage 
particles have increased bending flexibility, which could result in a reduced ability 
to align, and hence a reduced LD signal, so we concluded that the wild-type 
phage was already maximised the degree of orientation possible for a given 
stiffness particle. 
 
• Instability of the mutant phage  
Although it was demonstrated it is possible to construct and grow phages longer 
in length, the benefit from doing so does not seem to counterweigh the 
shortcomings. The yields obtained from growing the mutant phages were 
considerably lower (< 2 mg per milliliter of culture) than the titers typically 
obtained with the wild-type phage (> 8 mg per milliliter of culture). Perhaps, this 
could be improved by optimising the culture conditions used to grow these 
mutants. Almost intuitively, it is not difficult to imagine why the mutant phage 
would be harder to grow in the laboratory. A longer phage would require more 
energy to assemble and pack the viral proteins, and more resources to keep up 
with that need. From a purely Darwinian point of view, if there were a benefit 
for the M13 bacteriophage to be longer, would it not have evolved and already 
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exist in nature? It was observed that in successive propagations, the phages had a 
tendency to go back to its wild-type original size. It is possible this is due to 
cross-contamination, in which a small population of wild-type phage (i.e. 
M13mp18 phage plasmid with no insert) thrives and grows more successfully, 
becoming the dominant population in subsequent generations, which ultimately 
led to batch-to-batch variability between bacteriophage preparations. Perhaps, 
this could be due to genetic instability of the constructed phage plasmids – 
diagnostic gels and sequencing data showed that the plasmids engineered for the 
production of longer phages could delete out the inserted fragment of DNA. 
This could be a result of the specific sequence of DNA inserted, and also the size 
of the DNA fragment – large inserts are thought to be more likely to get deleted 
from the original plasmid [15,16]. One way to improve the method would be to 
acquire synthetic DNA instead of cutting it out of a plasmid, to ensure the entire 
inserted DNA is junk (i.e. does not code for genetic elements) and it does not 
interfere with the phage life cycle or pose a metabolic burden to the bacteria. 
 
Although it was disappointing that the work to create the longer phage did not 
increase sensitivity, in the long run for the biosensor, the much easier to produce 
wild-type phage can be concluded to provide an optimal signal per its length, so 
the result was appreciated by the Linear Diagnostics team. 
 
 
5.2.2 Mutation to introduce an extra tryptophan to the p8 proteins of the phage 
5.2.2.1 Context 
Another method to increase the number of tryptophans in the phage capsid 
could be by simply adding the amino acid to the sequence of every p8 protein 
(Chapter 2, method 2.11.4). In comparison with the wild-type phage, this would 
result in a mutant phage with double the amount of tryptophan in its surface (i.e. 
the mutant phage would have two tryptophan residues per p8 protein). This 
would create the possibility of easily probing the phage LD signal in the aromatic 
region, at 280 nm.  
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5.2.2.2 Results and discussion 
This genetic mutation can not be inserted at random as certain changes to the p8 
protein sequence lead to dysfunction of the assembly of the phage during its life 
cycle, compromising its viability [17]. An extra tryptophan was added to the N-
terminal of the wild-type p8, as it is generally considered the least likely region to 
negatively affect the p8 structure. Additionally, two glycines were introduced to 
act as a linker between the p8 protein helix and the added tryptophan. 
Mutagenesis on the phage was confirmed to be successful by DNA sequencing 
analysis and matrix-assisted laser desorption/ionisation time-of-flight mass 
spectrometry (MALDI-TOF MS) (Fig. 5.13) (Chapter 2, method 2.8.1). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.13: MALDI-TOF MS spectrum of the mutant phage with an extra 
tryptophan on p8 protein. Expected Mw ~ 5496 Da.  
 
 
Assuming independent effect from both tryptophan molecules, adding an extra 
tryptophan to every p8 protein was thought to enhance the overall fluorescence 
of the phage, having a similar effect to what was observed on the mutant longer 
phage particle – increased number of p8 proteins translated into a more intense 
intrinsic fluorescence profile. Unexpectedly, this was not the case. 
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Figure 5.14: Intrinsic fluorescence of the mutant phage with an extra tryptophan on p8 
protein. FDLD spectra of 1012 virions/mL wild-type p8 phage (WT p8, dashed line) and 
mutated p8 phage (Trp p8, solid line) zoomed on the aromatic (260-280 nm) region. 
Average spectra of three independent measurements using the parameters given in Table 
3.1 (Chapter 3). 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.15: Normalised emission fluorescence spectra of the mutant phage with an 
extra tryptophan on p8 protein. Emission fluorescence spectra of 1012 virions/mL wild-
type p8 phage (WT p8, dashed line) and mutated p8 phage (Trp p8, solid line). Spectra 
were normalised at maximum intensity peak (330 nm) to compare the shape of the 
curves. A 4-nm red-shift relative to the wild-type phage is indicated with a black arrow. 
Excitation wavelength was set at 280 nm. Average spectra of three independent 
measurements are shown. Data collected on a Jasco FP-6500 spectrofluorimeter. 
 
 
It was expected that, by doubling the amount of tryptophan residues on the 
phage capsid, this would be evident by FDLD, with a distinct amplification in 
signal. As shown in Fig. 5.14, this was not observed – the wild-type phage has a 
more intense intrinsic fluorescence than the mutated phage with an extra 
tryptophan residue. The emission spectra (Fig. 5.15) emphasises changes in 
spectral shape, displaying a 4-nm shift to a longer wavelength, of the mutant phage 
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spectra relative to the wild-type phage spectra. This red-shift assigns the 
tryptophans to a polar environment, which implies the added residues are more 
likely to be solvent-exposed. It was speculated that the extra trytophan would be 
more disordered on the phage surface as a result of the increased flexibility, 
which could retrospectively affect its spectroscopic signal. Molecular dynamics 
simulations, conducted by Dale Ang from Western Sydney University, gave a 
possible explanation for the results. It was observed that, contrary to the native 
tryptophan (position 26), which is exposed on the surface and generally 
maintains an orientation perpendicular to the long axis of the phage, the added 
extra tryptophan residue (attached to the flexible glycine linker) is able to interact 
with adjacent peptide chains. In doing so, there is the possibility of fluorescence 
quenching by the phenol group of the aromatic tyrosine residue, at position 24 
[18,19]. Additionally, the added tryptophan could be contact quenching the 
native tryptophan. These events could not only cancel any effect the added 
tryptophan could potentially have, but also interfere with the already existing 
intrinsic fluorescence of the phage.  
 
The determined concentration of the mutant phage was an inaccuracy only 
noticed upon later analysis of the collected data. In the experiments presented 
here, the extinction coefficient of the mutant phage was assumed to be the same 
as for the wild-type phage. However, this is an inadequate approach – the 
mutant phage, having one more tryptophan constituting its capsid, would have 
an increased overall extinction coefficient. By using the same extinction 
coefficient for the wild-type and mutant phage, the concentration of the latter 
was underestimated. Ultimately, inaccurate estimation of phage concentration 
would have had a considerable effect on the FDLD measurements.  
 
The extinction coefficient of the mutant phage could have been empirically 
determined. For example, one could freeze-dry a solution of the mutant phage, 
weight the resulting solid pellet, dissolve it in a precise amount of buffer, and 
measure this phage sample of known concentration on the UV-Vis to derive its 
extinction coefficient. Another approach could be to denature the phage and 
	  	   135	  
_________________________________________________________________"Chapter"5"
extract its DNA, and compare samples using gel densitometry: 1) run several 
samples of known concentration of wild-type phage through an agarose gel and 
establish a relationship between the concentration of the wild-type phage and the 
density of the DNA bands; 2) run the unknown sample of mutant phage on the 
same gel; 3) based on the calibration curve built from 1), estimate the 
concentration of the mutant phage. An approximation of the mutant phage 
extinction coefficient could also be theoretically determined, by adding the molar 
extinction coefficient of tryptophan at 269 nm multiplied by 2700 (the number 
of p8 proteins on the phage) to the molar extinction coefficient of the wild-type 
phage. By doing so, it was estimated that the mutant phage concentration was 
underestimated by less than 20% (note that most of the contribution at 269 nm 
derives from the viral DNA). The expected outcome from adding an extra 
tryptophan to the phage capsid was that its FDLD signal intensity would double. 
Correcting for the miscalculation of the extinction coefficient of the mutant 
phage would nevertheless result in a spectroscopic signal less intense than 
expected, supporting that the conclusions and reasoning underlined above are 
possibly still valid. 
 
 
5.2.3 Introducing of a cysteine to the p8 protein – the V31C mutation 
5.2.3.1 Context  
As discussed in Chapter 3, the p3 proteins of the wild-type phage have cysteines, 
but p8 proteins lack this amino acid in its sequence. For this reason, the first step 
in the bioconjugation protocol (Chapter 3, Fig. 3.15), in which the SATA (N-
succinimidyl S-acetylthioacetate) reagent is used to convert the primary amines 
of the p8 protein to thiol groups, is required in order to conjugate the antibodies. 
An alternative method to circumvent the necessity for this chemical step is to 
genetically introduce the cysteine in the p8 sequence.  
 
Initially, a cysteine residue was genetically introduced into the N-terminal of the 
p8 protein. However, this mutation resulted in very low production yields, 
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suggesting this mutation interferes with the phage life cycle in the host bacteria 
or compromises its secretion from the host. Due to cysteine reactivity, not all 
positions in the p8 protein tolerate the mutation. Hemminga and co-workers 
have methodically developed all possible mutagenesis combinations to introduce 
a cysteine onto the p8 protein sequence [20]. From the several mutations 
proposed in the literature, the V31C mutation, in which the valine in position 31 
of the p8 protein is replaced with a cysteine, was chosen for this work as it has 
been used for different applications by others [21-24]. The method for creating 
the V31C mutation on the wild-type phage, by site directed mutagenesis, is 
described in Chapter 2 (section 2.11.4.8). 
 
5.2.3.2 Results and discussion 
The success of the mutagenesis was checked by DNA sequencing, which 
confirmed that the mutant phage (i.e. the V31C phage) had 2700 cysteines 
throughout its capsid. An Ellman’s reagent test (Chapter 2, method 2.9.3) 
suggested these cysteines were exposed to the surface and not yet cross-linked to 
form disulfide bridges − the sample immediately turned yellow without the need 
to add any reducing agent, such as TCEP (Fig. 5.16). It was noticed, however, 
that a transparent gel-like precipitate formed over time, probably due to inter 
and intra cross-linking interactions between the V31C phages.  
 
 
 
 
Figure 5.16: The V31C phage. (Left) Sequence of the wild-type and mutated p8 
protein. These phages only differ on one amino acid, in which a valine was swapped for 
a cysteine, at position 31. (Right) Picture of the reaction between Ellman’s reagent and 
wild-type (WT) and V31C phage, in PBS buffer. The wild-type phage, which contains 
only an insignificant fraction of cysteines on the p3 proteins, does not react with the 
Ellman’s reagent, and therefore the solution does not turn yellow. The strong yellow 
coloration of the V31C phage sample indicates the abundant presence of thiols. 
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5.2.3.2.1 Maleimide-reactivity of the V31C phage 
Additional experiments, such as MALDI-TOF mass spectrometry (Fig. 5.17) 
and protein gels (Fig. 5.18), further confirmed the presence of the cysteines and 
suggested these were available to conjugate with maleimide moieties. This was 
essential for this work, as maleimide-derivatised antibodies are used in the 
bioconjugation protocol (Chapter 3, Fig. 3.15). 
 
 
 
 
 
 
 
 
 
 
Figure 5.17: MALDI-TOF MS spectra of wild-type phage and V31C phage after an 
overnight reaction with NEM. (NEM, N-Ethylmaleimide, Mw ~ 125 Da). (Blue 
spectrum) Wild-type p8. Max. peak at ~ 5246 Da. A small shoulder is also visible, and 
this was thought to be due to the slower interaction between the maleimides and the 
primary amines on the p8 proteins. (Green spectrum) V31C p8. Max. peak at ~ 5377 
Da.  
 
 
Wild-type and V31C phage were reacted with a final concentration of 50 mM 
NEM (N-Ethylmaleimide) overnight at room temperature, purified using Zeba 
spin columns, and subsequently analysed by MALDI-TOF MS (Chapter 2, 
method 2.8.1). It was expected that, if the V31C phage capsid had maleimide-
reactive cysteines, an increment of the mass of the p8 protein, corresponding to 
the mass of NEM, should be observable. As shown in Fig. 5.17, since there are 
no natural occurring cysteines in the wild-type p8 protein that the NEM could 
conjugate to, the p8 protein mass (~ 5246 Da) did not change. On the other 
hand, the mass of the p8 protein of the V31C phage increases, with a peak shift 
corresponding to the mass of the conjugated NEM to the cysteines in the p8 
protein. This experiment confirmed the cysteines (i.e. thiol groups) on the 
surface of the V31C phage are reactive with maleimides.   
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Another experiment was designed to demonstrate the maleimide molecules get 
conjugated to the p8 proteins of the V31C phage. The V31C phage was 
conjugated to a maleimide-derived fluorescent dye (AF647) and analysed on a 
Tris-Tricine gel – prior to Coomassie staining, fluorescence images of the gel 
were acquired (Chapter 2, method 2.7.3.1) (Fig. 5.18). 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.18: Tris-Tricine precast gel of the AF647-V31C phage. (Left) Coomassie blue 
stained gel. (Right) Fluorescent image of the gel prior to staining. 
 
 
Fig. 5.18 shows two pictures of the same gel – a stained gel image and a 
fluorescent image of the gel before being stained. The purpose of this experiment 
was to confirm that the p8 proteins of the V31C phage are maleimide-reactive. 
AF647 dye was conjugated to the V31C phage, and after PEG/NaCl 
precipitation, the conjugate was resolved on a 10−20% precast Tris-Tricine gel. 
Wild-type and V31C phage, not conjugated to AF647 dye, were also analysed 
on this gel to guarantee there was no detectable fluorescent bands arising from 
autofluorescence or detectable intrinsic fluorescence. Prior to staining, 
fluorescence images of the gel were acquired. Then, the gel was stained with 
Coomassie blue and imaged again (under white light). The broad band at around 
10 kDa visible on the stained gel, on the three samples, was assigned to be from 
p8 proteins. The fluorescent image of the gel shows a similar broad band, 
suggesting the p8 proteins of the V31C phage were labelled with AF647 
fluorescent dye. There is also a fainter band at the top of the gel, probably from 
aggregated product. The p8 protein band of the label-free wild-type and V31C 
phage is not visible in the fluorescent gel.  
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In summary, the constructed V31C phage was demonstrated to be viable (i.e. it 
was capable of infecting the bacterial host and assembling correctly) and to have 
one cysteine, and therefore a thiol group, on each p8 protein. These cysteines 
were confirmed to be reactive against maleimide moieties. The next step would 
be to adjust the bioconjugation protocol (Chapter 3, Fig. 3.15) to accommodate 
the use of the V31C phage instead of the wild-type phage. The protocol was 
followed as usual, but initiated at step b) (since there is no longer the need to use 
SATA to introduce thiol groups on the p8 proteins) – the V31C phage was 
conjugated to the maleimide-derivatised antibodies and purified as previously 
described. 
 
However, despite several attempts, the V31C phage modified with maleimide-
derivatised antibodies seemed to be inadequate for the biosensor immunoassay. 
As described above in this chapter, in order for a modified phage with antibodies 
to be considered sensitive to the presence of target bacteria, a drop on its LD 
signal must occur. While running the immunoassay using the modified V31C 
phage, there was no visible change on the LD signal, as it would be expected 
when bacteria are added.  
 
These results were puzzling. The protocol conditions were tuned to no avail − 
bioconjugation steps repeated with lower pH buffers, addition of a reducing 
agent to break possible disulfide bridges between phages (that would affect thiols 
accessible to maleimide groups) prior to conjugation with antibody, serial 
dilution of the concentration of V31C phage and maleimide-derivatised 
antibody, longer incubation times between V31C phage and antibody, longer 
interaction time between the target bacteria and the modified V31C phage. The 
conjugation of the V31C phage capsid with antibodies was considered as the 
most likely problematic step. It was possible that the conjugation of the 
maleimide-antibodies to the thiols on the p8 proteins of the V31C phage was 
not as straightforward as initially thought. Perhaps, the cysteines at position 31 
in the p8 proteins are harder to access/less exposed than the chemically 
introduced thiols at position 8. If so, it is possible that a steric hindrance 
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phenomenon is disrupting the conjugation of the antibody to the cysteine on the 
surface of the V31C phage.  
 
5.2.3.2.2 Cysteine (position 31) versus lysine (position 8)  
An important line of investigation would be to compare the positions of the thiol 
groups on the V31C phage and on the SATA-chemically modified wild-type 
phage (using the bioconjugation protocol described in Chapter 3). From looking 
at Fig. 5.19, it appears that the genetically introduced cysteines (position 31) on 
p8 protein are spatially closer to each other than the thiols generated by the 
SATA reagent on the lysine residues (position 8). 
 
 
 
 
 
 
 
 
Figure 5.19: Illustration of the partial side-view of the surface of the phage. A single p8 
protein helix is also shown. Position 31 of the p8 protein was labelled in red and 
position 8 of the p8 protein was labelled in blue. Images produced using Chimera (PDB 
entry: 2MJZ [25]). 
 
 
To better quantify this observable difference, the distances between adjacent 
reactive groups on the capsid of the phage were measured using the distance 
analysis tool on Chimera software. 
 
 
 
 
 
 
 
 
 
Figure 5.20: Distances between functional groups on the surface of the phage. (Left) 
Distances between adjacent cysteines at position 31. (Right) Distances between adjacent 
lysines at position 8. Distances determined using Chimera (PDB entry: 2MJZ [25]).  
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Fig. 5.20 illustrates the distances between the cysteines of the V31C phage (red), 
and the distances between the lysines of the wild-type phage (blue). Closest 
neighbouring thiol groups are diagonally separated by 2.1 nm on the V31C 
phage, and by 2.7 nm on the wild-type phage. In the azimuthal direction, the 
distance between the thiol groups on adjacent p8 proteins on the V31C phage 
and the wild-type phage are 2.6 nm and 3.5 nm, respectively. Overall, these 
measurements confirm that lysines at position 8 are more sparsely dispersed over 
the phage surface than cysteines at position 31. At the molecular level, these are 
significant differences. It is not implausible to speculate that shorter distances 
between conjugation sites over the surface of the phage may interfere with the 
conjugation of antibodies (~ 150 kDa).  
 
To get some perspective on this, an experiment using two different dyes was 
designed, in which their molecular weight was the considering factor. 7-
Diethylamino-3-((((2-maleimidyl)ethyl)amino)carbonyl)coumarin (MDCC) and 
Alexa Fluor 647 (AF647) have a molecular weight of 380 Da and 1250 Da, 
respectively. Both these dyes are maleimide-derivatives, but their mass differs by 
more than 3-fold, with MDCC being a smaller, more compact molecule.  
 
2 mg of V31C phage and SATA-modified phage were conjugated with 
equimolar amounts of MDCC and AF647, and purified by PEG/NaCl 
precipitation (Chapter 2, method 2.4.2.1). After fully resuspending the phage 
pellets in PBS buffer, the samples were assessed by LD (Chapter 2, method 
2.8.2). Fig. 5.21 shows plots of the LD phage signal zoomed in on the dye peak 
region (600-700 nm for AF647, and 350-550 nm for MDCC) – free-in-solution 
dye molecules can not align on their own, and therefore the LD signal collected 
is only from the dye conjugated to the phage particle. 
 
 
 
 
 
 
	  	   142	  
_________________________________________________________________"Chapter"5"
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.21: LD spectra of the phage zoomed at the dye (MDCC and AF647) 
absorption region. (Top) LD spectra normalised at 225 nm comparing the AF647 dye 
peak of a SATA-modified wild-type (WT) phage and a V31C phage. Inset zoomed at 
the AF647 dye peak on the V31C phage. (Bottom) LD spectra normalised at 225 nm of 
the MDCC dye peak on the V31C phage.  
 
 
Fig. 5.21 shows the LD spectra of phage-dye conjugates. The spectral data on 
the top suggests that AF647 dye labelling of the SATA-modified phage was 
more efficient than on the V31C phage. Also, illustrated on the spectral data on 
the bottom, the LD dye peak from the V31C-MDCC conjugate was greater 
than the LD dye peak derived from the V31C-AF647 conjugate. These data 
suggest two things – AF647, despite being a large dye molecule, conjugated 
efficiently to the chemically modified amines but not to the cysteines on the 
V31C phage; MDCC dye molecules were conjugated to the surface of the V31C 
phage to a greater extent than the AF647 dye. 
 
Although the two fluorophores, MDCC and AF647, have distinct spectral 
profiles and chemical properties that have not been considered here, it is possible 
that the observed differences in labelling of the p8 proteins are due to the size of 
the dye molecules and the arrangement of the functional groups on the phage 
surface. Extrapolating this line of thought, it is not unlikely that conjugating 
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antibodies to V31C phage would be spatially and energetically unfavourable, 
resulting in a low degree of labelling incompatible with the LD-based 
immunoassay. Molecular simulations could further clarify on the importance of 
the distances between adjacent cysteines, and how that could compromise the 
labelling of the phage surface. Naturally, the reasoning that steric hindrance 
phenomena disrupted the potential use of the V31C phage on the LD-based 
biosensor is only valid when assuming conjugation between V31C and antibodies 
was indeed unsuccessful. To confirm this was the case, ideally one should test the 
V31C-antibody conjugate, and check for the presence or absence of the antibody 
on the V31C phage capsid. This could be achieved, for example, by setting up an 
ELISA. The V31C-antibody conjugate could be attached to a 96-wells plate 
using anti-p3 antibodies as anchors. Then, an HRP-conjugated antibody, 
specifically against the antibody conjugated to the V31C phage, could be added, 
detecting the presence or lack of the antibody on the phage surface. Since the 
V31C phage was not compatible with the LD-based biosensor, an alternative to 
include thiols on the phage surface was envisioned. This involved cloning a 
cyclic-cysteine peptide on the N-terminal of the phage (as discussed in the 
“conclusion” section), which would create more exposed thiol groups along the 
phage capsid. 
 
 
5.2.4. Expression of a Salmonella-binding peptide on the surface of the phage 
5.2.4.1 Context 
Peptide-binding peptides have been used as an alternative to antibodies in 
diagnostics. Antibodies are expensive and relatively fragile molecules, and 
although antibody-antigen interactions are much stronger than peptide-peptide 
interactions, the latter are reported to be sufficient for most immunoassays 
applications [26]. Theoretically, the antibodies used in the LD-based biosensor 
could be substituted with a bacteria specific-binding peptide.  
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Peptide-binding peptides are generated by phage display biopanning [26-28] – 
an in vitro affinity technique for the selection of peptide sequences that bind to a 
target of interest, as described in Chapter 1. The first step of biopanning involves 
inserting a DNA fragment derived from a random library into the phage 
genome, so that the surface of the phage displays the coded peptide. Next, the 
resulting phage-peptide particles are exposed to a target of interest. The phage-
peptides that have affinity for a target will get captured, while the weakly bound 
phage-peptides will be washed off. The final step of biopanning is the elution of 
the phage-peptide strongly bound to the target. Typically, several rounds of 
biopanning are required to select a peptide-binding peptide. Successive rounds 
ensure increased specificity for the target and reduce library diversity, by 
highlighting the most essential amino acid sequences for target recognition and 
binding. The peptide-binding peptide displayed on the phage can then be 
sequenced and added to a database. 
 
A literature review was conducted to explore possible binding peptides that could 
replace the anti-Salmonella antibodies used in the immunoassay. A Salmonella-
binding peptide, with sequence NRPDSAQFWLHH, was reported by Morton 
et al. [29], and used for Salmonella detection platforms by Wang et al. in [30], 
and by Karoonuthaisiri et al. in [31]. According to the authors, the described 
Salmonella-binding peptide (named MSal020417) is specific for Salmonella spp., 
not interacting with other species, such as E. coli and Listeria monocytogenes, and 
it is capable of differentiating between different serovars of a bacteria [30]. 
 
5.2.4.2 Results and discussion 
We considered genetically inserting the 12 amino acid sequence into the p8 
protein of the phage. The underlying problem with introducing large peptides ( > 
6-mer) [32,33] into the p8 protein (which is a small 50 amino acid residues 
protein) is that the resulting phage may not be able to complete its life cycle and 
assemble properly, giving rise to very poor production yields. This challenge is 
well known among the bacteriophage scientific community, and scientists have 
designed clever ways to bypass it. The mosaic phage is an example of this - an 
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engineered biomaterial constructed to facilitate standard molecular biology on 
phage systems [32-35].  
 
The mosaic phage, also called type 88 phage, is a filamentous fd phage designed 
by Smith et al [36]. The mosaic phage has two types of p8 proteins – 3600 copies 
of a wild-type p8, and around 300 copies of a synthetic p8. The synthetic p8 
gene is controlled by a Tac promoter and is, therefore, inducible by IPTG, as 
demonstrated in Fig. 5.22 (Chapter 2, method 2.8.1). It has unique HindIII and 
PstI cloning sites, separated by a 21-bp spacer. Replacing this spacer with a 
DNA insert of interest may result in the display of several copies of the peptide 
encoded by the insert, which will be fused to the synthetic p8 and presented on 
the surface of the phage. The peptide of interest will then only be displayed on 
the synthetic p8 proteins, and because these are sparsely dispersed along the 
phage surface, these are less likely to disrupt the overall structure of the phage 
and compromise its viability. 
 
 
 
 
 
 
 
Figure 5.22: MALDI-TOF MS spectra of the mosaic phage. The expression of the 
synthetic p8 is tunable by IPTG. Both proteins can be assigned on a MALDI-TOF 
spectrum – a major peak at around 5240 Da from the wild-type p8, and a smaller peak 
at around 5550 Da from the synthetic p8 (indicated with arrows). (Left) fd mosaic 
phage induced with 100 µM IPTG. (Right) fd mosaic phage induced with 1 mM 
IPTG. 
 
The cloning of the Salmonella-binding peptide into the synthetic p8 was 
successful as confirmed by DNA sequencing and MALDI-TOF mass 
spectrometry (Fig. 5.23). This phage construct is denominated as MSal17 phage 
in this work. 
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Figure 5.23: MALDI-TOF MS spectrum of the constructed MSal17 phage. The peak 
assigned to the synthetic p8 (shown in Fig. 5.22) completely shifted with an increase in 
mass that corresponds to the 12-mer Salmonella-binding peptide (roughly 1680 Da). 
This peak is minor and badly resolved probably due to the low expression levels of the 
peptide on the phage.  
 
 
The MSal17 phage had the clear advantage of not needing any further chemical 
steps to be used in the previously described immunoassay. Therefore, after 
growing a stock of the MSal17 phage, this construct was readily tested in the 
LD-based biosensor. Interestingly, although there was an LD response when 107 
cells/mL were added (i.e. there was a drop in the phage LD signal when bacteria 
was added to the MSal17 phage, suggesting phage and bacteria were interacting), 
this was observable both with Salmonella and E. coli bacteria. This is not ideal, as 
it would mean the immunoassay is unspecific and would be useless with cocktail 
samples made of several bacterial species. Upon these results, an ELISA was 
designed to get some insight on the interaction between the constructed MSal17 
phage and bacteria. 
 
A scheme of the ELISA is shown in Fig. 5.24, and the method is described in 
greater detail in Chapter 2 (method 2.6.2). A 96-well microplate was coated with 
the bacteria – Salmonella enterica or E. coli – and incubated with MSal17 and 
wild-type phage. Anti-phage/HRP conjugate antibody was used as the detection 
element, and ABTS solution was added as the substrate. The absorbance at 410 
nm was then measured on a microplate reader. 
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Figure 5.24: Phage-binding ELISA. (Left) Illustration of the ELISA design, of a 
bacteria-coated well incubated with MSal17 phage. Detection by anti-phage/HRP 
conjugated antibody. (Right)  ELISA suggested wild-type phage had a minor 
interaction with both bacteria. The MSal17 phage seems to bind to the surface of 
Salmonella enterica Typhimurium, however, it also seems to non-specifically bind to E. 
coli. Data are mean values of three independent wells on the same ELISA plate; error 
bars represent standard deviation. 
 
 
As seen in Fig. 5.24, the ELISA suggested the constructed MSal17 phage might 
not be exclusively specific to Salmonella enterica, as it seems to have bound to the 
surface of E. coli bacteria as well. Another ELISA was set using three other 
Salmonella enterica serovars (Salmonella enterica Enteritidis, Salmonella enterica 
Infantis and Salmonella enterica Senftenberg) and E. coli, at a range of 
concentrations. The data collected are plotted in Fig. 5.25. 
 
 
  
 
 
 
 
 
 
 
Figure 5.25: Phage-binding ELISA to investigate MSal17 phage interaction with three 
Salmonella enterica serovars and E. coli. Salmonella serovars tested were Salmonella 
enterica Enteritidis, Salmonella enterica Infantis and Salmonella enterica Senftenberg, and 
E. coli was used as a control specie, since the Salmonella-binding peptide should not bind 
to it.  
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As shown in Fig. 5.25, although wild-type phage had some degree of non-
specific interaction with Salmonella enterica serovars, MSal17 phage substantially 
cross-reacted with E. coli bacteria. These data is consistent with the observed 
results on Fig. 5.24, further suggesting that the constructed MSal17 phage was 
not specific for Salmonella enterica bacteria. 
 
Replacing antibodies with bacteria-binding peptides would considerably drop the 
total cost of the existing biosensor, and it would simplify the bioconjugation 
protocols. Nonetheless, the MSal17 phage construct did not appear to be suitable 
for the LD-based biosensor (nor for the designed ELISAs). It is possible that the 
expression levels of the Salmonella-binding peptide on the surface of the phage 
were too low to produce a substantial and measurable difference on the LD-
based immunoassay. There are also some fundamental differences between this 
project and the work described in [30]. The exact sequence referred in [30] 
includes a flexible spacer followed by the Salmonella-binding peptide; this spacer 
was not included in the Msal17 phage construct. Although the use of the linker 
seemed to be related to manufacturing specification for phage display rather than 
for bacterial detection, it is possible this short amino acid linker would be 
advantageous to include in the MSal17 phage construct. The formulated 
hypothesis was that the Salmonella-binding peptide, cloned in the N-terminal of 
the synthetic p8, might be partially buried within the phage capsid, meaning 
some of the amino acids necessary for Salmonella recognition are in fact 
inaccessible. Furthermore, the work reported in [30] makes use of the 
Salmonella-binding peptide on its own, in contrast to have it displayed on the 
surface of the phage. The 3D conformational differences could have influenced 
the interaction between the binding-peptide and the Salmonella bacteria, and 
ultimately its affinity. 
 
Synthetic peptides, as the one described here, have been used as probes for 
microbial detection. There are several other peptide ligands with applications on 
the fields of food safety, environment monitoring and defense. These binding 
peptides could be displayed on the phage surface and be tested on the LD-based 
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assay for the detection of pathogens (Listeria monocytogenes [37,38], Pseudomonas 
aeroginosa [39], Salmonella spp. [40], Helicobacter pylori [41], Bacillus anthracis 
[42-44]). Moreover, biopanning for novel peptide sequences, targeting molecules 
of interest specifically to Linear Diagnostics’ biosensor, could be a relevant line of 
investigation to evaluate and expand on. 
 
5.2.5 Directional conjugation of antibodies to the surface of the phage by 
aldehyde-hydrazine chemistry  
5.2.5.1 Context 
One of the downsides of the protocol presented in Chapter 3 (Fig. 3.15) is the 
lack of control on the conjugation of the antibody to the phage surface. More 
specifically, the required step to maleimide-derivatise the antibodies prior to 
conjugation to the phage − this is achieved by a crosslinking reaction between the 
maleimide group from the SMCC (succinimidyl 4-(N-
maleimidomethyl)cyclohexane-1-carboxylate) reagent to the primary amines of 
the antibody. Antibodies have several amine groups in its structure, both in the 
Fab and Fc region (Fig. 5.26). Therefore, it is challenging, using this 
thiol/maleimide bioconjugation chemistry, to control to which amine on the 
antibody will the maleimide group get conjugated to, and hence, which direction 
the antibody will have once conjugated to the phage surface. Ideally, the 
bioconjugation chemistry will leave the antigen-binding site, essential for antigen 
recognition, intact. The thiol/maleimide bioconjugation protocol used by Linear 
Diagnostics does not allow for any control on the orientation of the antibodies 
on the phage – by not guaranteeing the antigen-binding site is available to 
interact with the target bacteria, the sensitivity of the biosensor might be 
compromised. Bearing this particular challenge in mind, an aldehyde-hydrazine 
chemistry protocol was devised. Aldehyde-hydrazine chemistry allows for 
directionality control of the conjugated antibody: instead of interacting with the 
dispersed amines, only the carbohydrates present on the Fc region of the 
antibody will be modified [45].  
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Figure 5.26: Simple illustration of a glycosylated antibody, highlighting some of its 
chemical groups. Light and heavy chains shown in red and blue, respectively. Amine 
groups are dispersed both in the Fab and Fc region of the antibody. Carbohydrate chains 
on glycosylated antibodies are linked only to the Fc region, away from the antigen-
binding site.  
 
 
 
5.2.5.2 Results and discussion 
A detailed protocol of the aldehyde-hydrazine bioconjugation is given in Chapter 
2 (method 2.4.2.2.2), and an illustration of this reaction is given in Chapter 3 
(Fig. 3.16). Firstly, the phage was treated with SANH (succinimidyl 6-
hydrazinonicotinamide acetone hydrazine), which modifies the primary amines 
of the p8 proteins to hydrazines. Then, the glycosylated antibody (e.g. anti-E. 
coli) was treated with sodium meta-periodate (NaIO4), which partially oxidises 
the Fc-linked carbohydrates, incorporating aldehyde groups. The hydrazine 
moieties on the phage are then reacted with the aldehyde-modified antibodies, 
producing a hydrazone conjugate. To our knowledge, this was the first time this 
bioconjugation method was used to conjugate antibodies to the phage’s surface. 
 
Quality control tests were implemented to confirm the successful modification of 
the phage and the antibody (step a) and step b), respectively, as indicated in Fig. 
3.16, Chapter 3). After modification of the phage with SANH, a colorimetric 
test using 4-nitrobenzaldehyde (p-NBA) confirmed hydrazine moieties were 
introduced to its surface (Fig. 5.27) (Chapter 2, method 2.9.1). The Purpald test 
(4-amino-3-hydrazino-5-mercapto-1,2,4-triazole) confirmed the presence of 
aldehydes on the oxidised antibodies (Fig. 5.28) (Chapter 2, method 2.9.2). 
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Figure 5.27: The 4-nitrobenzaldehyde (p-NBA) test on the SANH-modified phage. 
Absorbance was monitored to determine the levels of hydrazine incorporation on the 
phage. Colorimetric change, to yellow, can be tracked at around 390 nm. 5×, 10× and 
20× represent SANH molar excess over p8 proteins of the phage. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.28: Purpald test on glycosylated anti-E. coli antibody treated with 10 mM and 
1 mM NaIO4. NaIO4 oxidises the carbohydrates of the antibodies to aldehyde groups. 
The colour purple suggests the presence of aldehydes. 
 
 
The p-NBA test (Fig. 5.27) confirmed that hydrazine groups have been 
introduced to the phage capsid. The p-NBA test can be used to determine the 
amount of hydrazine moieties incorporated on the SANH-modified phage, by 
estimating the concentration of hydrazines in the sample (Chapter 2, method 
2.3.2). Phages modified with 10-fold SANH were estimated to have ~ 140 
hydrazine groups on their surface. A word of caution though, it was noticed that 
calculating phage concentration based on its absorbance at 269 nm could be an 
inaccurate approach. SANH, which normally absorbs at 320 nm, has its NHS 
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(N-Hydroxysuccinimide) group hydrolysed when conjugated to the phage 
amines [45]. This produces an absorbance peak shift to 260 nm, closely 
overlapping with the wavelength used to calculate phage concentration (269 nm) 
(Fig. 5.29). Therefore, there is a contribution of SANH to the UV-Vis 
absorbance of the SANH-modified phage, which would lead to an incorrect 
estimation of the amount of hydrazine groups introduced to the phage surface. 
The p-NBA test provided only with an approximation of the substitution level of 
hydrazine groups into the phage, and could be calculated more accurately by 
mass spectrometry.  
 
 
 
 
 
 
 
 
 
 
Figure 5.29: Monitoring of the absorbance peak shift of SANH. There is a peak shift, 
from 320 nm to 260 nm, over a period of 4 days, resultant from the hydrolyses of the 
NHS group in an aqueous buffer. 
 
 
 
5.2.5.2.1 Phage-antibody conjugate as a LD scaffold 
Before testing the phage-antibody conjugate on the biosensor assay, the samples 
were analysed on the LD. Surprisingly however, when comparing the LD 
spectrum of the SANH-modified phage (i.e. still not conjugated with the 
aldehyde-antibody) with the LD spectrum of the phage-antibody conjugate, a 
considerable drop in the overall LD phage signal was recorded (Fig. 5.30) 
(Chapter 2, method 2.8.2).  
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Figure 5.30: LD spectra of the (Left) SANH-modified phage, and of the (Right) 
phage-antibody conjugate. SANH-modified phage sample was diluted 10-fold prior to 
LD measurement; phage-antibody conjugate sample was measured without any dilution. 
5×, 10× and 20× represent the SANH molar excess over p8 proteins of the phage. 
 
 
The results in Fig. 5.30 suggest the phage lost its ability to properly align under 
flow, possibly indicating changes in its filamentous structure. Other experiments 
illustrated in this chapter demonstrated that changes to the phage high aspect 
ratio or to its surrounding environment were closely related to its LD signal 
(section 5.2.1; section 5.2.2). With that in mind, it was determined that the two 
more likely scenarios that could be linked to the decrease in phage alignment 
were either shredding of the phage into smaller, shorter particles, or aggregation 
between phages. Both these phenomena could be promoted by the 
bioconjugation protocol. Modifying the phage surface with SANH did not seem 
to negatively perturb its LD signal; however, it was possible the conjugation steps 
that followed were interfering with the phage structure. A pertinent observation 
was the formation of a gel-like structure while pelleting the phage-antibody 
conjugate. A gel precipitate, rather than a white pellet, suggested the 
hydrodynamic properties of the phage have changed possibly due to intra- and 
inter-phage associations. 
 
Because of the possibly damaging effect of aniline on the phage structure 
(personal communication, Dr. Dylan Domaille), an experiment simulating the 
last step of the bioconjugation protocol (i.e. overnight treatment with aniline 
incubated at 35 °C while mixing at 650 rpm) was replicated and plotted in Fig. 
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5.31. As shown, neither the incubation conditions nor the use of aniline seemed 
to have perturbed its LD signal. 
 
 
 
 
 
 
 
 
 
 
Figure 5.31: LD experiment to check whether aniline or the conditions used during this 
reaction (pH, temperature, speed of mixing) damaged the filamentous structure of the 
phage. (dashed black line) 0.5 mg/mL of SANH-modified phage in 0.1 M phosphate 
buffer pH 6 was left overnight at 4 °C. (solid black line) 0.5 mg/mL of SANH-modified 
phage in 0.1 M phosphate buffer pH 6 was incubated overnight at 35 °C, 650 rpm on a 
Thermomixer. (solid red line) 0.5 mg/mL of SANH-modified phage was treated with 
10 µl of 1 M aniline stock, in 0.1 M phosphate buffer pH 6 and incubated overnight at 
35 °C, 650 rpm on a Thermomixer. The reactions were then PEG/NaCl precipitated; 
the pellet was ressuspended in PBS buffer and measured on the LD.  
 
 
It was concluded that the aniline treatment interfered with the phage LD signal. 
The remaining option was the conjugation between the SANH-modified phage 
and the NaIO4 treated antibody. The phage-antibody conjugate was measured 
on the DLS (dynamic light scattering, Chapter 2, method 2.8.4) (Fig. 5.32) to 
get some insight on the size of the particles present on the samples. These results 
seemed to support the idea that the phage was aggregating, following 
conjugation with the treated antibody – there was an observable size shift from ~ 
60 nm to ~ 1000 nm, indicating large particles were present on the phage-
antibody conjugate sample. To confirm these findings, TEM images were also 
collected (Chapter 2, method 2.5.7). As shown in Fig. 5.33, it appeared the 
reaction between the SANH-modified phage and the NaIO4-treated antibody 
resulted in bulky aggregated conjugates, forming unexpected structures. This 
200 250 300 350
-0.05
0.00
0.05
0.10
0.15
Wavelength (nm)
LD
 (Δ
O
D
)
SANH-modified M13 in the fridge
SANH-modified M13 incubated but not treated with aniline
SANH-modified M13 incubated and treated with aniline
	  	   155	  
_________________________________________________________________"Chapter"5"
could explain the difference in the LD phage signal, since aggregated phage does 
not align as well as individual filamentous phage. 
 
 
 
 
 
 
 
 
 
Figure 5.32: DLS spectra of phage samples. Wild-type phage (black), 10-fold molar 
excess SANH-modified phage (red), phage-antibody conjugate (black dashed).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.33: TEM images of the phage-antibody conjugate. Phages seemed to be 
aggregating and assembling along their long axis (forming rope-like structures), or in a 
disorganised fashion forming bulky aggregates.  
 
 
The major factor contributing to aggregation and crosslinking between the 
phage-antibody conjugates was believed to be the conjugation step between the 
SANH-modified phage and the treated antibody. The conditions of the 
bioconjugation protocol were tuned – a range of concentrations of phage, 
antibody, SANH and sodium periodate were explored in independent assays. It 
was concluded, from LD data, that 1 mg of phage (modified with a ten-fold 
molar excess of SANH) conjugated to 250 µg of antibody (oxidised with 1 mM 
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NaIO4) while catalysed with 10 mM aniline, seemly did not promote as much 
aggregation between phages. The phage pellet was the usual white rather than a 
gel, suggesting the phages are not significantly aggregating using these 
conditions. A LD-based immunoassay (Chapter 2, method 2.8.2.2), shown in 
Fig. 5.34, was set using the constructed phage-antibody conjugate. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.34: LD-based immunoassay using the phage-antibody conjugate sample (i.e. 
oxidised anti-E. coli antibody conjugated to SANH-modified phage). Each LD 
measurement was repeated once, showing a similar trend. The assay was sensitive up to 
106 cells/mL. 
 
  
Fig. 5.34 shows an LD-based immunoassay for E. coli bacteria.  The phage-
antibody conjugate (SANH-modified phage conjugated with NaIO4 treated anti-
E. coli antibody) was sensitive to E. coli bacteria, which was illustrated by the 
drop in the phage LD signal compared with the phage LD signal when no 
bacteria or Salmonella (as a control) is added. Nonetheless, the achieved 
sensitivity to bacteria was not lower than 106 cells/mL, which is not an 
improvement to Linear Diagnostics’ current immunoassay (i.e. 105 cells/mL).  
 
An interesting behaviour was noticed when adding ethanolamine (25 µL of a 1 
M stock, pH 9.6) to the phage-antibody conjugate samples. Ethanolamine 
blocks unreacted aldehyde sites on the NaIO4 treated antibody. After 3 days, it 
was observed that the LD signal of a phage-antibody conjugate sample decreased 
when no ethanolamine was added, perhaps due to continuing crosslinking 
interactions between the unreacted aldehydes on the antibodies to the phages. 
Adding ethanolamine seemed to partially prevent this from happening, as the 
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LD signal of the phage-antibody conjugate with ethanolamine was relatively 
constant, suggesting these samples were more stable over time. This experiment 
seems to support the hypothesis that the antibody conjugation to the phage is a 
critical step on this protocol, and that inter-phage assembly and aggregation are 
occurring. Interestingly, from the TEM images on Fig, 5.33, it seems the phages 
are not only cross-linking into disorganised bulk aggregates, but also assembling 
along their long axis, with several phages interacting side-by-side. Typically, a 
glycosylated antibody has two carbohydrate chains on its Fc region, one at each 
side. Perhaps, this side-by-side interaction between several phages could be 
explained by a cross-linking phenomena occurring between the unreacted 
aldehyde groups of an antibody (already conjugated to a phage) to a different 
phage. By blocking the unconjugated aldehyde groups with ethanolamine, the 
aggregation that happens over time would be avoided. Logically however, using 
ethanolamine after conjugating the SANH-modified phage to the NaIO4 treated 
antibody, would only prevent aggregation that is occurring post-conjugation, and 
does not prevent aggregation that is already happening during the bioconjugation 
protocol. The above described reaction conditions, used for the immunoassay 
shown on Fig. 5.34, seemly did not promote aggregation between phages; 
however, it did not always result in homogeneous samples or successful 
immunoassays. Therefore, further optimisation of the bioconjugation protocol, 
more specifically titration of the optimal proportion phage/antibody, needs to be 
explored. To use the constructed phage-antibody conjugate on the LD-based 
immunoassay, aggregation (believed to be a consequence of the bioconjugation 
between the antibody and the phage) needs to be prevented – aggregated samples 
that are not homogeneous in solution have unknown and unpredictable 
rheological properties, which would naturally be reflected on their spectroscopic 
profile.  
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5.2.6 Magnetic beads purification method 
5.2.6.1 Context 
A more simplistic approach was to consider the immunoassay as it is (i.e. using 
the protocol described in Chapter 3), and reflect on reasons for the inability to 
make the immunoassay sensitive to a lower concentration of bacterial cells. 
Without modifying the chemical protocol established by Linear Diagnostics, one 
could consider the end product as it is: a chemically modified phage with 
antibodies conjugated to the p8 proteins.  
 
We hypothesised if there were free antibodies (i.e. unconjugated to the phage) in 
the immunoassay samples that could be compromising the sensitivity of the 
biosensor. To purify chemically modified bacteriophage samples, PEG 
precipitation [47] and desalting columns are commonly employed. PEG/NaCl 
precipitation and PD-10 columns are straightforward methods to purify phage 
particles without the need for complicated and time consuming techniques, such 
as dialysis or chromatography. However, it is likely unconjugated antibodies 
could be co-precipitating/co-eluting with the phage. It was considered that 
unconjugated antibodies in the immunoassay sample could pose a problem 
because they would interact with the added bacterial cells, which could 
compromise the overall sensitivity of the biosensor. To test this idea, a method to 
further purify the immunoassay sample was considered.  
 
5.2.6.2 Results and discussion 
Protein A conjugated magnetic beads have affinity for the Fc region of 
antibodies, which is a convenient feature for several immunoprecipitation and 
protein pull-down assays. Protein A immobilised onto surfaces is the commonly 
used method for purifying monoclonal antibodies from cell culture supernatants 
[48]. These magnetic beads could be a simple and fast strategy to purify the 
immunoassay samples from unconjugated antibody. A detailed protocol on how 
this was done is given in Chapter 2 (method 2.10.2). 
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The immunoassay samples (i.e. p8 proteins of the phage functionalised with 
antibodies, anti-Salmonella or anti-E. coli, as illustrated in Chapter 3) were tested 
on the LD-based biosensor as usual. An aliquot of the magnetic beads was added 
to each of the immunoassay samples and left mixing on a rotor for about an hour. 
A magnet was used to precipitate the beads, and the supernatants (i.e. the 
purified immunoassay samples) were collected. Both the magnetic beads and the 
supernantants were analysed – the supernatants were tested on the LD-based 
biosensor and the beads were analysed on a silver stained SDS-PAGE.  
 
The purified samples were tested on the LD-based biosensor. The LD results 
obtained from before and after purifying the immunoassay samples with the 
magnetic beads were then compared, as shown in Fig. 5.35.  
 
 
 
 
 
 
 
 
Figure 5.35: Phage-antibody conjugates before and after purification with magnetic 
beads. Four immunoassay samples (i.e. phage conjugated with antibodies along its p8 
proteins) were tested on the LD-based biosensor, before and after purification with 
magnetic beads, at a range of bacterial concentration. a) and b) show the LD signal at 
225 nm for two samples of anti-Salmonella phage. c) and d) show the LD signal at 225 
nm for two samples of anti-E. coli phage. 
 
 
Each data point on the plots of Fig. 5.35 represents the LD phage signal from 
the immunoassay samples at a range of bacterial concentrations (107–104 
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cells/mL). The immunoassay sample is considered to be sensitive to a certain 
bacterial concentration if the phage LD signal is lower than the phage LD signal 
when using the control bacteria. The most important observation from these data 
is that using the magnetic beads to purify the immunoassay samples did not seem 
to improve the sensitivity of the biosensor (i.e. lower concentrations of bacteria 
did not seem to have any effect on the phage overall alignment, not reducing its 
LD signal). The tested samples had a sensitivity of 105–106 cells/mL, which did 
not change by introducing the magnetic beads. It seemed the extra purification 
step was rather inconsequential to the performance of the immunoassay samples. 
 
To get some further insight, the magnetic beads used to purify the immunoassay 
samples were analysed on a SDS–PAGE. For this, the magnetic beads were first 
exposed to an elution protocol, to release the material that got attached to the 
beads, following manufacturer’s instructions. The magnetic beads were washed in 
PBS buffer, using a magnet to capture the beads between washes. This washing 
solution was kept, and analysed on the gel (lanes labelled as “SN sample”). The 
beads were then soaked in Laemmli buffer and incubated for 20 minutes at 70 
°C. The beads were captured using the magnet, and the eluted material was 
collected. The eluted samples were loaded onto the SDS-PAGE, under 
denaturing and reducing conditions, and run as usual (Chapter 2, method 2.7.2). 
The SDS–PAGE was then silver stained (Chapter 2, method 2.7.2.1). Fig. 5.36 
shows a picture of the result. 
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Figure 5.36: Silver stained SDS–PAGE of the eluted magnetic beads. Anti-Salmonella 
phage (sample a) and b); phage chemically conjugated with antibodies against 
Salmonella) and anti-E. coli phage (sample c) and d); phage chemically conjugated with 
antibodies against E. coli) were the four immunoassay samples tested on this experiment. 
The label “SN sample” represents the washing supernatant from the respective samples.  
 
 
 
At first glace, looking at the gel in Fig. 5.36, it seemed plausible to assume that 
the magnetic beads captured unconjugated antibodies in the immunoassay 
samples. The eluted samples from the beads showed two bands on the gel, at 50 
kDa and around 25 kDa, which we thought corresponded to the heavy and light 
chains of the antibodies, respectively. There was also a band at the bottom of the 
gel which initially was assigned to be aggregates of unconjugated AF647 dye in 
the immunoassay samples collected by the beads (which would be consistent with 
the observed fainter colour of the immunoassay samples after the purification 
protocol). However, there is the possibility that the bottom band is, in fact, 
derived from p8 proteins. The beads could have collected the modified phages in 
the samples, either non-specifically or by interacting with the antibodies 
conjugated to its surface. The 50 kDa and 25 kDa bands, which were initially 
assigned to be part of the antibodies, are also visible in gels from phage samples, 
so it is difficult to assign without a doubt that these bands derive from captured 
and reduced antibodies. A definite answer could be provided by excising, 
digesting and analysing the protein bands by mass spectrometry. A simpler 
option could be to test two control samples: one sample in which the magnetic 
beads are mixed with unmodified phages, and another sample in which the 
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magnetic beads are mixed with unconjugated antibody. The magnetic beads 
would then be handled as before, and the eluted samples would be analysed on a 
silver stained gel. This should help assign the bands, and clarify on their origin. 
Furthermore, it would give an indication to whether or not the phage is 
unspecifically binding to the beads or if this is caused by the antibodies 
conjugated to its surface. If the latter was observed, this would further confirm 
there are antibodies conjugated to the phage surface.  
 
This particular magnetic beads purification assay did not provide with a 
conclusive answer to whether or not unconjugated antibody in the immunoassay 
samples significantly compromises the sensitivity of the biosensor. The LD-
based immunoassay on the tested samples was not improved by adding magnetic 
beads to the samples, but we are unsure if that was derived from an ineffectively 
purification method. However, if we were to assume the magnetic beads did not 
capture antibodies from the immunoassay samples, it would be indicative that 
only a small amount of unconjugated antibody must be present in the 
immunoassay samples, suggesting this must not be a factor limiting the 
sensitivity of the LD-based biosensor. If unconjugated antibodies were proven to 
be present on the immunoassay samples, there is a strong argument for 
comprehensive purification methods, which might include size exclusion 
chromatography. The His-tagged phage (Chapter 3) could be an alternative to 
circumvent this issue and avoid the need for further purification steps, as it would 
enable capturing and elution of mostly the His-tagged chemically modified 
phage particles.  
 
 
5.3 Conclusion 
The startup company Linear Diagnostics Ltd. built a diagnostic platform by 
incorporating LD spectroscopy with an immunoassay design, using filamentous 
phage particles as scaffolds. This pathogen detection biosensor explores 
differences in spectroscopic signal, elucidating on the presence of a given target 
of interest. One major drawback of the current biosensor is its sensitivity, with 
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the limit of detection being of the order of the 105 bacterial cells per milliliter of 
sample, making it incompatible for most clinical applications. The development 
of new methods to modify the phage surface was aimed at cutting on costs and 
time, and on increasing the sensitivity, simplicity and versatility of Linear 
Diagnostics’ platform. 
 
In this chapter, several examples of genetic and chemical engineering to the 
phage surface were illustrated, directed at improving an LD-based biosensor. 
Longer phage particles can be grown by inserting DNA fragments into the viral 
genome; nonetheless, it seems none of the existing phage-based biomaterials 
explore this feature. In here, we designed and successfully integrated longer 
mutant phages with a biosensing platform. However, it was noticed that these 
particular genetic constructs were unstable and unpredictable. An alternative 
method that does not require inserting large fragments of DNA could be 
explored; for example, removing the positively-charged lysines on the phage coat 
has been shown to result in a less tightly packed viral genome, which in turn 
originates phages with longer capsids [49]. To enhance the natural intrinsic 
fluorescence of the filamentous phages and explore it in a biosensor platform set-
up, an extra tryptophan was mutated onto the phage surface. This is another 
example of a rationally designed biological system that shows the genetic 
engineering of the phage may not be straightforwardly integrated with 
spectroscopy-based techniques. To simplify the method to label the phage 
surface with molecular recognition elements (i.e. antibodies), a mutant phage 
with a cysteine on its p8 proteins (V31C phage) and a phage expressing a 
bacteria-binding peptide (MSal17 phage) were designed. The V31C phage did 
not seem to respond to bacteria on the LD-based immunoassay, which led us to 
hypothesise the conjugation of antibodies to the surface of the phage was not 
efficient and might be compromised due to a steric hindrance effect. 
Modifications to a more exposed region of the p8 protein (i.e. lysine 8) seem to 
label more efficiently. With that in mind, a different design to include cysteines 
on the phage surface was envisioned. Although not described in this thesis, we 
successfully engineered a mutant phage with a cyclic-cysteine on the N-terminal 
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of its p8 proteins. To avoid excessive reactivity and cross-linking between phages, 
these cysteines were designed to be “locked” in disulfide bridges until a reducing 
agent is added. If steric hindrance was in fact the cause for unsuccessful 
conjugation of antibodies to the V31C phage, we imagined the cyclic-cysteine 
phage construct could be explored as an alternative. Replacing antibodies with 
bacteria-binding peptides would primarily decrease the costs of the immunoassay 
and completely eliminate the need for any bioconjugation protocol to modify the 
phage surface. Although the chosen Salmonella-binding peptide phage construct 
did not appear to work for our specifications, there are a vast number of other 
peptide ligand options that could be explored. We also trialled a hydrazine-
aldehyde bioconjugation protocol for the oriented immobilisation of antibodies 
onto the phage surface. Although we showed we could integrate this method 
with the LD-based immunoassay, we did not observe an improvement to the 
current sensitivity of the biosensor. Moreover, it was noticed that these phages 
had the tendency to self-assemble into bulk structures, creating intriguing gel-
like materials, which ultimately meant we were dealing with an unpredictable 
and non-homogeneous system. Other chemical functionalities could be explored 
by click chemistry [50] (e.g. azide-alkyne click chemistry). This approach could 
facilitate higher yields of conjugation of biomolecules to the phage, possibility 
positively affecting the sensitivity of the LD-based immunoassay. Another tactic 
to control the orientation of the antibodies within the phage surface could be to 
genetically introduce a Z-domain onto the p8 proteins [51-54]. The Z-domain 
is an immunoglobulin-binding protein that specifically binds to the Fc region of 
antibodies, facilitating conjugated antibodies with unrestricted antigen-binding 
regions. Cloning a Z-domain into the p8 protein would create a simple 
attachment point to antibodies, without the need for bioconjugation protocols. It 
was also considered that unconjugated antibody present in the immunoassay 
samples could be compromising the sensitivity of the biosensor. A purification 
method using magnetic beads was attempted, possibility suggesting free 
antibodies are not the limiting factor of the immunoassay.  
 
	  	   165	  
_________________________________________________________________"Chapter"5"
These experiments highlight the importance of carefully choosing how to 
engineer the filamentous phage, as the modifications may not be practical for the 
intended application and efficiently integrated with the planned analytical 
method. Genetic modifications to the phage proteins could replace the need for 
costly and lengthy chemical protocols; however, care must be taken to ensure the 
engineered mutations do not interfere with phage stability. Chemoselective 
approaches are normally simpler to design; on the other hand, batch-to-batch 
variability between different phage preparations makes it challenging to 
guarantee and control chemical modifications to the phage capsid. An 
integration of both systems would be ideal, enabling a plug-and-play phage-
based platform, which could be designed for applications on the biosensors field. 
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CHAPTER 6 – General conclusion 
 
 
Since it was first discovered, 102 years ago, bacteriophage has been of great 
interest to the scientific community, due to their remarkable simplicity in an 
otherwise complex biological environment. Particularly, phages were the seed to 
understanding key biological phenomena, laying the foundations for pioneering 
work in molecular biology. The filamentous bacteriophage, named this way 
because of its ~ 900 nm fibre morphology, became preeminent as a 
programmable biological entity, creating the possibility for building unique 
biomaterials with multiple nanotechnology applications. An example is the use of 
filamentous phages as biorecognition elements and scaffolding templates, in 
biosensor platforms. 
 
The focus of this work was on exploring phage surface modifications that could 
be integrated with biosensing platforms. Filamentous phages are a robust and 
versatile nanomaterial, tolerating both chemical and biological modifications. We 
made use of these features to tune the phage surface to our purposes, by either 
chemically and genetically modifying its proteins in a site-specific fashion, 
without disrupting their functionality. Filamentous phages, such as the M13 and 
the fd phage, have five structural proteins, but in this thesis only two of these 
were manipulated – the p8 protein, the major coat protein that covers the length 
of the phage, and the p3 protein, a minor coat protein at one end of the phage. 
We explored modifying these proteins in several different ways, as presented in 
Chapter 3. In this work, the p8 proteins of the phage were labelled with dyes, 
which is an important step for microscopy and spectroscopy-based techniques. 
The amine groups of the p8 protein were also modified to conjugate antibodies 
and to incorporate DNA molecules, which can be integrated into biosensing 
platforms. The p3 protein was modified to attach phages to surfaces by one-end 
only. In here, we attempted three methods to anchor phage particles to a surface, 
which enabled the design of a novel imaging platform, as described in Chapter 4.  
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The glycocalyx and wall shear stress (WSS) are known to be involved in 
cardiovascular dynamics, and therefore a better understanding of their 
physiological role could provide key information on vascular diseases. Chapter 4 
proposes a novel method to study the glycocalyx and WSS using a simple 
microfluidics design. For this, phage particles were fluorescently labelled, 
anchored to a surface and tracked under a microscope. The modified phage was 
first observed on a flat collagen-coated surface, and then tested on the surface of 
an endothelial cell (i.e. the cells that line the blood vessels). The data collected 
using our phage construct allowed us to estimate the local WSS at a non-
uniform surface, which is related to cells’ topography. To expand on this work, 
the developed fluorescent phage construct will be anchored to the wall of a blood 
vessel during in vivo experiments. 
 
We have also collaborated with the startup company Linear Diagnostics Ltd., 
which built a LD-based biosensor for the detection of pathogenic bacteria. This 
biosensing platform, which was designed as a portable device, is based on the 
phenomenon of linear dichroism and exploits the filamentous structure of the 
phage. In Chapter 5 we explored ways to improve and enhance the application of 
the filamentous phage as a recognition element in a spectroscopy assay. For this, 
we developed alternative methods to tune the phage surface either by genetic 
engineering or chemical modifications, envisioning increasing the sensitivity and 
simplicity of the current biosensing platform. Longer phage mutants were 
successfully grown and for the first time integrated with fluorescence and 
absorbance spectroscopic techniques. A phage containing an extra tryptophan 
was also designed, however we show that the fluorescence of this mutant was not 
as we expected, probably as a result of contact quenching between neighbouring 
tryptophan residues. A Salmonella-binding peptide was cloned to the surface of 
the phage as a possible replacement to the use of antibodies and, however we 
report this phage construct did not seem to be specific to the intended 
pathogenic bacteria, it illustrates the simplicity of phage cloning. Another 
example of this was the use of the V31C phage, containing a mutated version of 
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the p8 protein that includes a cysteine residue, as an alternative to bioconjugation 
modifications to the phage surface. An aldehyde-hydrazine bioconjugation 
protocol, for the directional conjugation of antibodies to the phage, was 
integrated with the LD-based immunoassay. Interestingly, we unintendedly 
made a gel-like phage material, which we believed was triggered by phage 
aggregation. We also attempted a purification method, using magnetic beads, 
which led us to the conclusion that is unlikely for unconjugated antibodies to be 
the cause for limited sensitivity of the LD-based immunoassay.  	  
Evaluated as a multi-million pound market, biosensors have a range of 
applications in medicine, pharma, defense and security, food safety, and 
environmental monitoring. The increased demand for portable and simple point-
of-care platforms makes it of paramount importance to explore biological 
elements that are inexpensive and easy to produce in mass, and that can be 
integrated with microfluidic devices. As demonstrated in this thesis, filamentous 
phages are an attractive scaffold for biosensors. By building a toolkit of 
engineered phages, we hope we will be able to further target this market and 
contribute for its expansion. 	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Appendix  
Publication: “Direct detection and measurement of wall 
shear stress using a filamentous bionanoparticle”  	  
